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Chromatin remodelling is a crucial nuclear process affecting replication, transcription and 
repair. Global reduction of DNA methylation is observed in Immunodeficiency-Centromeric 
Instability-Facial Anomaly (ICF) syndrome. Several proteins were found to be mutated in 
patients diagnosed with ICF, among them are LSH and CDCA7. LSH is a chromatin remodeller 
bearing homology to the members of Sf2 remodelling family. A point mutation in its ATPase 
lobe was identified in ICF. CDCA7 is a zinc finger protein that was recently found to be crucial 
for nucleosome remodelling activity of LSH. Several point mutations in its zinc finger domain 
were described in ICF patients.  
In vitro and in vivo studies have shown that LSH-/- phenotype demonstrates reduction of 
global DNA methylation, implying that chromatin remodelling LSH functions may be required 
for the efficient methyltransferase activity, linking this finding to ICF phenotype.   
Here, the LSH-mononucleosome interaction was explored in vitro using bioinformatics, 
biochemical, biophysical and structural techniques. LSH purification was further optimised, 
achieving near 100% purity, which is a useful improvement for any potential structural 
studies. LSH has been found to interact with the mononucleosome in vitro and no DNA linker 
was required for this interaction, indicating that LSH binds to the nuclesomal core through 
its ATPase domain. Qualitatively estimated Kd for this interaction was in nanomolar region, 
which did not translate into complex detection during size exclusion chromatography.  
CDCA7 was expressed in insect cell system and semi-purified, however, high nucleic acid 
presence in the final protein sample precluded any potential studies of CDCA7 interaction 
with chromatin.  
Homology and ab initio modelling for LSH and CDCA7, respectively, indicated that LSH is likely 
to bind the superhelical location 2 (SHL2), however, the exact location of CDCA7 and its 








LAY SUMMARY  
Genetic information in living organisms is stored in a molecule called DNA. Being a long 
molecule, DNA required a special organisation within the cell nucleus. Specialised proteins 
called histones form a structural basis for DNA storage. Together, DNA and histones form 
structures called nucleosomes. Nucleus-wide DNA-histone mass is termed chromatin. 
Dynamic properties of chromatin in the nucleus are ensured by a specific class of proteins 
termed chromatin remodellers. LSH is a putative chromatin remodeller. A protein called 
CDCA7 is likely to be crucial in ensuring the remodelling activity of LSH. When mutated or 
truncated, LSH supposedly loses its remodelling activity and is implicated in a rare genetic 
disease called Immunodeficiency, centromeric instability, facial anomaly (ICF) syndrome. 
CDCA7, when mutated, is also implicated in ICF syndrome, indicating that they participate in 
a common process associated with chromatin remodelling. Here, work has been done to 
elucidate the mode of LSH-nuleosome interaction. Furthermore, initial work has been carried 
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1.1 Chromatin organisation and modifications of DNA and chromatin 
 
1.1.1 DNA and chromatin  
DNA is a molecule that acts a universal carrier of genetic information across biological 
species. Structural characteristics of DNA conformation and organisation define the modes 
of gene expression. At the most basic level DNA exists in three forms: A, B and Z. The most 
common forms, A-DNA and B-DNA are both right-handed double helices, with B-DNA being 
the most common native cellular form and A-DNA predominating in dehydrating 
experimental conditions. Z-DNA is the least common form, having a left-handed orientation 
and a zigzag geometry that is formed by alternating purines and pyrimidines (Berg et al., 
2002).  
The helical topology of DNA forms major and minor grooves, which serve as binding 
interfaces for proteins and small molecules (Fratini et al., 1982; Heinemann et al., 1992). The 
major groove is the preferred site for transcription factor binding (Pabo and Sauer, 1984), 
however, certain proteins (e.g. the AT-hook motif-containing proteins) and antibiotics and a 
DNA fluorochrome Hoechst bind to the minor groove (Pjura et al., 1987).  
DNA is organised differently in prokaryotes and eukaryotes. Since prokaryotes do not contain 
the nucleus, they solve the problem of storing their large DNA molecule (around 0.5-10 Mbp) 
by compressing it through supercoiling into the nucleoid area via the action of the proteins 
HU and topoisomerase I (Boubrik et al., 1991; Siedlecki et al., 1983).  
Eukaryotic genomes have the advantage of being stored inside the nucleus, where DNA is 
packaged into nucleosomal subunits. Each nucleosome consists of DNA and the histone 
octamer - a protein heterocomplex consisting of pairs of four histone proteins H2A, H2B, H3 
and H4. The histones form a disk-like structure termed the octamer, which accommodates 
roughly two gyres of DNA (the total of 146-147 bp) in around 1.7 turn (Luger et al., 1997a). 





Figure 1.1 Mononucleosome architecture. A) A mononucleosome X-ray structure adapted from Luger 
et al. 1997 (PBD ID 1AOI). DNA is shown as sticks and ribbons. H2A – orange, H2B – red, H3 – blue, 
H4 – green. B) A schematic representation of a mononucleosome bound to H1 histone (from Cell 
Biology, 3rd edition 2017  (Johnson et al., 2017)). 
Neighbouring nucleosomes are connected via linker DNA of around 40-50 bp that protrudes 
from either side of the nucleosome. Cryo-electron microscopy studies showed that linker 
DNA provide a characteristic zigzag pattern in chromatin compaction (Bednar et al., 1998). 
Compaction is assisted by the accessory H1 histone that binds roughly at the nucleosome 
dyad symmetry axis between two linker DNA fragments (Fig. 1.1) (Johnson et al., 2017).  
 
1.1.2 Histones and nucleosomes 
In vitro experiments helped to elucidate histone octamer formation (Luger et al., 1997a). At 
high ionic strength (~2 M NaCl) histones form an octamer, whereas at physiological ionic 
strength (~150 mM) they exist as stable aggregates of H2A-H2B dimers and H3-H4 tetramers 
in the absence of DNA or as the octamer in the presence of DNA (Luger et al., 1997a). The 
H3-H4 tetramer is juxtaposed with the dyad axis, whereas the H2A-H2B dimers are situated 
on the side of the octamer disk opposite the dyad axis (Luger et al., 1997a) (Fig. 1.1). The 
Stability of the octamer is determined by the interaction between the histones. Each histone 
has a characteristic folding of its three alpha-helices, which are connected by two loops (L1, 
L2). Each heteromeric L1L2 interaction site serves as a DNA contact location (Luger et al., 




Figure 1.2 L1L2 loops of histones contacting DNA. A) H2A-H2B dimer (orange and red, respectively). 
B) H3-H4 dimer (blue and green, respectively). 
Histones have highly positive net charges with pI around 9-10 allowing them to tightly 
interact with negatively charged DNA at physiological conditions. DNA-histone octamer 
affinity measurements depend on multiple factors. Apart from salt concentration, 
temperature, nucleosome particle concentration and histone variants are other 
determinants of DNA-octamer affinity (Ausio et al., 1984; Jin and Felsenfeld, 2007; Yager and 
van Holde, 1984). Energetics studies with 5S ribosomal RNA gene and alpha-satellite DNA 
sequence involving electrophoretic mobility shift assay (EMSA) and velocity sedimentation 
studies, demonstrated Kd at picomolar concentrations (Gottesfeld and Luger, 2001). 
One of the common DNA sequences used in structural studies of the nucleosome is the 601 
Widom sequence (P.T Lowary and Widom, 1998) that was identified by the SELEX (Systemic 
Evolution of Ligands of EXponential enrichment) technique. The relative free energy (ΔΔG) of 
DNA binding to the histone octamer compared to 5S RNA gene was -2.9, indicating that the 
601 Widom sequence would have an affinity in the low picomolar range. The high stability of 
such recombinant nucleosomes making them a popular choice for structural studies. 
The net charge of the nucleosome depends on the DNA fragment. It was estimated that the 
octamer, despite positively charged histone N-termini, would also carry a significant portion 
of negative charge (214 positive charges, 72 negative charges based on the positively and 
negatively charged amino acids in the histone octamer). This would not completely offset 
highly negative charge of DNA (310 negative charges for a 155 bp DNA fragment) (Bertin et 
al., 2007), making the nucleosome overall negatively charged with asymmetrical positively 
and negatively charged patches on the histone octamer.  
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One of the important functional regions of the nucleosome is the acidic patch consisting of 
eight acidic residues located in the histones H2A (E56, E61, E64, D90, E91, E92) and H2B 
(E102, E110) (Kalashnikova et al., 2013). This cluster interacts with residues 16-24 of the H4 
tails of the neighbouring nucleosome (Luger et al., 1997a), therefore participating in 
chromatin compaction (Fan et al., 2004), as well as with several nucleosome-interacting 
proteins (Armache et al., 2011; Barbera, 2006; Makde et al., 2010; Roussel et al., 2008).   
 
Figure 1.3 A mononucleosome X-ray structure adapted from Luger et al. 1997 (PBD ID 1AOI) showing 
the location of the acidic patch (H2A (E56, E61, E64, D90, E91, E92) and H2B (E102, E110)) (in 
magenta). DNA is shown as sticks and ribbons. H2A – orange, H2B – red, H3 – blue, H4 – green. 
 
1.1.3 Histone tails and their modifications 
Molecular dynamics simulations demonstrated that histone tails can affect the overall 
structural stability of the nucleosome, with truncated tails of H2A and H3 introducing 
structural changes to the histone core (Biswas et al., 2011).   
Histone tails modifications is an important mechanism of epigenetic regulation. Histone N-
terminal tails carry positive charges due to the abundance of lysines and arginines. This 
property also makes them a convenient site for numerous covalent post-translational 
modifications (PTMs).  Acetylation is one of the most abundant PTMs, examples include 
H3K9, H3K14, H3K18, H4K5, H4K8 and H4K12 (Kouzarides, 2007). Those modifications act by 
5 
 
neutralising positive charges and are generally associated with transcriptionally active 
chromatin, enhancers and gene promoters (Wang et al., 2008). Along with acetylation, 
phosphorylation of H3S10 is also involved in charge neutralisation of histone tails and is 
correlated with chromatin condensation in mitosis and meiosis (Wei et al., 1998).  
Positively charged residues are also the sites for mono-, di- or tri-methylation. Bulky methyl 
groups may add local structural variations or act as a binding site for chromatin-interacting 
proteins. For instance, H3K9 methylation was shown to be the binding site for 
heterochromatin protein 1 (HP1) (Bannister et al., 2001). Ubiquitylation, due to addition of a 
large group, may affect nucleosomal conformation and introduce disruptions into intro- and 
internucleosomal interactions (Kouzarides, 2007).  
 
1.1.4 DNA methylation 
DNA is another chromatin site that undergoes methylation, wherein a methyl group is 
transferred from S-adenyl methionine to the fifth carbon of a cytosine forming 5 methyl-
cytosine (5mC) (Moore et al., 2013) predominantly on CpG dinucleotides (Bird, 1980). 
Nucleosomal DNA is protected from methylation, therefore, linker DNA is the main target or 
methyl group transfer (Felle et al., 2011). There are two types of DNA methylation: de novo 
and maintenance. De novo methylation is catalysed by two methyltranferases DNMT3A and 
DNMT3B, which modify DNA during embryonic development. These methylation patterns 
are stable and are crucial for gene imprinting, X chromosome inactivation and silencing of 
repetitive elements, with disruption of this mechanism implicated in numerous diseases 
(Gopalakrishnan et al., 2008; Jin et al., 2011).  
 
1.2 Chromatin remodelling  
1.2.1 ATP-dependent chromatin remodelling  
Enzymes utilising the energy from ATP hydrolysis are one of the most prominent actors in 
the chromatin metabolism. They confer a variety of outcomes in chromatin remodelling such 
as DNA unwrapping, nucleosome sliding, histone variant exchange and nucleosome eviction 




Figure 1.4 Schematic representation of possible functions of ATP energy-utilising chromatin 
remodelling complex. They include DNA unwrapping, nucleosome slinding, histone variant exchange 
and nucleosome eviction. All these actions affect accesibility of DNA to various DNA-binding proteins 
(DBPs), such as transcription factors (TFs), polymerases (pol) etc.  
 
The chromatin remodellers share a common RecA-like domain. The RecA protein is found in 
E. coli and is involved in DNA recombination (Clark and Margulies, 1965). In the centre of the 
RecA-like domain is a β-sheet with α-helices on each side (Ye et al., 2004). Lobe 1 contains a 
Walker A motif (or P-loop) containing a highly conserved motif A/GxxxxGKT/S, where x is any 
amino acid (Ye et al., 2004). The P-loop is responsible for the γ-phosphate coordination 
during ATP hydrolysis. The Walker B motif is located downstream from Walker A motif and 
contains the sequence hhhhDE, where h is a hydrophobic residue (Hanson and Whiteheart, 
2005). The ATP hydrolysis mechanism is as follows: the γ-phosphate is coordinated by 
arginines or lysines and the attacking water molecule is polarised by aspartates or glutamates 
(Ye et al., 2004). The transition state stabilisation also requires a Mg2+ (Ye et al., 2004). An 
ATP molecule is primarily bound to the lobe 1, however, hydrolysis requires participation of 
the lobe 2, and the interaction between the two lobes requires critically but not exclusively 
a presence of “arginine fingers” (Ye et al., 2004).  
Most commonly, chromatin-remodelling enzymes function as a part of large multisubunit 
complexes, wherein accessory subunits specify the targeting and functionality of the enzyme. 
7 
 
The most commonly accepted classification separates the chromatin remodelling enzymes 
into 4 groups according to the similarity of the accessory domains flanking the ATPase core 
and the remodelling outcome. These are: SWI/SNF (SWItching defective/Sucrose-Non-
Fermenting), ISWI (Imitation SWItch), Chromodomain-Helicase DNA binding (CHD) and 
INOsitol requiring 80 (INO80). Roughly, their functionalities correspond to the following 
areas: SWI/SNF primarily have a role in chromatin access, as the ATPase faces moderate 
inhibition from the accessory domains and is able to carry out octamer eviction and 
nucleosome unwinding; more controlled ATPases of ISWI and CHD provide the basis of 
forming pre-nucleosomal complexes and regularly spaced nucleosomal arrays; and INO80 is 
capable of nucleosome editing, wherein histone variants can be evicted and exchanged 




          
Figure 1.5 Helicases classification. A) Helicases at superfamily, family and subfamily levels. B) Rooted 
tree from hidden Markov model (HMM) on the basis on full length alignments of the helicase 
regions. Adapted from Flaus et al. 2006.  
 
 
Figure 1.6 Schematic representation of the domains in each subfamily of chromatin remodellers. HSA 
– helicase-SANT–associated domain; SnAC – Snf2-ATP coupling domain; Bromo - bromodomain; 
AutoN and NegC – ISWI regulatiory domains ; HSS - HAND–SAND–SLIDE domain; Chromo - 




1.2.2 Modes of DNA translocation 
The RecA-like lobes of the ATPase subunit are at the core of DNA translocation mechanism 
by chromatin remodellers. The two lobes act like “mittens” sequentially grabbing and 
releasing the DNA double helix via its backbone atoms, appearing as an inchworm-like 
processive movement along the DNA double helix. When this action is fixed from the 
remodellers’ perspective, this inchworm-like movement translates into pumping the DNA 
helix uni-directionally towards the nucleosome dyad. This movement results in DNA 
displacement from the-histone octamer and DNA translocation along the histone octamer 
surface, thus relaxing chromatin or exposing the DNA sites previously blocked by the contact 
with the nucleosome.  
A series of experiments with optical tweezers provided the first evidence of DNA 
translocation and DNA loop formation by the SWI/SNF subfamily members.  Optical tweezers 
are a well-established biophysical technique, where a DNA molecule is fixed between two 
polystyrene beads, one of which is attached to a force-measuring optical trap (dynamic) and 
the other is held by a pipette tip by suction (stationary). The force of DNA extension is 
translated into the movement of the optical trap using a laser and recorded using a charge-
coupled camera. The reduction in distance between the two ends of DNA may indicate 
formation of a loop. The optical tweezers experiments showed that a DNA loop could only 
form when a nucleosome, SWI/SNF complex and ATP were present (Zhang et al., 2006), 
indicating that the loop forms as an extension from the nucleosomal DNA, and effective 
remodelling requires nucleosomal context. Formation of the loop introduces a DNA torsion 
with accumulated energy, which subsequently translates into the loop relaxation, with the 
subsequent DNA rebound and translocation around the histone octamer. This remodelling 
behaviour was also found to be processive, as the complex could disengage from the 
nucleosome after a series of translocations (Zhang et al., 2006).  
The efficiency of remodelling is ensured by the nucleosome context and the remodeller’s 
accessory subunits, as demonstrated by comparison of a full RSC complex and its minimal 
version containing the ATPase core (Sirinakis et al., 2011). Expectedly, the full complex 
appeared to be more potent and less mobile than the minimal complex, however, the 
minimal complex was still capable of DNA translocation and even binding of free DNA.  The 
bend already present in a nucleosomal DNA was shown to be an energy-saving factor or a 
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store of energy that contributes to remodelling once released, as the minimal motor had to 
dispense its energy to bend the free DNA (Sirinakis et al., 2011). By anchoring to the 
nucleosome, the complex can exert the remodelling activity through a force sufficient to 
disrupt DNA-histone contacts. The complex was able to generate up to 30 pN of force, which 
exceeds the typical forces required to disrupt the DNA (~23 pN) (Sirinakis et al., 2011). This 
powerful movement was, however, susceptible to stalls when gaps were introduced to the 
DNA sequence (Harada et al., 2016).  
Fluorescent resonance energy transfer (FRET) is a powerful technique to study the behaviour 
of chromatin remodellers. It allows detection of the distance between two fluorophores 
conjugated at different locations on a nucleosome, e.g. green fluorescent protein (GFP) on a 
histone and red fluorescent protein (RFP) on the DNA terminal. A laser then excites GFP, and 
if RFP is located at a close enough proximity at this point (1-10 nm) and the spectra of the 
fluorophores overlap, the energy from GFP will be transferred to RFP. The transferred energy 
is measured using various approaches (sensitised emission, acceptor photobleaching, 
spectral imaging, anisotropy imaging), allowing nucleosome dynamics to be dissected in 
great detail, such as 1-2 bp step size per 1 hydrolysed ATP molecule (Saha et al., 2005), which 
confirmed the earlier findings from optical tweezer experiments (Sirinakis et al., 2011).  
The triple-helix strand displacement assay of RSC interaction with the octamer confirmed the 
processive movement of RSC along the DNA strand. This assay relies on the Hoogsteen base 
pairing interaction between a double-stranded DNA and a third helix of homopurine-
homopidimidine repeats (Kopel, 1996). This interaction is weak enough for the third helix to 
be displaced by the processive movement of the remodeller. Furthermore, RSC was shown 
to be capable of interaction with a single-stranded DNA, indicating that this processive 
movement requires the interaction with only one strand (Saha, 2002). The outcome of the 
translocation was postulated to be a DNA segment twist that is subsequently propagated as 
a wave, owing to the accumulation of energy from an undertwisted DNA (Saha, 2002), which 
is partially dissipated by the introduction of a gap on one of the DNA strands. This model is 
termed “wave-ratchet-wave” translocation, wherein the remodeller acts as a ratchet, 
engaging DNA and tracking its translocation unidirectionally from the 3’- to the 5’-end in 
small increments. This model is similar to the loop diffusion model, however, the energy 
required for DNA translocation, should come directly from the remodeller’s ATPase activity 
rather than from the energy accumulated in the loop formation. 
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This unidirectional movement can occur at either side of the nucleosome dyad axis, allowing 
DNA translocation on either side, depending of the remodeller binding orientation. The exact 
location of the engagement between the remodeller and the nucleosome was elucidated 
from the studies of RSC, where superhelical location 2 (SHL2), found two DNA helical turns 
away from the nucleosomal dyad axis, was protected from DNAase I digestion, indicating the 
remodeller binding location (Saha et al., 2005). This location was found to be crucial for other 
remodellers, such as ISWI (Hwang et al., 2014; Ranjan et al., 2015; Schwanbeck et al., 2004). 
Chromatin remodellers take advantage of the inherent flexibility of DNA at the SHL2, which 
would also explain the propensity across the remodellers to bind this region 
(Edayathumangalam et al., 2005; Luger et al., 1997a).  
Several studies point to the loop diffusion model to be more likely. SWI/SNF remodelleres 
were shown to form ~50 bp loops and ISWI – 9-11 bp loops (Schwanbeck et al., 2004, 
Strohner et al., 2005; Zhang et al., 2006; Zofall et al., 2006), which demonstrates that 
SWI/SNF are more disruptive than ISWI. ISW2 was in turn acting through torsional strain at 
SHL2 (Zofall 2006), indicating that loop formation is more likely to be formed in case of 
disruptive complexes such as SWI/SNF but not ISWI or Chd1. BRG1 remodeller in the context 
of a trinucleosome was able to generate DNA loops on the central nucleosome, providing 
enough force to overcome the neighbouring nucleosome barrier (Fan et al., 2003). A large 
loop (~50-100 bp) was hypothesised to form on the nucleosomal surface, however, the 
introduction on small gaps on the tracking strand stalled RSC progression, which is also 
consistent with a small ~1 bp bulge formation (Lorch et al., 1999; Saha et al., 2005).  
Molecular dynamics studies also highlight different possibilities of nucleosome remodelling: 
rotation-uncoupled mode associated with loop formation and rotation-coupled mode 
associated with corkscrew motion and 1 bp step size (Niina et al., 2017), however, chromatin 
remodelling through the loop formation on the surface of the nucleosome still remains a 
nebulous concept.  
Recently DNA torsion model, where DNA is translocated following formation of a small bulge 
has gained further ground, based on several solved structures, molecular dynamics modelling 
and biochemical studies of Snf2 family remodellers.  
Molecular dynamics simulation of Snf2 binding at SHL2 and formation of twist defects, which 
subsequently propagated along the nucleosome (Brandani et al., 2018). ATP binding is 
followed by lobes closure, lobe 1 detachment and movement towards lobe 2 by 1 bp 
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(Brandani et al., 2018). ATP hydrolysis is concurrent with the weakening of lobe 2 and DNA 
contacts and movement of lobe 2 towards the dyad by 1 bp. When ADP is released and cycle 
continues, and, hence, the processive movement of the remodeller occurs.  
Two states have been observed: a decreased twist in apo and ADP-bound state and an 
increased twist with ATP analogues at SHL2 position (Li et al., 2019; Winger et al., 2018). This 
finding is consistent with recently found distortions in sugar-phosphate backbone and in base 
stacking (Liu et al., 2017a). Diffusion of this twist is sufficient to disrupt the DNA-histone 
interactions, presumably without major octamer perturbations, at least in the case of ISW1 
(Yan et al., 2019a). Other findings indicate that twist defect is associated with octamer 
distortions at SHL2, such as histone dimers maintain their contact points with shifted DNA or 
form new contacts after DNA register shift (Bilokapic et al., 2018). Taken together, there is 
no one clear picture of nucleosome remodelling, and several modes of DNA translocation can 
be utilised by different chromatin remodellers to achieve specificity.  
 
 
1.2.3 SWI/SNF subfamily 
 
Figure 1.7 Cryo-EM structure of S. cerevisiae Snf2 (ScSnf2) in complex with NCP (PDB ID 5X0Y). 
Structure is taken from Liu et al. 2017 (Liu et al., 2017b). Histone octamer is shown in dark grey.  
The early findings regarding the SWI/SNF subfamily functions in octamer eviction came from 
the studies of the yeast complex RSC, whose catalytic subunit Sth1 is homologous to 
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Swi2/Snf2 of the SWI/SNF complex. These are large complexes of approximately 1 MDa with 
11-15 subunits, mediating remodelling activity of the ATPase subunit.  
Early experiments demonstrated that the RSC complex is capable of completely evicting the 
histone octamer and forming intermediate double nucleosomes (Lorch et al., 1999). Octamer 
eviction can play a critical role in gene expression regulation, if the nucleosomal DNA contains 
various regulatory regions, such as transcription activator binding sites. This was confirmed 
by using a chimeric transcription factor Gal4-VP16, which enhanced octamer transfer from 
the nucleosome (Gutiérrez et al., 2007; Owen-Hughes and Workman, 1996). Activation 
domains present on a transcription factor guide the localisation and stimulation of the 
remodeller.  
SWI/SNF complexes are capable not only of evicting octamers but also of sliding 
nucleosomes. To be precisely carried out, these distinct functions require accessory subunits 
and regulatory domains in the remodelling complex. Sth1, the catalytic subunit of the RSC 
complex, has two key domains: the N-terminal post-HSA domain and protrusion 1, located in 
the middle of the ATPase domain (Clapier et al., 2016). The Post-HSA domain is located 
immediately downstream the HSA domain that is known to interact with actin-related 
proteins (ARPs). ARPs play various roles in cellular processes and are a part of the RSC 
complex. Removal of ARPs improved nucleosome sliding but impaired ejection (Clapier et al., 
2016). Removal of the ARP-binding and ARP-bridging protein Rtt102, another subunit in RSC, 
reduced sliding, but did not affect ejection (Clapier et al., 2016).  
In Sth1, mutations introduced into the post-HSA domain that interacts with ARPs, produced 
a hyperactive remodeller with excessive ATPase activity, irregularly spaced nucleosomes and 
a lethal phenotype. By contrast, mutations in the protrusion 1 yielded improved coupling – 
the amount of translocation relative to the number of hydrolysed ATP molecules – and 
enhanced translocation and ejection (Clapier et al., 2016). Therefore, post-HSA and 
protrusion 1 play roles of a “break” and a “clutch”, respectively, specifying the function of 
RSC. 
Further insights into the functions of SWI/SNF remodellers come from the crystal structure 
of Swi2/Snf2 catalytic subunit in a resting state from the yeast Myceliophthora thermophila 
(Xia et al., 2016). The protein lacks a DNA binding domain (DBD) and, like RSC, Swi2/Snf2 
contains an N-terminal post-HSA domain, as well as a SANT-associated domain. The C-
terminus harbours a SnAc domain, which may interact with histone tails. Like RSC, Swi2/Snf2 
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interacts with ARPs through its N-terminus. The essential motifs for ATP hydrolysis are the 
motifs I (P loop) and VI (arginine fingers, which are disordered when inactive) located in the 
RecA-like lobes. The motifs Ib, II, V and core 2i were found to be essential for DNA binding 
(Xia et al., 2016).  
The two ATPase RecA-like lobes of M. thermophila SWI/SNF stack together in an inactive 
state, with their ATP hydrolysis-essential motifs distant from each other and the DNA binding 
domains exposed, rendering the protein in a poised state (Xia et al., 2016). By similarity with 
an RNA-binding helicase Vasa in a complex with RNA, the authors predicted that, upon 
substrate binding and activation, the lobe 2 would perpendicularly rotate relative to the lobe 
1 (Sengoku et al., 2006; Xia et al., 2016). Like in Sth1, HSA domain downregulates the 
remodelling activity and its removal yields a hyperactive enzyme (Xia et al., 2016).  
In complex with the nucleosome, Swi2/Snf2’s motif VI (arginine fingers) becomes ordered 
and is brought close to the ATP binding element of motif I (P loop) (Liu et al., 2017a). The C-
terminal Brace helices, upon activation, protrude from the lobe 2 to contact lobe 1 through 
interaction with protrusion 1, aiding communication between the two lobes (Liu et al., 
2017a). This brace domain is similar to the NegC domain in ISWI remodeller. However, unlike 
in ISWI, this domain has a positive regulatory function.  
The H4 tail is another point of contact in Swi2/Snf2-nucleosome interaction. It contacts the 
acidic surface on the lobe 2, which is similar to the acidic pocket in ISWI (see below) (Liu et 
al., 2017a). Again, unlike for ISWI, where H4 plays a critical regulatory role (see below), 
Swi2/Snf2’s remodelling activity is diminished but not blocked by interaction with the H4 tail 
(Liu et al., 2017a).  
Another important residue is W1185, which is also present in CHD and ISWI remodellers. Its 
bulky side chain is located within the ATP-hydrolysing motif VI and is inserted into the DNA 
minor groove (Liu et al., 2017a) (Fig. 1.7)). Mutation W1185A does not block ATP hydrolysis 




1.2.4 ISWI subfamily 
 
Figure 1.8 Cryo-EM structure of S. cerevisiae ISW1 in active conformation (colour coded) bound to 
NCP compared with inactive conformation (grey) (PDB ID 6JYL). From Yan et al. 2019 (Yan et al., 
2019a). ADP-Befx is shown in red.  
Compared with the SWI/SNF subfamily, ISWI chromatin remodellrs are generally smaller 
(around 0.5 MDa with 2-5 subunits) and are less disruptive to the nucleosome, providing 
enough force for sliding but not for histone eviction. This conclusion was illustrated by 
Drosophila melanogaster ISWI-containing NURF complex, wherein ISWI was estimated to 
translocate DNA forming 10 bp bulges (Schwanbeck et al., 2004). By contrast SWI/SNF was 
capable of producing as large as 50 bp increments (Zofall et al., 2006). ISWI complexes, such 
as CHRAC, ACF and RSF, are mostly involved in nucleosome spacing and array formation, 
except for the NURF complex, which degrades spacing regularity (Hamiche et al., 1999).  
Unlike SWI/SNF complexes, ISWI subfamily chromatin remodellrs require additional histone 
and nucleosomal epitopes to exert their action. Upon binding of the catalytic subunit of ISWI, 
distortions in the linker DNA adjacent to the nucleosome occur, and remodeller-nucleosome 
complexes form more readily in the presence of a linker DNA (Schwanbeck et al., 2004; 
Whitehouse et al., 2003).  
Interestingly, directionality of the nucleosome repositioning by ISWI was found to be strictly 
centre-to-end, i.e. the octamer is located at the centre of DNA molecule with a DNA linker 
on each side, transforming that orientation to asymmetrical positioning with no linker on one 
side and a long linker on the other. However, when ISWI remodeller is a part of CHRAC 
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complex, the directionality changes to end-to-centre (Längst et al., 1999; Whitehouse et al., 
2003). These data yet again stress the influence of the subunits and accessory domains on 
chromatin remodelling by the core ATPase. In ISW2 complex, a non-catalytic subunit Itc1 
determined the direction and extent of nucleosomal sliding by binding to a distal part of the 
DNA linker, which may provide a steric block between the nucleosomes ensuring regular 
spacing (Kagalwala et al., 2004).  
To dissect the role of linker DNA in ISWI remodelling, hydroxyl radical footprinting (HRF) was 
utilised. HRF is a sensitive technique with a principle similar to DNAse I digestion. HRF is based 
on cleavage by hydroxyl radicals of a hydrogen atom from C4 of the deoxyribose in the minor 
groove, which only happens when a DNA molecule is exposed. Therefore, the pattern of 
cleavage allows detection of regions protected by a bound protein. This method 
demonstrated that the NURF complex protected DNA on the linker region adjacent to the 
nucleosome, as well as within the nucleosomal core, at SHL2 site (Schwanbeck et al., 2004).  
The importance of a linker DNA was confirmed by the higher amount of ATP hydrolysed by 
ISWI in the presence of a linker compared to a nucleosome core particle only (Whitehouse 
et al., 2003). Further studies estimated the minimal required linker length for ISWI 
remodelling to be 20 bp, whilst > 67 bp was an optima length under competitive or limiting 
conditions (Kagalwala et al., 2004). A triple helix displacement assay hinted at the 
processivity deterioration of ISWI with a linker length between 0 and 60 bp, where 
displacement was more efficient on a shorter linker compared to a longer one (Whitehouse 
et al., 2003). 
This dependence on the linker length points to the importance of histone tails for ISWI 
function, as further movement from histones affects ISWI processivity and, by extension, 
remodelling activity. A nucleosome with tail-less histones was shown to be more thermally 
labile than the wild type, indicating lost electrostatic contacts between the histone tails and 
DNA (Hamiche et al., 2001). In the CHRAC complex, removal of all histone tails reduced 
affinity between ISWI and the nucleosome but did not disrupt the remodelling activity, 
whereas removal of H4 tails interrupted remodelling (Clapier et al., 2001). The location of the 
H4 histone tails appears to be crucial for remodelling, as it is located proximal to SHL2 – the 
site crucial for remodeller-nucleosome interaction, as well as for sensing the DNA linker 
length (Hwang et al., 2014). Isolated H4 fused to a GST-tag could neither interact with ISWI 
in a pull-down assay, nor could it activate ATPase activity of the NURF complex, 
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demonstrating that a full nucleosome is required as a remodelling substrate (Clapier et al., 
2001; Hamiche et al., 2001).  
The H4 histone tail harbours an important motif for chromatin remodelling - the basic patch 
which has the amino acid sequence KRHR at the residues 16-19 (Clapier and Cairns, 2012; 
Hamiche et al., 2001). The ATPase subunit of ISWI is known to have inhibitory domains AutoN 
and NegC on its N- and C-terminus, respectively. AutoN interaction with the ATPase domain 
negatively regulates ATP hydrolysis, whereas NegC does not block ATP hydrolysis but 
uncouples it from DNA translocation (Clapier and Cairns, 2012). The HSS (HAND-SANT-SLIDE) 
domain on the C-terminus of the protein binds to the DNA linker (Dang and Bartholomew, 
2007). Mutations in or removal of AutoN and NegC promotes nucleosome sliding even 
without the H4 basic patch, DNA linker or HSS domain (Clapier and Cairns, 2012), 
demonstrating that the ATPase domain has an intrinsic translocase activity. Therefore, ISWI 
should be controlled by regulatory domains. In ISWI, AutoN keeps the ATPase in a resting 
state, and the H4 tail competes with it for the ATPase binding site. This regulation of ISWI by 
AutoN is achieved due to its motif bearing high similarity to the H4 tail basic patch (Clapier 
and Cairns, 2012). The DNA linker provides a similar activating mechanism by binding to the 
HSS domain and triggering conformational changes in the NegC domain, antagonising its 
inhibitory activity (Clapier and Cairns, 2012). 
Further insights into ISWI function came from the high-resolution crystal structure of its 
catalytic core (AutoN-ATPase-NegC-HSS) in a complex with H4 peptide (Yan et al., 2016). 
AutoN was found to bind to the acidic surface of RecA-like lobe 2, whereas H4 competes with 
it for one of the AutoN binding sites. NegC also binds to lobe 2, resulting in allosteric 
regulation response to DNA linker. C-terminal HSS domain binds the DNA linker, which should 
be of a sufficient length (25 bp with affinity increasing with increasing DNA length to 146 bp). 
A shorter linker results in weaker binding to HSS domain, which, in turn, cannot disrupt NegC 
interaction with lobe 2 (Yan et al., 2016). The integrative approach of cross-linking coupled 
to mass spectroscopy (XL-MS) and small-angle light scattering (SAXS) of the full length ISWI 
showed that the ATPase domain exists in a resting open conformation with motifs I and II on 
lobe 1 and motifs VI on lobe 2 not aligned (Harrer et al., 2018). Nevertheless, the overall 
protein structure is relatively compact, with the C-terminal SLIDE domain forming extensive 
cross-links with the N-terminal and ATPse domains,indicating their close proximity) and SLIDE 
domain (Harrer et al., 2018). Upon activation, the protein adopts a more compact 
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conformation, as indicated by a reduced radius of gyration as measured by SAXS (Harrer et 
al., 2018).  
  
1.2.5 CHD subfamily 
 
Figure 1.9 Cryo-EM structure of S. cerevisiae Chd1 bound to NCP (PDB ID 5O9G). From Farnung et al. 
2017 (Farnung et al., 2017). 
The CHD subfamily is closely related to the ISWI subfamily in its mode of action, however, 
the domains of the ATPase subunit differ. Instead of an N-terminal AutoN domain that 
negatively regulates ATPase activity by engaging the ATPase domain, CHD proteins have two 
tandem chromodomains connected by a conserved acidic helix forming a wedge-like 
structure. This packs against the DNA binding surface of the ATPase core, thus inhibiting its 
activity by providing a “gating” mechanism. Disruption of the chromodomain-ATPase 
interface results in full activation of the ATPase domain (Hauk et al., 2010). Two Arg residues, 
or “arginine fingers”, conserved across chromatin remodellers, specifically R579 and R582 in 
S. cerevisiae Chd1, are present in the linker connecting the ATPase lobes, contacting the 
phosphate tail of ATP when the cleft is in the active, closed conformation (Hauk et al., 2010). 
The C-terminus of Chd1 has a DNA binding domain (DBD) that senses the DNA linker length, 
thus producing regularly spaced nucleosomal arrays. This mode of action was proposed to 
be guided by the kinetic “release” model: the remodeller initially binds the nucleosome at 
the position of the highest affinity, gradually shifts it to the position of lower affinity, which 
favours its disengagement (Rippe et al., 2007). In the inactive state of the CHD1 the N-
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terminus interacts with the DBD, as shown by BS3 cross-linking, and a short acidic patch in 
the N-terminus was shown to mediate this interaction (Sundaramoorthy et al., 2017). 
Interdomain communication ensures measured activity of the remodeller. The Chromo-
ATPase module provides the platform for DBD binding, as demonstrated by the abrogation 
of DBD binding upon chromo-ATPase deletion (Nodelman et al., 2017). DBD was shown to 
bind right at the edge of the nucleosome, interacting with the major groove (Nodelman et 
al., 2017). In turn, the deletion of the DBD disrupted the catalytic activity of the ATPase 
domain (Hauk et al., 2010; McKnight et al., 2011). The activity was restored by the addition 
of a heterologous DBD (McKnight et al., 2011; Patel et al., 2013). Interestingly, the DBD does 
not seem to be required for catalytic activity per se, with the DBD-truncated CHD1 still being 
able to shift the nucleosome (Patel et al., 2013), indicating that the ATPase has an intrinsic 
sliding activity. However, without a proper control from DBD, CHD1 could only produce 
disordered nucleosomal patterns, more similar to SWI/SNF remodellers (Patel et al., 2013), 
which lack a DBD.  
A cryo-EM approach revealed more details about the CHD1-nucleosome complex. It was 
shown that the ATPase lobes remain in a partially closed state in the absence of a nucleotide, 
but with addition of a non-hydrolysable ATP analogue ADP-BeF3 they close completely 
(Farnung et al., 2017), Fig. 1.9). Initial engagement with the nucleosome occurs in the 
partially closed, pre-translocation state. Complete closure of the lobes occurs upon ATP 
binding. The lobe 2 of the ATPase domain interacts with the H4 tail (Farnung et al., 2017) – 
similar interactions with histone tails are found in other remodeller families (Clapier et al., 
2001; Ferreira et al., 2007; Hauk et al., 2010; Hwang et al., 2014; Liu et al., 2017a; Yan et al., 
2016). The cryo-EM structure of CHD1? showed that the key for DNA recognition by the 
remodeller is the bend configuration of the DNA wrapped around the histone octamer, as a 
straight fragment of free DNA would result in a steric clash with the chromodomains (Farnung 




1.2.6 INO80 subfamily 
 
Figure 1.10 Cryo-EM structure of C. thermophilum INO80 bound to NCP (PDB ID 6FML). From 
Eustermann et al. 2018 (Eustermann et al., 2018). 
The proteins from INO80 subfamily perform a function of replication-independent histone 
variant exchange (Mizuguchi, 2004). Histone variants, such as H2A.Z and H3.3, are expressed 
throughout the cell cycle and they can be incorporated into chromatin independently of DNA 
replication. H2A.Z is a highly conserved histone variant of an evolutionary lineage distinct 
from that of H2A.  In yeast genomes, H2A.Z acts as a barrier between transcriptionally active 
domains and propagating heterochromatin (Meneghini et al., 2003). Even though H2A.Z-
containing nucleosomes are similar to the canonical ones, certain structural differences alter 
their biophysical properties making them a less stable nucleosomal species (Rudnizky et al., 
2016). This explains the preference for H2A.Z at promoters, which, in their active form are 
characterised by the presence of acetylated H2A.Z. In the absence of INO80 proteins, H2A.Z-
containing nucleosomes are mislocalised and their presence in promoters does not 
correspond to transcriptional changes (Papamichos-Chronakis et al., 2011).  
Heterogeneous nucleosomes (containing a mixture of H2A dimers: H2A-H2A, H2A.Z-H2A and 
H2A.Z-H2A.Z) have been found at gene promoters (Luk et al., 2010). The histone replacement 
reaction by an INO80 subfamily remodeller Swr1 is stepwise and unidirectional: H2A-H2A-
containing nucleosomes, but not H2A.Z-H2A.Z, could stimulate Swr1 ATPase, with the highest 
ATPase activity detected when both the H2A-H2A nucleosome and the H2A.Z-H2B 
replacement dimer were bound (Luk et al., 2010). Contrary to that mode of action, Ino80 
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ATPase can incorporate H2A into H2A.Z nucleosome in a concentration-dependent manner, 
but cannot perform a H2A-to-H2A exchange (Papamichos-Chronakis et al., 2011), 
highlighting the importance of an H2A.Z-specific epitope. These observations led to a 
proposed model, wherein Swr1 deposits H2A.Z at a broad range of sites across the genome, 
with Ino80 performing the reverse reaction, only leaving H2A.Z at metabolically important 
sites, such as promoters (Papamichos-Chronakis et al., 2011).  
The mechanism of H2A.Z exchange was elucidated by comparison of H2A and H2A.Z 
structures. Whereas the C-terminal domain was found to play an important role in histone-
chaperone binding (Hong et al., 2014), the α2 helix and loop 2 were found on the H2A surface 
and in contact with Swr1 (Ranjan et al., 2015). Similarly to other remodelling families, INO80 
proteins interact with the SHL2 site on the nucleosome, and this interaction can be blocked 
by introduction of gaps at this site (Ranjan et al., 2015).  
The mode of action of INO80 family protein has been reinforced by the 3D structure of SWR1 
complex obtained by cryo-EM (Nguyen et al., 2013). SWR1 is a 1 MDa complex consisting of 
14 subunits. The Swr1 ATPase is in the core of the complex and is surrounded by three 
functional modules. The N-module includes: the actin-related protein Arp4 which is capable 
of binding canonical nucleosomes and histones; Swc4 containing a SANT domain that binds 
unmodified histone tails; and Bdf1 containing bromodomains for binding acetylated 
histones. The C-module contains Swc3, Swc2, Arp6 and Swc6 and binds free H2A.Z-H2B 
dimers. Finally, the heterohexameric Rvb1/Rvb2 module consists of the AAA+ ATPases Rvb1 
and Rvb2, which form a ring structure. The complex adopts a more elongated conformation 
upon nucleosome binding, with the Swr1 subunit and the C-module extending away from the 
Rvb1/Rvb2 ring (Nguyen et al., 2013). SWR1 was observed to make limited contacts with the 
nucleosomal substrate, unlike the remodellers from other families, which may explain the 
specialisation of INO80 proteins for histone dimer exchange (Nguyen et al., 2013). The INO80 
complex, however, was shown to make extensive contacts with the nucleosome (Tosi et al., 
2013), possibly promoting conformational change in the nucleosome and histone dimer 
dissociation. In the resting state, both complexes adopt a closed conformation (Watanabe et 




1.2.7 Mot1 – a remodeller not interacting with the nucleosome 
Mot1 (modifier of transcription 1) is an essential SNF2/SWI2 family remodeller in 
Saccharomyces cerevisiae. Like the other members of this remodeller family, Mot1 has 
conserved ATPase domains comprising the lobes RecA 1 and 2. Unlike the major remodellers 
described above, it does not interact with a nucleosome to exert its remodelling activity. Its 
main function is transcription regulation through interaction with TATA binding protein (TBP) 
and double-stranded DNA. TATA binding protein is a transcription factor binding the TATA 
box – a DNA sequence found upstream of the transcription start site of promoters of some 
eukaryotes.  
Mot1 can both repress and activate transcription. The predominant role in transcription 
repression is conferred by ATP-driven dissociation of TBP from dsDNA and activation via 
preinitiation complex (PIC) reorganisation. These effects were shown to be exerted through 
direct localisation to Mot1-repressed and Mot1-activated promoters (Auble et al., 1997; 
Dasgupta et al., 2002).  
Mot1 has two major regions: a nonconserved N-terminal part containing HEAT repeats 1-5 
(aa 289-1225, Uniprot ID P32333) and a conserved C-terminal part that contains the ATPase 
domain and HEAT 6 domain (1284-1787, UniProt ID P32333) (Auble et al., 1997). The N-
terminus targets Mot1 towards TBP and the C-terminus, while aiding TBP-DNA complex 
recognition, primarily binds to the DNA upstream of the TATA box and acts in the ATP-driven 
dissociation reaction, thus removing TBP from dsDNA and exerting transcription repression 
(Auble et al., 1997). The ATPase domain stabilises the Mot1-TBP-DNA ternary complex and is 
activated in the presence of TBP (Auble et al., 1997). DNA alone does not activate the ATPase 
domain and the presence of TBP-DNA complex is required for that (Adamkewicz et al., 2000; 
Chicca et al., 1998; Wollmann et al., 2011). 
Interestingly, the Mot1-TBP interaction was found to play a role in positive regulation of 
transcription through redistribution of TBP from high-affinity TATA-containing sites to lower-
affinity poly(dA-dT) tracts (Zentner and Henikoff, 2013). These tracts alter chromatin 
architecture and disfavour nucleosome formation, thus making DNA accessible for binding 
by DNA-interacting proteins (Segal and Widom, 2009). There has been evidence showing that 
Mot1 assists TBP binding to DNA by clearing the promoters from repressive marks, this way 
facilitating activation of transcription (Andrau et al., 2002).  
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Even though Mot1, unlike many other Swi2/Snf2 family proteins, has not been directly linked 
to nucleosome organisation, MNase experiments demonstrated its involvement in +1 
nucleosome positioning – the strongly positioned first nucleosome in the array between the 
promoter-associated nucleosome-free region and the gene body – through a mechanism that 
is unclear (True et al., 2016).   
Recent structural studies have shed light on Mot1’s interaction with TBP and DNA. The crystal 
structure of Mot1 in resting state showed that Mot1 exists in the auto-inhibited resting state 
where the N- and C-termini are in close proximity to each other (Butryn et al., 2018). Upon 
binding to TBP-DNA-NC2 (the transcription regulator negative cofactor 2) complex, Mot1 
induces DNA bending, which facilitates its dissociation from TBP (Fig. 1.11) (Butryn et al., 
2015).  
 
Figure 1.11 Crystal structure of Mot1-TBP-DNA-NC2 complex shown as a cartoon. Yellow – the N-terminal HEAT 
repeats (HR) of Mot1, orange – insertion domain of Mot1, blue – TBP, green – a TBP-associated protein NC2 (H 
– NC2 helices), grey – DNA. Mot1 binds predominantly to TBP via contact with helix H5 of NC2. Figure from 
Butryn 2015.  
 
 
1.3 Lymphoid-specific helicase (LSH) 
1.3.1 Biological functions of LSH 
Lymphoid-specific helicase (LSH), also known as HELLS, PASG, SMARCA6 or Nbla10143, is a 
member of the SNF2 family of chromatin-remodelling ATPases characterised by the presence 
of two RecA-like ATPase lobes containing seven conserved helicase motifs (Wu and Brosh, 
2012). LSH is common to mammals but close homologues are also present in Arabidopsis 
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thaliana (DDM1) (Jeddeloh et al., 1999), yeast (Basenko et al., 2016; Geiman et al., 1998; 
Laurent et al., 1992), Xenopus laevis and Danio rerio (Meehan et al., 2015). 
Initially the Lsh transcripts had been identified by Northern blot in the lymphoid cell lineage 
exclusively (hence the designation as “lymphoid-specific”) (Jarvis, 1996). Initial knockout (KO) 
studies confirmed its importance for the lineage by showing that LSH is required for T-
lymphocyte proliferation (Geiman and Muegge, 2000). Later it was also detected in testis 
(Geiman et al., 1998) and, consequently, deemed to have a role primarily in recombination, 
particularly through DNA repair (Brosh, 2013), since these tissues are highly active in 
Variable, Diverse and Joining (VDJ) and meiotic recombination, respectively. Independently 
from that, LSH had been identified in MO7e cell line as a decreased transcript following 
cytokine withdrawal and revealed to belong to SNF2 family chromatin remodellers (Lee et 
al., 2000).  
Further research demonstrated that in adults LSH is not restricted to lymphocytes and testis 
but is common to actively proliferating cells including the spleen, thymus, bone marrow and 
small intestine (Raabe et al., 2001). At the embryonic stage, LSH is ubiquitously expressed 
throughout the organism – a pattern recapitulated in cancer cell lines (Raabe et al., 2001). 
Thus, LSH expression positively correlates with cell proliferation.  
In the cellular context, LSH localisation is restricted to the nucleus, in accordance with the 
protein’s putative functions, and correlates with the S phase (Geiman and Muegge, 2000). 
Treatment of HEK293 nuclei with micrococcal nuclease (MNase) and subsequent sucrose 
gradient fractionation confirmed tight association of LSH with chromatin (Meehan et al., 
2015). Immunofluorescent staining after LSH overexpression in MEFs showed that LSH 
predominantly has a diffused nuclear pattern with only occasional pericentric 
heterochromatic clustering, which increases with co-overexpression of LSH along with a 
chromo- and chromo-shadow domain active HP1α (Meehan et al., 2015). This pattern is 
consistent with the result after Triton X-100 wash, where about 50% of LSH could be Triton 
X-100 extracted whereas the other 50% remained tightly associated with chromatin (Yan, 
2003). This pattern was found to be cell cycle-dependent: more LSH was tightly associated 
with chromatin during S phase than in the rest of the cell cycle (Yan, 2003).  
Diffused nuclear localisation of LSH was contrasted to that of its ATPase deficient mutant LSH 
K237Q, which showed increased chromatin residence time, manifesting in distinct nuclear 
foci (Lungu et al., 2015). The authors also noticed that this interaction was dependent on 
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H3K9me3 modification. However, along with the intact ATPase domain, H3K9me3 was found 
to be important for LSH release from chromatin, rather than recruitment of LSH to it (Lungu 
et al., 2015).  
The ATPase domain was also shown to be crucial for LSH effects on cell cycle progression 
(Fan, 2005; Geiman and Muegge, 2000; Yan, 2003; Zhou et al., 2009). The Intact ATPase 
domain blocks cells in S phase upon LSH overexpression, whereas a point mutation K254Q 
abrogates this effect (Raabe et al., 2001). Thus, LSH effects appear to be highly cell-type and 
cell-line dependent. 
 
1.3.2 LSH knockouts  
The human Lsh gene is located on the chromosome 10 and is encoded by 22 exons, whereas 
its close homologue, the mouse Lsh, is located on the chromosome 19 and is encoded by 21 
exons. There are two published murine knockout (KO) variants of LSH, both of which were 
generated by homologous recombination. The first one (KO1) targeted exons 6 and 7 
(helicase domains I, II and partly IIa) and the phenotype was characterised by normal 
embryonic development, but early post-natal lethality, reduced body weight and renal 
lesions, possibly due to mitochondrial abnormalities (Geiman et al., 2001). The second one 
(KO2) targeted exons 10-12 (helicase domains II, III and IV) and resulted in low levels of 
protein, which was also unstable (Sun 2004). This LSH hypomorph resulted in impaired 
growth, and premature aging manifested in wasting syndrome, bone fragility and early 
lethality (Sun, 2004). At the cellular level, LSH KO2 mice showed global hypomethylation and 
replicative senescence (Sun, 2004). It should be noted that the truncated version of mutated 
LSH was still detectable after immunoprecipitation, albeit only in small amounts, which could 
account for post-natal survival of LSH KO2 mice compared to KO1.    
 
1.3.3 The role of LSH in DNA methylation 
The analysis of the genome-wide methylation profile of the murine LSH KO1 demonstrated 
the global loss of DNA methylation at both single-copy genes and repeat sequences (Dennis, 
2001; Tao et al., 2011). This was later confirmed in the murine embryonic stem cells (mESCs) 
and murine embryonic fibroblasts (MEFs) (Fan et al., 2003.; Myant et al., 2011; Zhu et al., 
2006). Comparison of genic and intergenic regions after LSH deletion, however, 
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demonstrated a more pronounced effect on methylation levels of intergenic regions (Yu et 
al., 2014). LSH has also been found to affect the imprinting of and directly associate with a 
site on the Cdkn1c gene (Fan, 2005), however, this was the only imprinted gene linked to 
LSH.    
Treatment of the LSH WT MEFs with a demethylating agent 5’-azacytidine resulted in an 
increase of centrosome numbers and a phenotype similar to that of the LSH knockouts – an 
indication that the changes associated with LSH perturbations are dependent on DNA 
methylation (Fan et al., 2003). The influence of LSH on DNA methylation was found to be 
independent of the expression of the DNA methyltransferases – DNMT1, DNMT3A and 
DNMT3B (Dennis, 2001). An experiment in which LSH-deficient MEFs were transfected with 
an episomal vector demonstrated that LSH is indispensable for de novo methylation but is 
not required for maintenance methylation (Zhu et al., 2006). The effect of LSH on DNA 
methylation was shown to be more pronounced in highly expressing genes (Tao et al., 2011).  
LSH was shown to affect promoter methylation patterns of development-associated genes, 
such as HOX, Oct4 and Nanog (Myant et al., 2011; Xi et al., 2009; Termanis et al., 2016; Xi et 
al., 2007; Zhu et al., 2006). In the LSH KO model a subset of Hox genes were hypomethylated 
and derepressed in mouse embryonic fibroblasts (MEFs), as well as in brain and liver (Xi et 
al., 2007). By contrast, LSH knockdown (KD) in embryonic stem (ES) cells resulted in partial 
expression of these genes and maintenance of stemness characteristics, such as anchorage-
independent growth and alkaline phosphatase production (Sichuan Xi, Theresa M. Geiman, 
2009). Moreover, LSH was found at Oct4 and Nanog promoters by chromatin immuno-
precipitation (ChIP). However, in vivo experiments showed that Oct4 subsequently 
undergoes methylation in later embryonic developmental stages (Xi et al., 2009; Zhu et al., 
2006), suggesting an additional or compensatory methylation mechanism, at least in these 
genes. In LSH rescue experiments, ectopic expression of wild-type LSH in LSH-null mouse 
embryonic fibroblasts (MEFs) repressed Rhox2a and Rhox6 expression (Termanis et al., 
2016), but not HoxC6 gene, consistent with the previous finding that not all Hox genes are 
affected by LSH (Xi et al., 2007).  
As noted earlier, despite diffuse nuclear localisation, LSH has a certain affinity for major and 
minor satellite repeats in pericentromeric heterochromatin and co-localises with HP1α 
(Dunican et al., 2015; Yan, 2003). This pattern was found to be independent of the pre-
existing CpG methylation (Yan, 2003). The analysis of the protein-coding genes in LSH KO 
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MEFs revealed that, even though both exhibited reduced methylation levels, silent genes 
faced more dramatic loss of methylation than active genes both at transcription start sites 
(TSS) and gene bodies (Yu et al., 2014). This indicated that methylation in active and silent 
genes occurs though distinct mechanisms, and LSH has a non-redundant function in 
methylation of silent genes.  
The effect of LSH on DNA methylation was shown to be direct, as indicated by the association 
of LSH with the sequences that subsequently gained methylation, which was found to be 
independent of the presence of a functional ATPase domain in LSH (Ren et al., 2015). In 
contrast, deletion of the DEAH domain (325-342 aa), abolished LSH localisation on the repeat 
elements (Ren et al., 2015). Mutation of the ATPase domain (K237A), however, altered 
nucleosome occupancy, with the levels decreasing upon cell differentiation in LSH KO 
condition (Ren et al., 2015).    
The analysis of repeat elements also showed reduction in CG methylation in KO MEFs. 
However, unlike the protein-coding genes, some repeat sequences, such as intracisternal A-
particles (IAPs), and major and minor satellite repeats, demonstrated some de-repression 
(Dunican et al., 2013; Huang, 2004; Yu et al., 2014). Changes in expression of previously 
repressed sequences were not solely based on changes in methylation status and in addition 
were associated with differential histone modifications.   
 
1.3.4 LSH and histone modifications 
The interplay between DNA methylation and histone modifications has a crucial influence on 
gene expression. Hence, it is not surprising that manipulations of LSH have various effects on 
histone modification status, and vice versa. For instance, treatment with histone deacetylase 
(HDAC) inhibitor trichostatin A (TCA) abolished LSH association with chromatin (Yan et al., 
2003), indicating that LSH requires histone PTMs, namely acetylation, for binding. This can 
be due to local structural changes that affect LSH binding or global rearrangements in 
chromatin architecture.  
Changes in repetitive sequences (major and minor satellite repeats, IAPs and LINEs) upon LSH 
deletion involve not only loss of DNA methylation, but also gain of active histone marks, such 
as acetylation and methylation at H3K4 (Dunican et al., 2013; Yan, 2003; Yu et al., 2014), and 
loss of a repressive mark – methylated H3K9 (Dunican et al., 2013). Promoters of some genes 
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encoding development-associated transcription factors also underwent loss of methylation 
on H3K9 (Myant et al., 2011). Contrary to this, one study showed that the regions, which 
underwent the greatest loss of CG methylation, acquired the repressive H3K27me3 mark, 
indicating possible redundancy in silencing mechanisms (Yu et al., 2014).  
 
1.3.5 LSH and senescence 
The LSH KO MEFs showed impaired centrosome formation and subsequent de-regulation of 
cell division (Fan et al., 2003). Interestingly, this defect did not lead to any detectable cell 
transformation, and the LSH-deficient cells, on the contrary, failed to proliferate even after 
introduction of SV40 large T antigen (Fan et al., 2003), indicating resistance of LSH-deficient 
MEFs to the cancerous phenotype. This was accompanied by an increase in centrosome 
numbers compared to the WT and deregulation of spindle formation, resulting in aberrant 
cell division and subsequent senescence as a response mechanism (Fan et al., 2003). On the 
contrary, the overexpression of LSH leads to a delay in senescence (Zhou et al., 2009). 
The link between LSH deficiency and cellular senescence was further explored in a study of 
the relationship between LSH and a tumour suppressor protein p16 that stalls progression 
through cell cycle by inhibiting cyclin dependent kinases (Zhou et al., 2009). In that study, 
LSH and p16 were shown to have opposite effects on the progression to senescence of a 
human lung fibroblast cell line 2BS: LSH overexpression rescued the proliferative phenotype 
and resulted in a decrease in p16, whereas LSH shRNA knock-down resulted in an increase in 
p16 expression – an effect that was shown to be mediated by HDAC1 and HDAC2. 
Interestingly, silencing of both LSH and p16 rescued the proliferative phenotype (Zhou et al., 
2009), demonstrating that LSH effects in proliferation may be performed by another protein. 
This study contradicts the earlier finding that LSH overexpression in 2BS cells leads to cell 
cycle arrest and the intact ATPase domain is crucial for this effect (Raabe et al., 2001).  
It was found that LSH promoter activity is under the control of E2F1 - a transcription activator 
involved in the control of cell cycle and mediating either cell proliferation or apoptosis (Niu 




1.3.6 LSH in DNA integrity maintenance during replication and repair  
LSH has been implicated in DNA integrity maintenance during replication and repair (Burrage 
et al., 2012). Its possible role in replication has been primarily linked to chromosome 
segregation fidelity. It has been recently found that Irc5 (Increased Recombination Centers 
5), the LSH homologue from Saccharomyces cerevisiae identified in DNA damage response 
screen, associates with the Scc1 subunit of the cohesin complex (Litwin et al., 2017). Cohesin 
is a multisubunit complex that is formed in late G1 as a 3-dimensional cylindrical structure 
connected to the sister chromatids, tethering them to each other during cell division ensuring 
proper alignment and segregation (Nasmyth, 2011).  
When Irc5 is disrupted, cohesin levels on the centromeres and chromosome arms decrease, 
causing mild premature separation of sister chromatids and the phenotype similar to that 
with cohesin loading complex mutants (Hakimi et al., 2002; Huang, 2004; Litwin et al., 2017), 
indicating that Irc5 may be crucial for cohesion in certain locations or under specific 
conditions.  
The absence of Irc5 resulted in reduction of the cohesin loading complex protein Scc2 levels, 
which was accompanied by reduction of Scc2 and cohesin subunit Scc1 interaction and 
compromised cohesin assembly (Litwin et al., 2017). On the other hand, when a cohesin 
loading complex DAEA box yeast mutant had wild-type Irc5, it could survive in semi-
permissive (30oC) conditions (Litwin et al., 2017), but not in the case of an ATPase-deficient 
Irc5 mutant, which highlights the importance of Irc5 chromatin remodelling activity in 
cohesin loading and sister chromatid separation. Similar mechanismmay be relevant for LSH 
functions.  
LSH is also linked to the repair of double-strand breaks (DBSs), both in germline and somatic 
cells. Improper repair of DBSs leads to chromosomal instability and cancer development 
(Jackson and Bartek, 2009). There are two repair mechanisms in the cell: canonical non-
homologous end joining (c-NHEJ) and homologous recombination (HR). HR is based on the 
presence of a sister chromatid as a repair template, which occurs in S and G2 (San Filippo et 
al., 2008). 
In oocytes, LSH KO leads to incomplete DSB repair (DBSR) and impaired establishment of 
crossovers in meiosis, which correlated with the loss of methylation at repeat sequences (De 
La Fuente et al., 2006). Similarly, in spermatocytes, double-strand breaks could not be 
efficiently repaired, which was indicated by the persistence of asynapsed chromosomes 
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(Zeng et al., 2011). These findings contradict the initial localisation of LSH outside the areas 
of active meiotic division (Raabe et al., 2001). In somatic cells, LSH KO leads to a decrease in 
H2AX histone variant phosphorylation, which is a modification acquired straight after DNA 
damage to mark the areas that need to be repaired, and reduced survival after ionising 
radiation exposure with no change detected in the levels of 5meC (Burrage et al., 2012), 
indicating that there are non-redundant functions of LSH in DNA damage repair in promoting 
efficient phosphorylation upon DNA damage.  
A recently identified interaction of LSH with a DNA repair-associated protein CtIP reinforced 
the role of LSH in chromatin remodelling. LSH is involved in DSBR during HR in 
heterochromatin in G2 through recruitment of CtIP at DSB locations (Kollarovic et al., 2018). 
CtIP is an endonuclease that interacts with the MRE (Mre11/Rad50/Nbs1) DNA damage 
sensor complex and promotes end resection on DSBs to generate 3ˈ-end single strands 
(Makharashvili and Paull, 2015), which is a crucial step in HR (Sartori et al., 2007).  
DSBR in heterochromatin is complicated by the condensed environment, resulting in less 
efficient repair of DSB and more frequent mutations in heterochromatin due to the 
condensed environment and repetitive sequences (Schuster-Böckler and Lehner, 2012; 
Woodbine et al., 2011). Therefore, chromatin remodelling and decondensation are essential 
for heterochromatic DSBR. LSH is likely to create a permissive environment in 
heterochromatin for DSBR machinery recruitment and activity (Kollarovic et al., 2018). This 
role of LSH in DSBR was, however, redundant, since its deficiency did not result in dramatic 
loss of HR (Kollarovic et al., 2018). Therefore, it is conceivable that its role in DSBR is restricted 
to heterochromatin.  
LSH activity in DSBR requires the intact ATPase domain, as opposed to the mutated ATP-
binding lysine K254R (corresponding to K237 in murine LSH), which failed to recruit CtIP to 
DSBs (Kollarovic et al., 2018). This interaction was direct as indicated by co-
immunoprecipitation and His-pull-down (Kollarovic et al., 2018). 
 
1.3.7 LSH in disease 
Genome-wide perturbations in DNA methylation and histone PTMs upon LSH point-
mutations or complete deletion have numerous implications in disease, notably in cancer. As 
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noted previously, LSH is highly expressed in the lymphoid lineage and actively proliferating 
cells.  
Tumour protein p63, whose overexpression results in overcoming senescence, induction of 
stem-like properties and tumour formation, was found to act by activating LSH through 
consensus binding sites – LSH was found to be imperative for senescence bypass and able to 
overcome a Ras-induced senescent phenotype (Keyes et al., 2011). E2F transcription factor 
has also been found to require LSH for its oncogenic functions, whereas knockdown of LSH 
ablated E2F-mediated gene expression upon re-entry to the cell cycle (von Eyss et al., 2012).  
LSH has also been found to suppress expression of fumarate hydratase by recruitment of G9a 
– an epigenetic silencing factor (He et al., 2016). Fumarate hydratase is an enzyme present 
in mitochondria, and it plays a prominent role in the Krebs cycle, facilitating oxidative 
metabolism and supporting anabolic reactions. Suppression of fumarate hydratase leads to 
alterations in cellular metabolism and diversion in energy production from oxidative 
phosphorylation to glycolysis – the phenomenon known as the Warburg effect. By 
suppressing production of a Krebs cycle intermediate, LSH supports the metabolic switch.  
A form of LSH with a C-terminal in-frame deletion of 75 bp was found in 57% of acute myeloid 
leukaemia and 37% acute lymphoblastic leukaemia samples used in the study (Lee et al., 
2000). Intriguingly, this deleted region contains a motif that has been observed to couple ATP 
hydrolysis to chromatin remodelling (Smith and Peterson, 2005).    
Interestingly, not only overexpression of LSH can lead to proliferative abnormalities. A subset 
of LSH-null mice developed hematopoietic neoplasms as indicated by histopathology of 
spleen, liver and bone marrow – the regions where LSH is highly expressed (Fan et al., 2008). 
An RNA screen in renal cell carcinoma identified LSH as one of the differentially expressed 
genes compared to normal kidney cells. Statistical analysis demonstrated that lower 
expression of LSH correlated with longer survival time and could potentially be used as a 
prognostic marker (Chen et al., 2017). LSH was also found to be a negative predictor of 
survival in astrocytomas and glyoblastomas – this time LSH expression was dependent on 
E2F1 transcriptional activation (Xiao et al., 2017).  
Cancer, however, is not the only disease affected by LSH. ICF (Immunodeficiency, 
centromeric instability, facial anomaly) syndrome is an extremely rare autosomal recessive 
disease, characterised by fatally low immunoglobulin counts with normal or decreased B and 
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T lymphocyte counts. At the molecular level, the disorder is manifested by reduced 
methylation of juxta-centromeric heterochromatin repeats of chromosomes 1, 9 and 16 
(Ehrlich et al., 2008; Thijssen et al., 2015). The genes with mutations implicated in ICF 
syndrome are LSH, de novo DNA methyltransferase DNMT3B, zinc-finger-containing ZBTB24 
and CDCA7 (cell division cycle associated 7). All these genes were found to be involved in 
centromeric CpG methylation – a manifestation of genetic heterogeneity that converges in a 
single disease (Thijssen et al., 2015). 
 
1.3.8 LSH homologues 
Apart from LSH variants in human, mouse, zebrafish and clawed frog (see Homology 
Modelling section), there are several LSH homologues in more distant species,for which 
experimental data have been collected.  
Decrease in DNA Methylation 1 (DDdm1) is a chromatin remodeller found in Arabidopsis 
thaliana. Mutations in Ddm1 result in methylation loss mainly in heterochromatin, and to a 
smaller extent in genes (Jeddeloh et al., 1999). Like LSH, Ddm1 mediates cytosine 
methylation for repetitive sequence repression in plants, specifically centromeric 
retrotransposons and centromeric satellite repeats, which is essential for non-coding RNA 
expression from repetitive sequences (Tan et al., 2018). RNA-directed DNA methylation 
(RdDM) is a process in plants in which short interfering RNAs (siRNAs) mediate transposon 
methylation. Ddm1 knockouts in tomato showed severe hypomethylation of 
heterochromatic transposon regions in CG and CHG, but increased for CHH (C = cytosine, H = 
A, T or C) (Corem et al., 2018), and the function of Ddm1 was antagonistic to RdDM in rice 
and tomato (Corem et al., 2018; Tan et al., 2018).  
The function of Ddm1 was linked to the presence of the linker histone H1: inactivation of H1 
in a Ddm1-deficient phenotype resulted in restored methylation, indicating that DNA 
methyltransferase require Ddm1 to bypass the H1 barrier for heterochromatic silencing 
(Lyons and Zilberman, 2017; Zemach et al., 2013). Interestingly, Ddm1 was found to be crucial 
for methylation of nucleosomal DNA, which was inhibited by H1 in the absence of Ddm1 and 
restricted primarily to the DNA linker regions (Lyons and Zilberman, 2017). 
The homologues from S. cerevisiae Irc5 is a Snf2 family member (Flaus and Owen-Hughes, 
2011) identified in a genome-wide analysis as gene, deletion of which resulted in an increase 
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of Rad52 foci in proliferating cells (Alvaro et al., 2007). Irc5 has recently been found to 
participate in cohesin loading, which requires its intact ATPase domain (Litwin et al., 2017) 
(see Section 1.3.6). However, this function of Irc5 is not linked to DNA methylation, since it is 
absent in yeast. 
An even more distant homologue from the mould Neurospora crassa called Mus30, or 
Chromatin Remodelling Factor 5, was also found to play a crucial role in preventing genome 
instability with its levels increased following DNA damage, and this function depended on 
association of Mus30 with Neurospora WDR76 (Basenko et al., 2016).  The human homologue 
of WDR76 is an E3 ubiquitin ligase linker protein and was recently found as a potential 
tumorigenesis suppressor through degradation of Ras GTPase (Jeong et al., 2019). The lack 
of Mus30 affected neither double strand break repair (DSBR), HR nor NHEJ (Basenko et al., 
2016).   
Taken together, the insights into LSH homologues provide additional information about 
possible functions of LSH in DNA methylation as well as additional pathways not directly 
related to DNA methylation.  
 
1.3.9 LSH structure and domains 
LSH is classified as a chromatin remodelling protein belonging to the Snf2-like subfamily of 
SF2 superfamily of helicase-like proteins (Mueller-Planitz et al., 2013). An extensive study of 
Snf2 subfamily members based on sequence similarity placed LSH in close proximity to the 
Snf2 protein – a catalytic component of SWI/SNF chromatin-remodelling complex from 
Saccharomyces cerevisiae (Flaus, 2006).  
There is no crystal structure of LSH available, and all structural insights come from the 
sequence similarity to characterised protein. The N-terminus of LSH is disordered and 
contains a coiled coil motif (residues 14-96) that may interact with other proteins. In a pull-
down experiment with an LSH fragment, GST-LSH (1-503) resulted in binding of a de novo 
DNA methyltransferase DNMT3B to the fragment (Myant and Stancheva, 2008). Residues 
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126-131 represent a nuclear localisation signal; upon its disruption via site-directed 
mutagenesis the subcellular localisation of LSH changes (Lee et al., 2000) (Fig. 1.12).  
 
 
Figure 1.112 Schematic structure of LSH from Mus musculus with coiled coil domains (CC), SNF2 
ATPase domain and the C-terminal helicase domain.  
One of the main features of the Snf2-like family proteins, including LSH, is the seven helicase-
like motifs, spanning the ATPase region. The ATPase region consists of two RecA domains of 
alpha-beta topology, which are connected by the elongated linker between the helicase 
motifs III and IV (Flaus, 2006). The region between residues 202 and 394 belongs to the DEAD-
like helicase superfamily and includes the ATP-binding Walker A (phosphate-binding loop 
GILA DEMGLGKT in M. musculus LSH) and Walker B motifs (Mg2+-binding aspartate). The 
ATPase mutant LSHK237Q (part of the Walker A motif) has shown slight reduction in ATPase 
activity compared to the weakly active ATPase in vitro by thin layer chromatography (Kevin 
Myant’s thesis).   
A study of Snf2 identified a tryptophan (W1185) residue in the C-terminus upstream of motif 
VI, which plays an important role in interaction with the nucleosome core (Liu et al., 2017a). 
The residue inserts itself into the minor groove of DNA and interacts with the 3’-strand. This 
residue is conserved in mouse LSH (W679) and in Chd1 and ISWI remodellers. Site-directed 
mutagenesis of this residue to a smaller one or a charged one could reveal its role in LSH 
interaction with NCP.  
DDM1, an LSH homologue in Arabidopsis thaliana, has been found to interact with 
nucleosomal DNA and to remodel it upon ATP addition (Brzeski and Jerzmanowski, 2003). 
The addition of the protein to a nucleosome resulted in the octamer sliding from the end to 
the centre of the nucleosome, resulting in distinct nucleosomal species visible on the gel 
(Brzeski and Jerzmanowski, 2003). A high degree of sequence similarity (49.4% by EMBOSS 
Needle) between DDM1 and LSH indicates that the latter possesses a similar mode of action. 
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However, the absence of NCP remodelling activity by LSH in vitro shows that additional co-
factors or binding partners are likely required.   
 
1.4 Cell division cycle-associated protein 7 (CDCA7) in health and disease  
1.4.1 Zinc finger proteins 
Zinc finger proteins (ZFPs) are some of the most abundant proteins across species. Their 
interaction partners include DNA, RNA and proteins and their functions span such processes 
as transcriptional regulation, protein degradation, DNA repair, signal transduction (Cassandri 
et al., 2017). ZFPs are implicated in a variety of diseases related to tumorigenesis, diabetes, 
neurodegeneration and beyond (Cassandri et al., 2017). 
The classic zinc finger domain contains C2H2 motif, in which two cysteines and two histidines 
are coordinated by a zinc ion (Fig. 1.13 A) (Zhang et al., 2011). This motif, however, is not 
applicable to all ZFPs, and other abundant non-classical ZFPs include RING (Really Interesting 
New Gene) (Linke et al., 2008), PHD (Plant Homeodomain) (Borgel et al., 2016) and LIM 
(Lin11-Isl1-Mec3) containing proteins (Turner and Miller, 1994) (Fig. 1.13 A, B). The classic 
C2H2 ZF domain has a common conserved motif TGEKP connecting adjacent ZFs (John H Laity 
et al., 2000) and transitioning from disordered to ordered state upon binding to DNA (J. H. 
Laity et al., 2000).  
 
 
Figure 1.13 Zinc finger domain. A) Schematic representation of the most common types of zinc finger 
domain (from Cassandri 2017); B) Crystal structure of the Cys2His2-type zinc finger domain of human 
transcription factor DPF2. The residues chelating the zinc atom (C211, C214, H227, H232) are shown 
in red sticks (from Zhang et al. 2011).  
 
RING ZFD are distinct from the classical C2H2 ZF-containing motif (Miller et al., 1985). 
Described RIGN ZFDs contain eight conserved residues (cysteines and histidines), which 
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coordinate two zinc ions, four residues per zinc ion (Borden and Freemont, 1996). RING ZFD 
are similar to LIM ZFD and PHD ZFD, however, the central histidine residue is located in 
distinct positions within the motif (Borden and Freemont, 1996). The initial role for RING-
containing proteins was assumed to be protein dimerisation but more research 
demonstrated this domain to be present abundantly in E3 ubiquitin ligase – a protein 
transferring a ubiquitin molecule from E2 conjugating enzyme to the substrate (Joazeiro and 
Weissman, 2000). This function is well characterised in the case of the proto-oncoprotein 
Mdm2, whose E3 ligase activity is required for the protein p53 ubiquitylation and 
degradation, resulting in oncogenic phenotype (Lindstrom et al., 2007). Mutations in Mdm2 
ZFD results in Mdm2 escaping degradation itself and causing uninhibited degradation of p53, 
an indication of a cancerous phenotype (Lindstrom et al., 2007).  
 
1.4.2 CDCA7 
CDCA7/JPO1 is a ZFP that was identified in a differential expression analysis of cell cycle genes 
and was shown to have expression patterns similar to cell-division-cycle (CDC) and cyclin 
genes (Walker, 2001). The CDCA7 gene produces a conserved protein of around 47 kDa, with 
the orthologues found across different species such a human, chicken and frog (OrthoDB 
query, https://www.orthodb.org/?query=cdca7). Its expression peaks at the transition from 
G1 to S phase (Whitfield et al., 2002). CDCA7 is highly expressed in undifferentiated cells and 
in the colon, thymus and small intestine, with low levels in the spleen, bone marrow and 
peripheral leukocytes (Prescott et al., 2001).  
 
CDCA7 in transcription  
CDCA7 is a responsive gene of a proto-oncogenic transcription factor c-Myc, which plays a 
prominent role in the cell cycle, apoptosis and cell differentiation (Prescott et al., 2001). 
CDCA7 does not possess strong transformation activity but it enhances a transformation-
defective c-Myc mutant, possibly through the involvement in anchorage-independent 
growth (Jiménez-P et al., 2018; Prescott et al., 2001). Even though c-Myc was shown to bind 
directly to the CDCA7 gene, the CDCA7 gene did not show any significant sequence 
conservation at and around the c-Myc binding site, as opposed to the majority of the c-Myc 
target genes (Haggerty et al., 2003). CDCA7 interacts with c-Myc in a phosphorylation-
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dependent manner: the unphosphorylated form of CDCA7 is present in the nucleus and is 
associated with c-Myc, but following phosphorylation of threonine 163 by protein kinase B 
(PKB/AKT), it dissociates from c-Myc, binds to 14-3-3 protein and is sequestered to the 
cytoplasm (Gill et al., 2013). 
c-Myc is not the only transcription factor targeting CDCA7 expression. CDCA7 is also a direct 
target of E2F1 and E2F4 transcription factors that play a crucial role in cell cycle regulation 
and DNA replication, with both proteins having strongly correlating expression patterns 
(Goto et al., 2006). Notch, a transcription factor essential for normal developmental 
processes, targets CDCA7 in embryonic hematopoietic development: induction of CDCA7 
resulted in maintenance of hematopoietic stem cell (HSC) population through activation of 
the HSC precursors and downregulation of CDCA7 induced hematopoietic differentiation 
(Goto et al., 2006).  
CDCA7 has inverse expression pattern with a transcription factor Pax6 in cortical 
neuroepithelium progenitors, indicating that Pax6 has a repressive effect on CDCA7 
expression and that this process is required for the normal generation of intermediate neural 
progenitors (Huang et al., 2017).  
CDCA7 is not only the target of TFs but itself has been found to possess transcriptional activity 
in its C-terminal cysteine-rich zinc finger domain (Goto et al., 2006). It was found to be 
involved in transmissible gastroenteritis virus (TGEV) pathogenicity via microRNA action: 
microRNA miR-4331 was targeting 3ˈ UTP of CDCA7 mRNA, resulting in transcription 
inhibition of TGEV gene 7 (Song et al., 2015). Even though in the study by Song et al. CDCA7 
has not been directly shown to possess transcriptional activity, the results reinforced that 
notion that it is a part of a transcriptional pathway. Interestingly, CDCA7 is also a target of 
long non-conding RNA in promoting colorectal cancer and this process is counterbalanced by 
CDCA7 downregulation through the action of microRNA miR-302e (Li 2019).  
 
CDCDA7 in cancer  
CDCA7 involvement in transcription links it to cancer development and progression. 
Moreover, its close homologue CDCA7L has been extensively linked to cancer (see below). 
CDCA7 is often overexpressed in cancers, such as colon, rectum, ovary, lung, uterus and 
stomach, and particularly in acute and chronic myelogenous leukaemia (Osthus et al., 2005). 
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Ectopic expression of CDCA7 in transgenic mice correlated with an increased likelihood of 
development of solid tumours in B and T cells (Osthus et al., 2005). CDCA7 was found to be 
a predictor of poor prognosis in triple-negative breast cancer through increasing expression 
of EZH2, a marker of aggressive breast cancer (Ye et al., 2018).  
CDCA7 is elevated in lung adenocarcinoma, and its downregulation resulted in arrest in G1 
and subsequent apoptosis of cancer cells (Wang et al., 2019). CDCA7 is upregulated in 
Burkitt’s lymphoma and T- and B-lymphoid tumours cell lines and contributes to anchorage-
independent growth in lymphomagenesis (Jiménez-P et al., 2018). CDCA7 upregulation is 
associated with poor prognosis in triple-negative breast cancer and predicts metastatic 
relapse through upregulating EZH2, which is a marker of aggressive breast cancer (Ye et al., 
2018). Consistent with this, CDCA7 silencing was shown to decrease lymphoma tumour cell 
invasion, which was linked to alterations in cytoskeleton formation through effects on actin 
and myosin, highlighting CDCA7 important role in metastasis (Martin-Cortazar 2019).  
 
1.4.3 CDCA7 in Immunodeficiency, Centromeric Instability and Facial 
Anomalies (ICF) syndrome   
Like with LSH, CDCA7 mutations are implicated in the recessive autosomal disorder 
Immunodeficiency, Centromeric Instability and Facial Anomalies (ICF) syndrome. Whereas 
the LSH mutation-associated form of ICF is termed ICF4, the CDCA7-associated form is 
termed ICF3 and is linked to several homozygous missense mutations (R274C, R274H, G294V, 
R304H in human) located in the zinc finger domain (Thijssen et al., 2015). These mutations, 
like in the case of the other proteins implicated in ICF, are associated in hypomethylation of 
pericentromeric heterochromatin (Thijssen et al., 2015) but not subtelomeric 
heterochromatin methylation, as it is the case with DNMT3B (ICF1) (Toubiana et al., 2018). 
Another ICF-related protein ZBTB24 (ICF2 form) was found to affect transcription of CDCA7 
and it was enriched in the CDCA7 promoter, indicating that it is a CDCA7 transcription factor 
controlling CDCA7 expression through its BTB (BR-C, ttk and bab) domain (Wu et al., 2016a). 
The converging actions of the ICF-associated proteins were further elucidated by the finding 
that LSH requires CDCA7 to carry out its chromatin remodelling function (as demonstrated 
by nucleosome remodelling assay) (Fig. 1.14) and ICF-associated CDCA7 mutations abrogate 
LSH recruitment to chromatin (Jenness et al., 2018).   
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Apart from LSH, CDCA7 interaction with classic non-homologous end joining (C-NHEJ) 
proteins Ku70 and Ku80 was demonstrated by co-immunoprecipitation experiments (Unoki 
et al., 2018). ICF mutations of CDCA7 as well as nuclease treatment abrogated the interaction 
(Unoki et al., 2018), indicating that CDCA7 interacting with Ku70 and Ku80 is bridged by DNA 
or a nucleosome, and that CDCA7 mutations may result in the ICF phenotype not only 
through loss of DNA methylation but also through genome instability. Nevertheless, CDCA7 
mutations are still linked to altered DNA methylation, as indicated by the analysis of the 
global methylome of ICF patients, which revealed differential methylation in CpG-poor 
regions of genes related to neuronal development in patients with CDCA7 mutations (Velasco 
et al., 2018).  
 
1.4.4 CDCA7-LSH interaction 
Recent findings identified CDCA7 as a direct interaction partner of LSH (Jenness et al., 2018), 
and this interaction provides molecular conditions for LSH ATPase activation. Mass 
spectrometry of unmodified or silent chromatin of Xenopus egg extracts showed 
stoichiometric levels of LSH and CDCA7, indicating that they form a complex through the cell 
cycle, with the exception of M phase and cytokinesis. However, immunodepletion of either 
protein did not deplete the other, indicating that only a fraction of each protein exists in the 
complex (Jenness et al., 2018). Importantly, this interaction is conserved, since exogenously 
expressed CDCA7L also interacted with LSH in egg extract (Jenness et al., 2018) 
LSH binding to chromatin was dependent on CDCA7, but CDCA7 did not need LSH for 
chromatin binding, and CDCA7 ICF mutants R274C/H and R304H blocked its binding to 
chromatin and failed to recruit LSH (Jenness et al., 2018).  
The nucleosome remodelling performed by Jenness et al. (2018) utilised a mononucleosome 
with symmetric 20 bp DNA linkers on each side and an engineered PstI restriction site 15 bp 
into the nucleosomal core. Following remodelling, the PstI site is exposed and cleaved by PstI 
restriction enzyme. The samples are then resolved on a PAGE (native or denaturing). 
Remodelled nucleosomal species or cleaved DNA (on a native or denaturing gel, respectively) 




Figure 1.14 Nucleosome remodelling assay used to detect chromatin remodelling by LSH in the 
presence of CDCA7 as described in Jenness et al. 2018. Nucleosomal DNA contains a PstI restriction 
site that is protected by the nucleosomal core. After remodelling is performed the site shifts from 
the core and becomes accessible to PstI restriction enzyme. Enzymatic cleavage results in generation 
of a nucleosomal species of a smaller size. The size difference is observed on a native or denaturing 
gel as a shift of a nucleosome (native) or free DNA (denaturing).  
 
1.4.5 Cdca7L - a close homologue of CDCA7 
CDCA7 has 45% protein sequence identity and 77% in the C-terminal region with its 
homologues CDCAL/JPO2/R1. The C-terminus of CDCA7 contains a RING zinc finger domain 
(Bartholomeeusen et al., 2007). CDCA7L was identified as an inhibitor of monoamine oxidase 
A (MAO A) – an enzyme that causes degradation of the crucial neurotransmitters serotonin, 
dopamine and norepinephrine and produces neurotoxic reactive oxygen species – by directly 
binding to MAO A promoter in vivo (Chen et al., 2005). CDCA7L is also a c-Myc responsive 
gene and protein interacting partner, which rescues transforming activity in a 
transformation-defective c-Myc mutant (Huang et al., 2005). MAO A inhibiting function of 
CDCA7L was found to be involved in apoptosis inhibition: c-Myc-mediated expression of 
CDCA7 inhibited MAO A (Ou et al., 2006). The MAO A inhibition, in turn, was accompanied 
by the increase in cell-cycle regulators E2F1 or cyclin D1, thus enhancing cell proliferation (Ou 
et al., 2006). 
There is ample evidence of CDCA7L involvement in malignancy formation. CDCA7L is 
upregulated in common the cancer hepatocellular carcinoma (HCC) and promotes its 
progression from G1/G0 to S phase through activation of ERK1/2 signalling pathway and 
cyclin D1 (required for progression through G1) expression (Tian et al., 2013). It is also 
expressed in human glioblastoma cells, and its high expression was a poor prognostic 
indicator for glioma patients (Ji et al., 2019; Shen et al., 2019). Downregulation of CDCA7L 
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was associated with blocking of cell cycle in G1/G0 through reduction of cyclin D1 expression 
(Ji et al., 2019), indicating that cyclin D1 is a target gene of CDCA7L.  
CDCA7L overexpression results in metastatic medulloblastoma through interaction with 
LEDGF/p75 protein and regulation of protein kinase B/AKT signalling (Chan et al., 2016; 
Huang et al., 2005). The interaction with p75 is mediated by the N-terminal 61-residue region 
on CDCA7L (residues 58-119) and allows p75 to tether CDCA7L to chromosome during mitosis 
(Maertens, 2006). This CDCA7L-p75 interaction was shown to prevent binding of the p75 C-
terminus to HIV-1 integrase and overexpression of CDCA7L resulted in a modest inhibition of 
HIV-1 replication (Bartholomeeusen et al., 2007). Interestingly, CDCA7L overexpression 
resulted in transactivation of HIV-1 (Bartholomeeusen et al., 2007), indicating that its 
function as a transcription factor is separate to its function as a competitive binder of p75.  
At the epigenetic level, CDCA7L repression in melanoma cells was associated with loss of 
















1.5 Aims of the project 
LSH is a putative remodeller and not only does its functions have implications for cancer, DNA 
repair and de novo DNA methylation but it also has an elusive implication in the ICF 
syndrome. Previously, LSH structure was attempted to be elucidated by high and low 
resolution structural methods, however, due to a large degree of disorder a detailed LSH 
structure is hard to solve. Therefore, it was decided to investigate structural aspects of LSH 
and using homology modelling, as well as to optimise expression of LSH for structural studies.  
I attempted to further investigate LSH-nucleosome complex with various DNA linker lengths 
and histone variants and to form LSH-nucleosome complex to study its biochemical, 
biophysical and structural properties. 
In a parallel study, a newly identified binding partner of LSH termed CDCA7 was studied in 
more details. Like LSH, CDCA7 has limited structural information and no structural 
information for its homologues, therefore, I used ab initio modelling in attempt to gain 
further understanding of its interaction with LSH and DNA. Expression, purification and 
characterisation of CDCA7, as well as investigation of the possible complex formation 














2. MATERIALS & METHODS  
2.1 LSH and CDCA7 cloning, expression and purification  
 
2.1.1 Protein constructs and their characteristics  
 
The following constructs were used in the present study:  
 





Tag (C- or 
N-
terminal) 








LSH M. musculus 1-821 C-6xHis pFL Sf9 96 77070 8.2 
LSH_K2
37Q* 
M. musculus 1-821 C-6xHis pFL Sf9 96 77070 8.2 
CDCA7 M. musculus 1-382 N-GST-3C pFL Sf9 44 23920 8.94 
CDCA7 M. musculus 1-382 N-GST-3C pEC-
KCG 
E. coli 44 23920 8.94 
CDCA7_
T1 
M. musculus 64-382 N-GST-3C pEC-
KCG 
E. coli 37 22180 8.64 
CDCA7_
T2 
M. musculus 151-382 N-GST-3C pEC-
KCG 
E. coli 27 22180 8.99 
Antibiotic resistance: pFL – ampicillin, pEC-KCG – kanamycin  
*Previously cloned by Simon Varzandeh 
 
2.1.2 DNA manipulations  
2.1.2.1. Primers used for LSH and CDCA7 cloning 
The constructs were amplified with the following primers purchased from integrated DNA 
Technologies: 
Table 2.2 Primers used for amplification of the of LSH and CDCA7 constructs used in cloning. 
Name  Sequence (5’ to 3’) 
LSH_full_length_F (Sf9) TTTCGCGGATCCATGGCCGAA 
LSH_full_length_R (Sf9) CTCGTCGACTCAGTGGTGATGGTTTT 
CDCA7_full_length_F_LIC (Sf9) CCAGGGGCCCGACtcgTCCGACTCCGAGGAAGAAGA 
CDCA7_full_length_R_LIC (Sf9) GAGTTCGAGATGCAGGCCTAAGCAGTCGGTGGCGGTCTG 
CDCA7_full_length_F_LIC (E. coli) CCAGGGGCCCGACtcgATGGAAGCACGTCGTGCACG 
CDCA7_T1_F_LIC (E. coli) CCAGGGGCCCGACtcgCGTCATAGCGGTCCGCTGC 
CDCA7_T2_F_LIC (E. coli) CCAGGGGCCCGACtcgGGTCGTCATTCACTGCCTGGTCA 
CDCA7_R_LIC (E. coli) CAGACCGCCACCGACtgcTTAGGCCTGCATTTCAAATTCTTGTTTCAG 
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M13_F CCC AGT CAC GAC GTT GTA AAA CG 
M13_R AGC GGA TAA CAA TTT CAC ACA GG 
 
2.1.2.2. PCR  
Templates for PCR amplification were either previously generated in the lab or cDNA was 
purchased from GeneArt (Thermo Fisher Scientific). Polymerase chain reaction (PCR) (Table 
2.3) was carried out on the Biometra TProfessional Gradient 96 Thermocycler. To clone the 
protein constructs, Q5 polymerase (NEB) was used, according to the manufacturer’s 
protocol.  
The thermocycler programme was as follows: 
 
Table 2.3 PCR programme used for construct amplification with Q5 DNA polymerase. 
Step  Temperature  Time  Cycles  
1 98oC 1 min  
2 95oC 30 s 30x 
3 68oC 30 s 
4 72oC 1 min  
5 72oC 3 min  
6 4oC Hold  
 
Table 2.4 Reagents with stock concentrations and volumes used in PCR reactions for protein 
constructs amplification. 
Reagent (stock concentration) Volume  
5x Q5 buffer 10 µl 
dNTPs (10 µM) 1 µl 
DMS0 (100%) 2.5 µl 
Primer_F (10 µM) 1 µl 
Primer_R (10 µM) 1 µl 
DNA template (10 ng/µl) 1 µl 
Q5 DNA polymerase 1 µl 
ddH2O 31.5 µl 
Total  50 µl 
 
2.1.2.3. Plasmid restriction digest 
Plasmids containing the appropriate insert and backbone were incubated with FastDigest 
restriction enzymes (Thermo Scientific) (see Table 2.4) for 30-60 min at 37oC, and 2-5 µl of 
each reaction sample was run of 0.5-1% (w/v) agarose gel prepared with SafeView DNA stain 
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(NBS Biologicals). The appropriate bands were visualised using a UV lamp, cut out, purified 
from the gel using QIAGEN QIAquick Gel Extraction kit and eluted with 30 µl ddH2O. 
 
Table 2.5 Reagents and their volumes used in the plasmid restriction digest.  
Reagent and stock concentrations Volume  
Restriction enzyme (e.g. SalI or BamHI) 1 µl 
DNA to 1 µg X µl 
Buffer (10x) 2 µl 
ddH2O To 20 µl 
 
 
2.1.2.4 DNA ligation  
Ligation reactions involved the gel-purified vector and insert DNA approximately at the molar 
ratio 1:3, respectively. The reaction (Table 2.5) was incubated at room temperature for 1h or 
at 16oC overnight. 1 µl of each resulting reaction was then used to transform chemically 
competent E. coli DH5α cells. 
 
Table 2.6 Reagents and their volumes used for DNA ligation.   
Reagent and stock concentrations Volume  
T4 DNA ligase  1 µl 
T4 DNA ligase buffer (10x) 2 µl 
Vector DNA 100 ng X µl 
Insert DNA 200-500 ng X µl 
ddH2O To 20 µl 
 
 
2.1.2.5 Ligation-independent cloning (LIC) 
Ligation-independent cloning (LIC) is an efficient method for construct generation. It relies 
on the production of a vector and an insert with complementarity regions. The insert is then 
incubated with dATP and T4 DNA polymerase, which possesses a 3'-5'exonuclease activity 
that creates the complementary overhangs. The vector is incubated with dTTP and T4 DNA 
polymerase. These reactions generate complementary overhangs, which ligate when the 
insert and vector are mixed together. Adding only one of the four nucleotides (dATP or dTTP) 
allows balancing out the exonuclease and polymerase activity of T4 DNA polymerase, stalling 
of T4 DNA polymerase and creates the overhangs. 
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CDCA7 coding DNA sequence (CDS), codon-optimised for either insect cell or bacterial 
expression, was purchased from GeneArt (Thermo Fisher Scientific). The CDS was amplified 
using the standard PCR protocol with Q5 polymerase (see Section 2.1.2.2 PCR) and primers 
containing LIC-specific overhangs (see Table 2.2). 2 µg of vector was incubated with 20 U of 
ZraI in 100 µl reactions to linearise the vector. The insert and vector were gel-extracted using 
QIAquick Gel Extraction Kit and then, in preparation for LIC, incubated in the presence of 
dATP and dTTP, respectively, using the reaction mixtures described in Tables 2.6 and 2.7.   
 
Table 2.7 Components and their volumes used for insert preparaton for LIC.  
Reagent and stock concentrations Volume  
Gel-purified PCR product of the insert 
DNA (600 ng) 
X µl 
10x T4 DNA pol. buffer  2 µl 
dATP (25 mM) 2 µl 
DTT (100 mM) 1 µl 
T4 DNA pol. (LIC-qualified from Novagen)  0.4 µl 
ddH2O  X µl to 20 µl 
  
Table 2.8 Components and their volumes used for linearised vector preparaton for LIC. 
Reagent and stock concentrations Volume  
Linearised vector (450 ng) X µl 
10x T4 DNA pol. buffer  3 µl 
dTTP (25 mM) 3 µl 
DTT (100 mM) 1.5 µl 
T4 DNA pol. (LIC-qualified from Novagen)  0.6 µl 
ddH2O  X µl to 30 µl 
 
Mixes were incubated at RT for 30 min, followed by enzyme inactivation at 75oC for 20 min. 
Linearised LIC pFL vector for insect cell expression containing an N-terminal GST tag was a 
kind gift from the Cook lab. 1 µl of linearised vector and 2 µl of insert were mixed and 
incubated at RT for 10 min, followed by addition of 1 µl of 25 mM EDTA with a further 10 min 
RT incubation to inactivate any residual enzymes in the mixture. 2 µl of the reaction were 




2.1.2.6 Bacterial transformation and colony screening 
Chemically competent E. coli DH5α cells were thawed on ice and 50-100 ng of plasmid DNA 
(~0.5-1 µl) was added to them. The reaction was incubated on ice for 20-30 min, heat-
shocked at 42oC and was let to recover on ice for 2 min. 200 µl of antibiotic-free SOC medium 
was added to each reaction. The cells were incubated with shaking at 37oC for 1h, streaked 
onto an agar plate containing relevant antibiotics (ampicillin for pFL and kanamycin for pEC-
KCG) and incubated overnight at 37oC. 
The next day the colonies were checked, and plates left at 4oC during the day to avoid colony 
overgrowth. In the evening the colonies were picked and inoculated in 5 ml or LB medium 
containing relevant antibiotics and incubated overnight.  
The following morning the test cultures were pelleted and processed according to QIAGEN 
Miniprep kit manufacturer’s protocol. The absorbance at 260 nm of purified DNA was 
measured on a Nanodrop (Thermo Fisher Scientific) to determine the DNA concentration. 
The purified DNA was digested with relevant restriction enzymes to confirm the clones that 
had the expected size and intact restriction sites and separated on 0.5-1% (w/v) agarose gel.  
 
2.1.2.7. Sanger sequencing 
Plasmids were verified by Sanger sequencing using construct-specific primers. The 
sequencing mixes were as follows:  
Table 2.9 Mixes used in Sanger sequencing reactions.  
Reagent and stock concentrations Volume  
5x Big Dye buffer  5 µl 
5x Big Dye Terminator v3.1 (Thermo Fisher) 5 µl 
3.2 µM sequencing primer  1 µl 
Plasmid DNA (200-500 ng) X µl 
ddH2O X µl to 10 µl 
 
The mixes were run on a PCR thermocycler. The thermocycler programme was as follows:  
Table 2.10 Biometra TProfessional Gradient 96 Thermocycler programme for Sanger 
sequencing with Big Dye terminator. 
Step  Temperature  Time  Cycles  
1 90oC 30 s  
25x 2 50oC 20 s 
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3 60oC 4 min 
4 60oC 1 min 15 s  
5 4oC Hold  
 
Sanger sequencing was carried out on the isolated clones by Edinburgh Genomics. 
Sequencing chromatograms were analysed in Benchling software by comparing to the 
template sequence. Correct clones were used for downstream applications.  
 
2.1.3 Insect cell work 
2.1.3.1 Preparation of EMBacY competent cells  
Buffers:  
TFB1 (100 ml): 30 mM KAc, 100 mM RbCl, 10 mM CaCl2*2H2O, 50 mM MnCl2*4H2O, 15% (v/v) 
glycerol, pH 5.8 
TFB2: 10 mM MOPS, 10 mM RbCl, 10 mM CaCl2*2H2O, 15% glycerol, pH 6.5 
A stock of EMBacY was spread on a plate containing 50 µg/ml kanamycin, 10 µg/ml 
tetracycline and 100 µg/ml carbenicillin and incubated at 37oC overnight. A single colony was 
inoculated into 5 ml LB with appropriate antibiotics (same as on the plate) and grown 
overnight. The culture was diluted to 250 ml with LB pre-warmed to 37oC and MgSO4 added 
to 20 mM. The cells were grown to OD600 ~0.6, transferred to autoclaved and chilled 
centrifuge tubes, left on ice for 10 min and spun down at 4,000 g for 5 min at 4oC. Pellets 
were resuspended by gentle pipetting in 50 ml of ice-cold TFB1 buffer and left on ice for 5 
min. Cells were pelleted at 1,400 g for 10 min at 4oC and resuspended by gentle pipetting in 
5 ml (per 125 ml of cells) of ice-cold TFB2 buffer and left on ice for 15 min. Cells were 
aliquoted in 100 µl into pre-chilled Eppendorf tubes in sterile conditions, snap-frozen in liquid 
nitrogen and stored at -80oC.  
2.1.3.2 Bacmid preparation  





Table 2.11 Antibiotics used for bacmid preparation.  
Antibiotic  Final concentration  
Gentamycin  10 µg/ml 
Kanamycin  50 µg/ml 
Tetracyclin  10 µg/ml 
 
Prior to plating the cells, 100 µl of 0.1 M IPTG and 100 µl of 20 mg/ml X-gal for blue-white 
screening were added to the plates, which were allowed to dry for 30-60 min at 37oC. For 
bacterial transformation, a vial of EMBacY competent cells were retrieved from -80oC and 
thawed on ice. 30 ng of pFL plasmid containing the construct of interest were added to the 
cells, gently flicked and incubated on ice for 45 min, following by a heat shock for 60 s at 42oC 
and recovery on ice for 3 min. 900 µl of SOC media was added and the cultures were 
incubated at 37oC with 250 rpm agitation for 4-5 h. Following that, the cultures were 
centrifuged at 13,000 rpm for 1 min, 750 µl of the supernatant was removed and the cell 
pellets were resuspended in the remaining supernatant. 40 µl and 200 µl of the culture were 
streaked onto the prepared agar plates to allow for better colony separation and incubated 
at 37oC overnight or longer, until the colour develops in the blue-white colony screening. 
Once the colour developed, white colonies, which contained the construct, were re-streaked 
on a fresh plate to select for true positive colonies.  
To purify bacmids, a single colony was inoculated into 10 ml of LB with the relevant antibiotics 
(see Table 2.11) at 37°C and 250 rpm overnight. The cells were pelleted and resuspended in 
250 µl of P1 resuspension buffer containing 100 µg/ml RNase A of QIAprep Spin Miniprep Kit. 
250 µl P2 lysis buffer was added and thoroughly mixed by inversion, followed by addition of 
350 µl N3 neutralisation buffer and mixed. The samples were centrifuged at 13,000 rpm for 
10 min at 4°C. DNA-containing supernatant was then added to fresh tubes containing 800 µl 
100% isopropanol and mixed. The samples were centrifuged at 13,000 rpm for 15 min at 4°C. 
Supernatants were discarded and the pellets washed in 500 µl 70% ethanol and centrifuged 
at 13,000 rpm for 5 min at 4°C. The pellets were air dried and resuspended in 50 µl of EB 
buffer. The sample concentrations were measured at 260 nm, with the 260/280 ratio used 
to assess DNA purity, diluted to 1 µg/µl, aliquoted in 50 µl for single-use to avoid freeze-
thawing and stored at -20oC. Insert-specific and bacmid-specific (M13) primers were used to 
assess plasmid integration into the bacmid backbone. PCR reactions were visualised 
following a 1% agarose run and staining with SafeView (NBS Biologicals). The presence of an 




2.1.3.3 Insect cell culture 
Sf9 insect cells isolated from the Spodoptera frugiperda cell line IPLB-Sf-21-AE was used for 
transfection and amplification of recombinant baculovirus, as well as protein expression. 
Immediately after resuscitation from cryogenic storage, the cells were maintained as an 
adherent culture in T75 flasks (Corning with vented cap) in approximately 10 ml of Sf-900 II 
SFM (Thermo Fisher Scientific) at 27oC without antibiotics. The day after resuscitation, the 
media was changed, and cells were allowed to reach 100% confluence. Following that, the 
cells were detached by applying horizontal forceful impact on the flask. The suspension 
cultures were maintained at 27oC with 100 rpm agitation in conical baffled flasks with the 
culture –to-flask volume ratio in ml not exceeding 1:4.  
 
2.1.3.4    Transfection of Sf9 cells 
All transfection and protein expression work in insect cells was carried out in a sterile cabinet. 
An aliquot (50 µl at 1 µg/µl) of a relevant bacmid was mixed with 500 µl of pre-warmed Insect 
cell medium Sf-900 II SFM and gently flicked. 20 µl of X-tremeGENE HP DNA transfection 
reagent (Sigma-Aldrich) was added to the mix and gently flicked again. The transfection mix 
was left for 30 min at room temperature (in the cabinet). Meanwhile, healthy (97-100% 
viability) Sf9 cells were diluted to 1*106 cell/ml and 2 ml was added to each well in clear 6-
well plates. Following the transfection mix incubation, 110 µl of the mix was added to each 
well, gently mixed and incubated at 27oC. Fluorescence intensity was monitored every 24 h. 
After 72-96 h, supernatants containing baculovirus were pelleted by centrifugation and 
filtered in a sterile syringe through a 0.22 µm filter into a sterile 15 ml Falcon tube. The virus 
was labelled V0 (viral generation 0) and stored at 4oC for no more than 2 months wrapped in 
foil for light protection.  
 
2.1.3.5 Baculovirus amplification 
The V0 stock was used to produce subsequent viral generations of increased viral titres. V1 
was generated by adding 2.5 ml of V0 to 50 ml of Sf9 cells at a cell density 1.5*106 cells/ml 
(1:20 v/v virus:cell culture). The cells were grown for ~72h or until the total fluorescence of 
the culture reached around 90%. The cells were pelleted by centrifugation and filtered in a 
sterile syringe through 0.22 µm filter into a sterile 50 ml Falcon tube. The virus was labelled 
V1 (viral generation 1) and stored at 4oC for no more than 2 weeks wrapped in foil for light 
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protection. The pellets were used for a confirmatory pull-down assay (see Section 2.3.4) For 
V2 generation, 1 ml of V1 was added to 50 ml of Sf9 at a cell density 1.5*106 cells/ml (1:50 
v/v virus:cell culture) and the process was repeated. Either V1 or V2 generation was used for 
protein expression.  
 
 
2.1.3.6 Protein expression tests in Sf9 using baculovirus  
1 ml of V1 or 0.75 ml of V2 baculoviral generation was added to 50 ml of Sf9 at a cell density 
1.5*106 cells/ml (1:50 or 1:75 v/v virus:cell culture, respectively). The cells were grown for 
~72h or until the total fluorescence of the culture reached around 90%, after which they were 
pelleted and subjected to a pull-down and/or Western blot to confirm expression of the 
correct protein construct. The virus:cell culture ratio that showed the most viable cultures or 
better protein expression levels was selected for the large-scale expression.  
 
2.1.3.7 Large scale protein expression in Sf9  
Sf9 cells at a density 1.5*106 cells/ml were infected with V1 or V2 at a ratio 1:50 or 1:75, 
depending of the baculovirus strength. For co-infection, two viruses were added to the same 
cell culture. The total Sf9 culture volume was between 0.5 and 2L. Cells were grown for 72h 
with fluorescence and viability monitored every 24h. Cells were pelleted by centrifugation at 
4000 rpm in large centrifuge buckets, the supernatant was discarded, and the pellets were 
frozen in liquid nitrogen and stored at -80oC until further manipulations.  
 
2.1.3.8 LSHWT purification 
Buffers:  
Lysis buffer: 50 mM HEPES pH 7, 500 mM NaCl, 5% glycerol, 2 mM MgCl2, 4 mM beta-
mercaptoethanol, 0.2 mM PMSF, 1x cOmplete EDTA-free protease inhibitor tablet (Sigma-
Aldrich).  
Ni-NTA wash buffer: 50 mM HEPES pH 7, 500 mM NaCl, 5% glycerol, 4 mM beta-
mercaptoethanol, 0.2 mM PMSF, 20-40 mM imidazole (two-step wash), 1x EDTA-free 
protease inhibitor tablet  
Ni-NTA elution buffer: 50 mM HEPES pH 7, 500 mM NaCl, 5% glycerol, 4 mM beta-
mercaptoethanol, 0.2 mM PMSF, 500 mM imidazole, 1x EDTA-free protease inhibitor tablet  
LSH low salt buffer: 50 mM HEPES pH 7, 150 mM NaCl, 5% glycerol, 4 mM beta-
mercaptoethanol, 0.2 mM PMSF, 1x EDTA-free protease inhibitor tablet  
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LSH high salt buffer: 50 mM HEPES pH 7, 1 M NaCl, 5% glycerol, 4 mM beta-mercaptoethanol, 
0.2 mM PMSF, 1x EDTA-free protease inhibitor tablet  
LSH gel filtration buffer: 50 mM HEPES pH 7, 500 mM NaCl, 5% glycerol, 4 mM beta-
mercaptoethanol, 0.2 mM PMSF, 1x EDTA-free protease inhibitor tablet  
 
Around 5 to 10 g of LSHWT-containing Sf9 pellets were resuspended in 5 ml of lysis buffer and 
sonicated on ice for 30 s on/15 s off for the total of 3 min at 30-40% amplitude. Lysate was 
incubated with 3 µl of 250 U/µl of Benzonase nuclease (Sigma) or 50 µl of 2000 U/ml of 
DNAseI (from bovine pancreas, Sigma) on ice for 30-60 min. At this and each following step 
an aliquot was taken for further visualisation by SDS-PAGE. The insoluble fraction was 
pelleted by centrifugation at 50,000 g for 45 min at 4oC. The clarified lysate was loaded onto 
HiTrap IMAC FF 1 ml column on the ӒKTApure system, washed with Ni-NTA buffer and eluted 
with Ni-NTA elution buffer. Fractions were run on 12% SDS-PAGE and stained with Quick Blue 
Coomassie stain (Avidity Science). The protein-containing fractions were then applied onto 
HiPrep 26/10 desalting column and eluted with low salt buffer. The fractions containing the 
protein were pooled and loaded onto Resource S (GE Lifesciences) ion exchange column and 
eluted by salt gradient (150 mM - 1 M) with high salt buffer. The fractions containing the 
protein were again pooled and concentrated to 500 µl for injection onto Superdex200 10/300 
24 ml gel filtration column. Purified protein was run on 12% SDS-PAGE and stained with 
Coomassie stain. Protein concentration calculated from measurement of absorbance at 280 
nm on the Nanodrop with MW and extinction coefficient/1000 settings. Protein was 
concentrated to 0.8-1 mg/ml, aliquoted in 40 µl aliquots, snap-frozen in liquid nitrogen and 
stored at -80oC.  
 
2.1.3.9 LSHK237Q purification 
LSHK237Q-containing Sf9 pellets were processed the same way as LSHWT but HiPrep 26/10 
desalting and Resource S ion exchange columns were omitted since the mutant was meant 
to be used for biochemical assays and did not require high purity.   
 
2.1.3.10 CDCA7 purification 
Buffers: 
Lysis buffer: 50 mM HEPES pH 7, 500 mM NaCl, 5% (v/v) glycerol, 2 mM MgCl2, 4 mM β-
mercaptoethanol, 0.2 mM PMSF, 2x EDTA-free protease inhibitor tablet  
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GSH high salt wash buffer: 50 mM HEPES pH 7, 1 M NaCl, 5% (v/v) glycerol, 4 mM β -
mercaptoethanol, 0.2 mM PMSF 
Around 5 to 10 g of GST-CDCA7-containing Sf9 pellets were resuspended in 5 ml lysis buffer 
and sonicated on ice for 30 s on/15 s off for the total of 3 min at 30-40% amplitude. The 
Lysate was incubated with 3 µl of 250 U/µl of Benzonase nuclease (Sigma) or 50 µl of 2000 
U/ml of DNAseI (from bovine pancreas, Sigma) on ice for 30-60 min. At this and each 
following step an aliquot was taken for further visualisation by SDS-PAGE. The insoluble 
fraction was pelleted by centrifugation at 50,000 g for 45 min at 4oC. 
Meanwhile, GSH resin was prepared. 1 ml of resin (bed volume) was used for every 1 L of cell 
culture at 1-2 million/ml cell density. The appropriate resin volume was transferred to an 
Eppendorf tube and spun at 8,000 rpm and the storage buffer was discarded. The resin was 
washed twice with ddH20 and twice with CDCA7 lysis buffer for equilibration. The 
equilibrated resin was then added to the clarified supernatant, and the mixture was 
incubated for 2-3h at 4oC with rocking. Following that, the sample was micro-centrifuged for 
2 min at 5,000 prm and the flow-through transferred to a fresh tube. The resin was washed 
twice with lysis buffer, then twice with high-salt wash buffer and then twice in lysis buffer 
again. 1 ml of lysis buffer was added to the resin following the washes and 10 µl of 3C-6xHis 
protease (Sino Biological) at 1000 U/ml was added for an overnight incubation (16-18h). The 
samples were checked on an 12% SDS-PAGE gel. Protein concentration was measured by BSA 
titration and the protein aliquoted in 50 µl aliquots, snap-frozen in liquid nitrogen and stored 
at -80oC. 
 
2.2 Preparation of nucleosomes  
2.2.1 Histone expression and purification 
The following histones were prepared:  










H2A  1-129 14 4470 
H2B  1-125 14 7450 
H3  1-135 15 4470 
H3T 28-135 12 4470 
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H4  1-102 11 5960 
Histones were not tagged.  
Acidic patch mutant histones (H2A: E65A E90A E91A; H2B: E105A) were expressed and 
purified by the Wilson lab (University of Edinburgh) following the standard protocol used in 
this study.  
 
2.2.1.1 Preparation of inclusion bodies  
Buffers:  
Wash buffer 1: 50mM Tris pH 7.5, 100mM NaCl, 1mM EDTA, 1mM benzamidine, 1% (v/v) 
Triton X-100 
Wash buffer 2: 50mM Tris pH 7.5, 100mM NaCl, 1mM EDTA, 1mM benzamidine 
Unfolding buffer: 7 M guanidine-HCl, 20 mM Tris pH 7.5, 10 mM DTT 
Urea buffer A (low ionic strength): 7 M urea, 100 mM NaCl, 10 mM Tris pH 8, 1 mM EDTA, 5 
mM β-mercaptoethanol, 0.2 mM PMSF 
 
Xenopus laevis histone constructs (see Table 2.12) were a kind gift from the Voigt lab 
(University of Edinburgh). Recombinant core histone proteins, along with a truncated version 
of H3 lacking 1-27 N-terminal residues (Luger et al., 1997a), were expressed in BL21 E.coli 
cells from a pET3 vector containing ampicillin resistance gene. All agar plates contained 100 
µg/ml of ampicillin. BL21(DE3)pLysS was used for H2A, H2B, H3 and H3T (with the addition 
of 34 µg/ml of chloramphenicol), and BL21(DE3) for H4. Additionally, the histone-containing 
plasmids were separately transformed into XL10 Gold E. coli cells for preparation of plasmid 
stocks. DNA was purified by the Qiagen plasmid Miniprep kit and stored at -20oC for future 
bacterial transformations. Both transformations were carried out following a standard 
transformation protocol. In brief, competent cells were allowed to thaw on ice, and around 
50 ng of DNA was added to them. Cells were allowed to recover on ice for 20 min, heat-
shocked for 35 s at 42oC, further recovered on ice for 2 min. 200 µl of SOC media was added, 
and the cells were recovered at 37oC for 30 min-1h with shaking. Following this, they were 
plated onto agar plates containing 100 µg/ml of ampicillin and 34 µg/ml of chloramphenicol, 
where required, and incubated at 37oC overnight. The following day, colonies were picked 
from plates and inoculated into 50 ml LB media containing 100 µg/ml of ampicillin and 34 
µg/ml of chloramphenicol, where required. The following day, starter cultures were 
amplified in 2 L LB at 37oC with shaking and allowed to reach to OD600 = 0.5-0.7. Protein 
55 
 
expression was induced with 0.2mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 3h, 
following the cell harvest by centrifugation at 4000 rpm for 20 min at 4oC. Cells then were 
resuspended in 40 ml of Wash buffer 1, centrifugation repeated, supernatant removed and 
the pellets snap-frozen in liquid nitrogen or 100% ethanol-dry ice mix and stored at -80oC 
until further manipulations.  
For the protein purification stage, cells were thawed in a warm water bath, and the freeze-
thaw cycle repeated. Cells were sonicated for 2 min at 40% amplitude (10 s on/off). Lysates 
were centrifuged at 23,000 g for 45, and pellets containing the inclusion bodies collected. 
The pellets were washed twice in Wash buffer 1 and then Wash buffer 2, with centrifugation 
steps of 10 min at 4oC and 20,000 g performed after each wash. To solubilise inclusion bodies 
and release the protein, unfolding buffer was added to cell pellets and left at room 
temperature (RT) for 1-2h with stirring. This was followed by centrifugation at RT for 20min 
at 23,000 g. Supernatants containing histones were dialysed into urea buffer A (low salt). 
Following this, precipitates were removed by 20 min centrifugation at 4oC and 23,000g. 
  
2.2.1.2 Tandem ion exchange chromatography  
Buffers:  
Urea buffer A (low ionic strength): 7 M urea, 100 mM NaCl, 10 mM Tris pH 8, 1 mM EDTA, 5 
mM β-mercaptoethanol, 0.2mM PMSF (same as in the previous section)  
Urea buffer B (high ionic strength): 7 M urea, 1 M NaCl, 10 mM Tris pH 8, 1 mM EDTA, 5 mM 
β-mercaptoethanol, 0.2mM PMSF 
Histones were purified using HiTrap Q (anion exchange) and SP (cation exchange) columns 
on an AKTA Pure system. Buffer A (low salt) was used for equilibration and wash, and a linear 
gradient 0-50% of buffer B (high salt) was used for histone elution. The samples were loaded 
onto HiTrap Q (top) and SP (bottom) columns connected together and washed extensively. 
HiTrap Q column collected negatively charged contaminants and was dismantled, and 
histones eluted from HiTrap SP column using gradient elution with buffer B. Peak fractions 
were analysed on 15% SDS-PAGE, and relevant fractions pooled. Histone were dialysed into 
ddH2O and their concentrations were measured by Bradford assay (Thermo Fisher Scientific) 
using serial dilutions 1:20, 1:40 and 1:80 and confirmed on 15% SDS-PAGE. Following 
quantification, histones were dialysed into water containing 5 mM β-mercaptoethanol and 




2.2.1.3 Histone octamer formation  
Refolding buffer: 10 mM Tris pH 8, 1 mM EDTA, 2 M NaCl, 5 mM β-mercaptoethanol 
Equal amounts of histones (at least 1mg each) in either unfolding or urea buffer B were mixed 
and dialysed into 500 ml of pre-chilled refolding buffer at 4° C for 2h, overnight and then 2h 
again the next day. Samples were then centrifuged at 13,000 rpm for 15 min at 4o C to remove 
precipitations, transferred to new tubes and centrifugation step repeated. Large 
precipitations indicate wrong histone ratios. Recovered histone octamers underwent gel 
filtration on a Superdex 200 10/30 column (24 ml). Elution was performed for 1.5 column 
volumes (CV). Fractions of aggregates and octamers were run on 20% SDS-PAGE for 1.5-2h 
for good resolution. Fractions were pooled, and octamers were measured by Bradford assay. 
For long-term storage, octamers were aliquoted for 1-use portions, snap-frozen in liquid 
nitrogen and stored at -80oC.   
 
2.2.1.4 Primers for 601 Widom DNA sequence amplification 
601 Widom DNA sequence for subsequent nucleosome reconstitution was amplified with the 
following primers to produce DNA fragments of different lengths.  
Table 2.13 Primers used for generation of 601 Widom DNA sequence. IR800 – near-infrared 
fluorescent label covalently attached to the indicated primers.  









2.2.1.5 PCR amplification of 601 sequence with various DNA linkers 
Four DNA fragments containing the strong nucleosome positioning Widom (W) 601 sequence 
were amplified with/without the following DNA linkers: 0W0 – no linker, 6W0 – 6 bp linker, 
12W0 – 12 bp linker, 25W0 – 25 bp linker. The reverse primer IR800-R-601-0_NCP was 
conjugated with IR800 fluorophore (791 nm excitation, 809 nm emission). All primers were 
purchased from Integrated DNA Technologies. Primers containing a fluorescent tag were 
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purified by HPLC. The pBlueScript-601 plasmid containing 601 Widom was used as a 
template. For preparation of 601 Widom DNA, homemade (prepared in the Stancheva lab, 
University of Edinburgh) Taq polymerase was used. 
 
Reaction mixes were scaled up to 2, 5 or 10 ml to obtain enough DNA for nucleosome 
reconstitution (tens of micrograms of DNA). The reaction composition is described in table X 
below.  
 
Table 2.14 Reagents and their stocks for preparation of Widom 601 DNA for nucleosome 
recostitution.  
 
Mixes were added in 100 μl aliquots into PCR tubes and PCR performed using the parameters 
described in Table 2.15 below.   
 
Table 2.15 PCR programme for amplification of Widom 601 DNA 
 




Volume for 50 
µl reaction 
(µl) 
Volume for 5 
ml reaction 
(µl) 
Volume for 10 ml 
reaction (µl) 
MgCl2 (50 mM) 6 mM 6 600 1200 
dNTP (10 mM) 200 µM 1 100 200 
DMSO (100%) 7% 3.5 350 700 
Taq buffer 10x 1x 5 500 1000 
Fwd primer (10 
µM) 
200 nM 1 100 200 
Rev primer (10 µM) 200 nM 1 100 200 
Template 10 ng/µl 200 pg/µl 1 80 160 
Taq polymerase 2.5 U/ml 1 100 200 
H2O  30.5 3050 7100 
Step   Temp ( oC)  Time  Cycles  
1 Initial denaturation  98 30 s  
2 Denaturation  98 20 s 30x 
3 Annealing  55oC 30 s 
4 Elongation  70oC 30 s 
5 Final elongation  70oC 3 min  




After the PCR reaction, samples were pooled, and purification of the PCR products 
performed using the Invitrogen PureLink PCR purification kit. Samples were run on 1% 
agarose gel, stained with Safe View and scanned on a Geldoc scanner and Odyssey 
scanner (Li-Cor) at 800 nm wavelength to check both DNA content and fluorescence 
intensities. Absorbance of the purified fragments was measured at 260 nm on 
Nanodrop. Samples were stored in the PCR purification elution buffer at -20oC.  
 
2.2.1.6 Oligonucleotide annealing  
Oiligos were resuspended in ddH2O to a 1 mM stock before being checked using UV 
spectroscopy and adjusted to 0.5 mM. Equal volumes of complementary oligonucleotides 
were mixed with equal volumes of 2x TEN buffer (20 mM Tris pH 7.5, 100 mM NaCl, 2 mM 
EDTA). The mixture was heated to 90°C for 10 mins in a heat block, with a hot block covering 
the Eppendorf lids to prevent condensation. The heat block was turned off and blocks were 
removed with slow cooling to room temperature for ~4 h. The annealed oligonucleotides 
were analysed using 20% native PAGE. If the DNA was IR800 labelled the gel was scanned on 
an Odyssey scanner (Li-Cor). 
 
 
2.2.1.7 Nucleosome reconstitution by salt gradient dialysis 
 
Buffers: 
TE buffer: 10 mM Tris pH 8, 1 mM EDTA 
6% TBE gel: 5.5 ml ddH2O, 2.5 ml 2x TBE, 1 ml 30% acrylamide, 25 μl 10% APS, 10 μl TEMED 
 
For a small-scale reconstitution (100 nM DNA), each Widom DNA fragment of interest was 
mixed with an histone octamer at an appropriate molar ratio (in the range of 0.5-1 moles 
DNA to 1 moles of histone octamer) in refolding buffer and added to 0.1 ml Slide-a-Lyzer 
(Thermo Fisher Scientific) dialysis tubes (10,000 MW CO). Samples were placed in 200 ml 
refolding buffer and 800 ml of TE buffer was added drop-wise by a peristaltic pump at a 
flow-rate 1 ml/min at 4oC with gentle stirring. Following that, the samples were incubated 




For large-scale reconstitution (using 500 nM-1 µM DNA), the small scale reconstitution 
reactions of an appropriate ratio were used as a guideline, the amounts of each reagent 
were multiplied by 5, mixed and added to 0.5 ml Slide-a-Lyzer dialysis tubes (10,000 MW 
CO), with the downstream process the same as for the small scale reconstitution. 
 
Following dialysis, samples were transferred to fresh Eppendorf tubes and spun at 13,000 
rpm for 3 min at 4oC to remove any precipitates.  To assess nucleosome reconstitution, 5 μl 
of each sample were mixed with 5 μl of 20% (v/v) glycerol and run on a native 6% TBE gel 
(see Table 2.3.2 for gel recipe) (ran in 0.5x TBE buffer) alongside their respective free DNA 
fragments at 100 V and 4oC for 1h. Gels were scanned on an Odyssey scanner (Li-Cor) 
immediately after the run (for the oligos containing a fluorophore) or stained with SafeView 
nucleic acid stain and visualised on Geldoc scanner (DNA without a fluorophore). To 
calculate Nucleosome yields, absorbance at 260 nm was measured on Nanodrop, gel images 
were processed in Image Studio Lite software (https://www.licor.com/bio/image-studio-
lite/) to estimate the percentage of free DNA in nucleosome samples.     
 
2.2.1.8 Electrophoretic mobility shift assay (EMSA) 
Buffers: 
Binding buffer 5x: 100 mM HEPES pH 7, 250 mM NaCl, 50% (v/v) glycerol, 5 mM DTT 
LSH storage buffer: 50 mM HEPES pH 7, 500 mM NaCl, 10% (v/v) glycerol, 1 mM DTT 
Running buffer 1x: 60 mM Tris, 40 mM CAPS 
 
EMSAs were performed in 20 μl reaction volumes in binding buffer. LSH was diluted in its 
storage buffer to 10x final concentration and 2 μl added to each respective reaction (titration 
range 0-250 nM LSH), followed by addition of 18 μl nucleosomal master mix (4 μl of 5x 
Binding buffer, nucleosome to the final concentration of 10 nM, ddH2O to the final volume 
of 20 μl). Reaction mixes were incubated at 4o C for 30 min. Samples were then loaded onto 
0.5% (w/v) agarose gel made with Tris-CAPS buffer pH 9.4 and run in 1x Tris-CAPS buffer (pH 
9.4) for 1h at 110 V at 4o C. The gels were visualised on an Odyssey scanner (Li-Cor).  
 




Denaturing gels were prepared manually, unless indicated otherwise, according to the 
following recipe:  
Table 2.16 Components of the SDS-PAGE gels for different gel percentages.  
 Resolving Stacking 
Component 8% 12% 15% 20% 4% 
ddH2O 2.4 ml 1.75 ml 1.2 ml 0.4 ml 1.5 ml 
Tris-HCl 1.25 ml 1.25 ml 1.25 ml 1.25 ml 625 μl 
10% SDS 50 μl 50 μl 50 μl 50 μl 25 μl 
30% acrylamide (29:1) 1.3 ml 2 ml 2.5 μl 3.3 ml 335 μl 
10% APS 25 μl 25 μl 25 μl 25 μl 12.5 μl 
TEMED 15 μl 15 μl 15 μl 15 μl 15 μl 
 
Loading dye 4x: 200 mM Tris-HCL pH 7, 8% (w/v) SDS, 20% (v/v) Glycerol, a 0.04% (w/v) 
bromophenol blue, 100 mM DTT 
Gels were run in the following buffer: 
SDS-PAGE running buffer: 25 mM Tris, 250 mM Glycine, 0.1 % (w/v) SDS 
 
Following the run, gels were rinsed in ddH2O, and stained with 10-20 ml of either Quick Blue 
Coomassie dye (Avidity Science) (for mass spectrometry studies) or homemade Blue Silver 
stain (see below) (for all other applications).  
Blue Silver stain (Colloidal Coomassie): 10% H3PO4, 10% AmSO4, 20% MeOH, 0.1% G-250 
Following the stain, gels were destained in ddH2O until no background stain remained.  
 
2.3.2 Native PAGE 
Native gels were prepared manually according to the following recipe: 
Table 2.17 Components and their volumes for preparation of native PAGE of different percentages.  
 Gel percentage 
Component 4.5% 6% 20% 
ddH2O 6 ml 5.5 ml 0.8 ml 
2x TBE 2.5 ml 2.5 ml 2.5 ml 
30% acrylamide (29:1) 1.5 ml 2 ml 6.7 ml 
10% APS 50 μl 50 μl 50 μl 
TEMED 15 μl 15 μl 15 μl 





2.3.3 Western Blot 
Buffers:  
Transfer buffer 1x: 25 mM Tris, 192 mM glycine 
Ponceau Red dye: 0.1% (w/v) Ponceau Red, 5% (v/v) acetic acid 
Blocking buffer: 5% (w/v) powdered skimmed milk + 0.1% (v/v) Tween-20  
Wash buffer 1: PBS + 0.1% (v/v) Tween-20 
Wash buffer 2: PBS  
 
Protein resolved on an SDS-PAGE gel were wet-transferred onto a nitrocellulose membrane 
at 400 mA and 4oC for 1h, visualised with Ponceau Red dye and blocked with blocking buffer 
for 1h at RT. The relevant primary antibody was diluted in blocking buffer to an appropriate 
concentration (see Table 2.18 for antibodies) and added to the membrane for 1h at RT or 
overnight at 4oC. The membrane was washed for 30 min at RT with Wash buffer 1 and 
incubated with the fluorophore-conjugated secondary antibody (Table 2.19) in blocking 
buffer for at least 30 min at RT protected from light. The membrane was then washed in 
Wash buffer 1 for 15-30 min at RT, following with Wash buffer 2 for 15-30 min at RT. Proteins 
were visualised on an Odyssey scanner (Li-Cor).  
Table 2.18 Primary antibodies used for Western blots.  




(recognition of 1-223 aa)  
Santa Cruz, sc46665 1:1000 
α-CDCA7 Rabbit polyclonal 
(recognition of 51-128 aa)  
Abcam, ab223717 1:1000 
α-GST Rabbit polyclonal Thermo Fisher, cab4169 1:1000 
 
Table 2.19 Secondary antibodies used for Western blots. 
Antibody Type  Catalogue number Dilution 
IRDye 680  Donkey anti-Rabbit  LI-COR, 926-68023  1:10000 
IRDye 800 Donkey anti-Mouse  LI-COR, 926-32212  1:10000 
 
 





Lysis buffer: 50 mM HEPES pH 7, 150 mM NaCl, 5% (v/v) glycerol, 2 mM MgCl2, 4 mM β-
mercaptoethanol, 0.2 mM PMSF, 1x EDTA-free protease inhibitor tablet  
 
Ni-NTA wash buffer (for single protein): 50 mM HEPES pH 7, 500 mM NaCl, 5% glycerol, 4 
mM β-mercaptoethanol, 0.2 mM PMSF, 10 mM imidazole, 1x EDTA-free protease inhibitor 
tablet  
 
GSH wash buffer (for single protein): 50 mM HEPES pH 7, 500 mM NaCl, 5% glycerol, 4 mM 
β-mercaptoethanol, 0.2 mM PMSF, 1x EDTA-free protease inhibitor tablet  
 
Wash buffer (for protein-protein interaction): 50 mM HEPES pH 7, 150 mM NaCl, 5% 
glycerol, 4 mM β -mercaptoethanol, 0.2 mM PMSF, 1x EDTA-free protease inhibitor tablet  
 
Pellets of 50 ml V1 or V2 cultures (see Section 2.1.3.5 for v1 v2 production) were resuspended 
in 2 ml lysis buffer and lysed by mild sonication (Soniprep 150, MSE) on ice at 25% amplitude 
for 2 min at 10 s on/off.  The concentrations of total lysates were measured by Bradford 
assay, and 100-500 µg of total cell lysate of a single protein was used. To check protein-
protein interactions, lysates were mixed and incubated for 1h at 4oC. Meanwhile, 15 µl (bed 
volume) per sample of the relevant resin was washed in ddH2O twice and equilibrated in lysis 
buffer. Each lysate or the lysate mix were added to the resin and incubated with rotation for 
1-2h. Following that, the samples were spun in a cooled microfuge at 7,000 rpm. The Flow-
through was removed and the samples were washed 3 items with wash buffer. Following 
that, the samples were run on SDS-PAGE and stained with Coomassie or subjected to 
Western blot.  
 
 
2.4 Biophysical techniques  
2.4.1 MALDI-ToF and MALDI-FT-ICR mass spectrometry  
 
Protein samples previously resolved on SDS-PAGE gels were processed for mass 
spectrometry (protein confirmation or identification) as follows:  
 
Buffers:  
Buffer 1: 200 mM ammonium bicarbonate (ABC), 50% acetonitrile (ACN) 
Buffer 2: 200 mM ABC, 50% ACN, 20 mM DTT  
Buffer 3: 200 mM ABC, 50% ACN, 50 mM iodoacetamide  
Buffer 4: 20 mM ABC, 50% ACN 
Buffer 5: 50 mM ABC, 13 μg/ml trypsin 
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Proteins were run on an SDS-PAGE gel, stained with Quick Blue Coomassie dye (Avidity 
Science) and thoroughly destained in ddH2O. The bands of interest were cut out with a clean 
scalpel, cut into a few smaller pieces and placed into an Eppendorf tube. The samples were 
incubated twice in 300 μl Buffer 1 for 30 min at RT, then in Buffer 2 for 1h at RT, then in 
Buffer 3 for 20 min at RT and protected from light. The samples were washed 3x with 500 μl 
in Buffer 4, spun at 13,000 for 2 min and dehydrated with ACN for 5 min. ACN was then 
removed and gel pieces allowed to dry. The samples were then rehydrated in 150 μl Buffer 
5, first on ice, then at 32oC overnight, to digest the proteins along with a trypsin blank sample. 
The next day the samples were sonicated for 5 min in the water bath sonicator.  
 
2.4.2 Matrix preparation for MALDI-ToF 
The Matrix mixture can be prepared up to 2 weeks prior to use and stored at 4oC. 10 mg of 
α-Cyano-4-hydroxycinnamic acid (CHCA) was mixed with 500 μl ddH2O to saturation, 500 μl 
acetonitrile and 10 μl 0.01% trifluoroacetic acid (TFA). 1 μl of the sample prepared as in 
Section 2.4.1 was spotted on a stainless steel 100 sample plate (Applied Biosystems) in 
triplicates, then an equal volume of matrix was added to it and allowed to air dry. Proteins 
were confirmed or identified by MALDI-ToF on Bruker UltraflexExtreme instrument using 
peptide calibration standard (Covered mass range ~1000-3200 Da, Bruker 8206195). The 
Mascot server (http://www.matrixscience.com/search_form_select.html) was used to 
identify proteins and the ProteinProspector tool (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msfitstandard) was used to verify known proteins.  
 
2.4.3 Size-exclusion chromatography coupled with multi-angle light 
scattering (SEC-MALS)  
SEC-MALS was carried out using the ӒKTApure system with a Superdex200 10/300 24 ml 
column coupled with a UV detector, Viscotek SEC-MALS-20 scattering detector and Viscotek 
VE-3580 refractive index detector. The column was equilibrated with SEC running buffer (50 
mM HEPES pH 7, 100 mM NaCl, 5% glycerol, 4 mM β-mercaptoethanol, 0.2 mM PMSF, 1x 
EDTA-free protease inhibitor tablet) overnight (at 0.5 ml/min flow rate). 100 μl BSA at 1 
mg/ml was injected and the monomer peak corresponding to 66 kDa was used to calibrate 
the mass. Samples were injected in 100 μl volumes at concentrations varying from 0.5 mg/ml 
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to 5 mg/ml. Analysis of the mass was performed using the OmniSEC software package 
(Malvern Pananalytical).  
 
 
2.5 Protein sequence alignment and homology modelling 
Sequence alignments were performed using Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) and visualised using JalView 
(http://www.jalview.org/). Protein sequences were aligned in full or as separate domains, as 
indicated in the tables.  
Sequences used in homology modelling sections: 
Protein  Species  UniProt/PDB ID  
LSH M. musculus Q60848 
LSH H. sapiens Q9NRZ9 
LSH B. taurus E1BCV0 
LSH D. rerio B7ZD98 
LSH X. laevis Q4V835 
CDCA7 M. musculus Q9D0M2 
CDCA7L M. musculus Q922M5 
Chd1 S. cerevisiae P32657 
Ino80  S. cerevisiae P53115 
Ino80 C. thermophilum 6FML_G 
Snf2  S. cerevisiae P22082 
Iswi S. cerevisiae P38144 
Snf2h H. sapiens O60264 
Mot1 C. thermophilum 6G7E_B 
Mtiswi  T. thermophilus 5JXR_B 
DDM1  A. thaliana Q9XFH4 
Irc5 S. cerevisiae P43610 
Mus30 N. crassa Q7SAC4 
 
Homology modelling and one-to-one threading was performed using Phyre2 server and 
model quality was assessed using Phyre Investigator (Kelley et al., 2015). Ab initio modelling 
was performed using I-TASSER (Yang et al., 2015) and Phyre2 in intensive modelling mode. 





2.6 Structural methods  
2.6.1 Gradient fixation of nucleosomes and LSH-nucleosome complexes 
(GraFix) 
To improve sample quality for potential electron microscopy studies, GraFix (gradient 
fixation) method was used (Kastner et al., 2008a; Stark, 2010). Briefly, solid sucrose was 
dissolved in binding buffer containing 20 mM HEPES pH 7 and 50 mM NaCl to concentrations 
of 10% (w/v) (light solution) and 30% (w/v) (heavy solution). 0.2% (v/v) EM-grade 
glutaraldehyde was added to the heavy solution (for unfixed controls this step was omitted). 
Approximately 1 ml of the light solution was added to Beckman ultracentrifugation 2.4ml 
tubes, followed by careful injection of the heavy solution to the bottom of the tube with a 
blunt-end needle. Continuous gradients were then formed by BioComp gradient master, 
model 107 (programme - sucrose 10-30% (w/v)), followed by 1h incubation of the gradients 
at 4oC for temperature equilibration.  
Following that, ~100 μl of a sample were very carefully added on top of the gradient, avoiding 
bubble formation. The samples were centrifuged in an Optima Ultracentrifuge at 35,000 rpm 
in a TSS-55 rotor for 20 h at 4oC. Samples were manually fractionated immediately and 100-
150 μl fractions were collected. Samples were run on 4.5% TBE native PAGE (see Section 
2.3.2) at 100V for 1h at 4oC and visualised using Licor scanner owing to the fluorescent IR800 
labelling of nucleosomes. To verify successful cross-linking, the samples were additionally run 
on 12% SDS-PAGE and visualised on Licor scanner or by colloidal Coomassie staining if only 
unlabelled protein was used.  
 
2.6.2 LSH-NCP chemical crosslinking  
Chemical crosslinking was carried out using either BS3 (Thermo Fisher Scientific) or EDC 
(Thermo Fisher Scientific) in the presence of sulfo-NHS (Thermo Fisher Scientific). BS3, EDC 
and sulfo-NHS were dissolved in 20 mM HEPES pH 7 to 10 μg/μl stock concentration and then 
diluted to the required experimental concentrations (Tables 2.20, 2.21). EDC and sulfo-NHS 
were mixed at the ratio 1:2 (w/w). LSH stock in gel filtration buffer (50 mM HEPES pH 7, 500 
mM NaCl, 5% glycerol, 4 mM β-mercaptoethanol, 0.2 mM PMSF, 1x EDTA-free protease 
inhibitor tablet) at 77.1 μM (7.4 mg/ml) was used at the final concentration of 2.5 μM. 
Recombinant nucleosome core particle (NCP) stock (final dialysis stem into 50 mM HEPES pH 
7 buffer) at 1.7 μM was used at the final concentration of 0.5 μM. Both components were 
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mixed to their final concentrations with the 10x reaction buffer (200 mM HEPES pH7, 750 
mM NaCl) with ddH2O added to 20 μl making the final NaCl concentration 100 mM and 
incubated for 30 min on ice. Following that, the samples were incubated with the relevant 
crosslinker for 2h at 4oC. Reactions were quenched by addition of 1 μl of 1 M Tris pH 7, and 
the samples were run on a precast SDS-PAGE 4-20% gradient Mini PROTEAN TGX gel (BioRad) 
and stained with Quick Stain Coomassie.  
Table 2.20 Components and their volulmes used in the BS3 crosslinking test experiment. 
 LSH + BS3 LSH + NCP + BS3 
BS3 (μg) 0 0 10 20 30 10 20 30 
BS3 (μl) 0 0 1 2 3 1 2 3 
LSH (μl) 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 
NCP (μl) - - - - 6 6 6 6 
Buffer 10x (μl) 2 2 2 2 2 2 2 2 
ddH2O 17.4 11.4 10.4 9.4 8.4 16.4 15.4 14.4 
Final V (μl) 20 20 20 20 20 20 20 20 
 
Table 2.21 Components and their volulmes used in the EDC+sulfo-NHS crosslinking test experiment. 
 LSH + EDC+sulfo-NHS LSH + NCP + EDC+sulfo-NHS 
EDC (μg) 0 0 10 20 30 10 20 30 
EDC (μl) 0 0 1 2 3 1 2 3 
Sulfo-NHS (μg) 0 0 20 40 60 20 40 60 
Sulfo-NHS (μl) 0 0 2 4 6 2 4 6 
LSH (μl) 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 
NCP (μl) - - - - 6 6 6 6 
Buffer 10x (μl) 2 2 2 2 2 2 2 2 
ddH2O 17.4 11.4 10.4 9.4 8.4 16.4 15.4 14.4 






3. HOMOLOGY MODELLING OF LSH 
3.1 Introduction 
Since very limited and low-resolution structural information is only available for LSH (see 
Simon Varzandeh’s thesis, University of Edinburgh), I decided to utilise homology modelling 
to gain any further insights into the mode of action of LSH in chromatin remodelling and its 
potential disruption by ICF-associated mutations.  
To investigate structural aspects of murine LSH (UniProt Q60848) and to obtain any insights 
into its complex with the nucleosome homology modelling approach was used. Homology 
modelling is a useful approach for getting an estimation of a protein structure, when no 
structural information is available, but a protein has a number of close homologues with 
known structures. Being a part of SNF2 subfamily, LSH has several close homologues covering 
the highly conserved ATPase domain (see Section 1.2), therefore, it was a good candidate for 
homology modelling, that here was performed using Phyre2 server. 
3.2 LSH homology modelling  
A member of the SNF2 family LSH has minimal structural information available, therefore, it 
is useful to conduct a bioinformatics and homology modelling investigation that may provide 
further insight regarding the protein’s structure and function. The initial step is examination 
of its secondary structure. The server PsiPred (Jones, 1999) provides the secondary structure 
prediction based on the protein sequence. It is well established that certain residues have 
higher propensity to participate in the formation of secondary structure: Methionine, 
alanine, leucine, glutamate, and lysine (“MALEK”) are more likely to be found in α-helices, 
since their steric and electrostatic properties favour formation of a peptide spiral with 
stabilising hydrogen bonds. Larger amino acids, such as tryptophan and tyrosine, have 
disrupting effect on α-helices and are more likely to be found in β-sheets.  
Secondary structure prediction by PsiPred based on LSH sequence indicates that a large part 
of the protein consists of α-helices with intermittent β-sheets (Fig. 3.1). This pattern is 
relevant to the two RecA domain lobes and is compatible with the observed structure of 
other RecA-contaning proteins, where a β-sheet core of each lobe is surrounded by a bundle 
of α-helices (Ye et al. 2004). The residues crucial for ATPase activity – the arginine fingers 
R690 and R693 and lysine K237 that coordinate ATP are all located in the helical regions. This 




Figure 3.1 Secondary structure prediction of LSH by PsiPred 
(https://www.ncbi.nlm.nih.gov/pubmed/10493868). Numbers on each side are amino acid positions in the 
protein. Pink – α-helix, yellow – β-sheet, grey – random coil. LSH domains are labelled as indicated, K237 is in 
green, Q682 (murine LSH) is in red, arginine fingers R690 and R693 are in purple.  
 
The N-terminal part of LSH (14-94 aa) was predicted by the server COILS to harbour a coiled 
coil (CC) (Fig. 3.2), which is feasible from the secondary structure prediction that indicated 
abundance of α-helices in that region. When submitted to the server MARCOIL (Delorenzi 
and Speed, 2002), the N-terminal region of LSH was shown to harbour a heptad repeat 
pattern (Fig. 3.3), reinforcing the notion of a coiled coil located in that region.  
 
Figure 3.2 Prediction of coiled coil patterns in the sequence of murine LSH by the server COILS. X axis 
– LSH residues, Y axis – probability for a coiled coil. Windows represent the number of amino acids 




Figure 3.3 N-terminal region of murine LSH with a heptad repeat pattern as indicated by MARCOIL server. 
Core positions a and d are in red, surface positions are in blue. Percentage probability to form coiled coil are in 
brackets.  
Canonical coiled coils contain a heptad repeat structure, labelled as a-g for each of the seven 
positions of the heptad. The hydrophobic core of the heptad are in positions a and d and the 
rest of the positions are predominantly solvent-exposed hydrophilic residues (Ludwiczak et 
al., 2019). In the LSH sequence, position a contains a mixture of charged and polar uncharged 
residues, but position d has a few isoleucines and a tryptophan, adding to its hydrophobic 
qualities (Fig. 3.3). Positions b, e and g are dominated by hydrophilic residues, which is in line 
with their position on the surface of the coiled coil (Fig. 3.3). 
Most of the LSH sequences is highly conserved. This predicted coiled coil region is conserved 
in LSH across species, however, it is unique to LSH and is not present in its homologues or in 
other member of the chromatin remodelling family (Fig. 3.4 and 3.5). The C-terminal region 
is also conserved and unique to LSH, indicating that the regions flanking the ATPase domain 
possess specific function related to the LSH translocase activity but dissimilar the functions 
of the other chromatin remodellers. The residues required for binding and hydrolysing ATP – 
the arginine fingers and lysine K237 – are all conserved across the species (Fig. 3.4). The 
glutamine Q682 of murine LSH mutated to arginine in ICF syndrome (corresponds to Q699 in 
human LSH) is not present in yeast Snf2 and Ino80 (Fig. 3.5), where it is replaced with 









Figure 3.4 LSH homologues across species. Multiple sequence alignment was performed by Clustal Omega and 
visualised in JalView. LSH domains are labelled as indicated, K237 is in green, basic patch is in brown, Q682 
(murine LSH) is in red, arginine fingers R690 and R693 are in purple.  
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To investigate structural aspects of murine LSH (UniProt Q60848) and to obtain any insights 
into its complex with the nucleosome, a homology modelling approach was used, utilising 
Phyre2 server for model generation. Being a part of SNF2 subfamily, LSH has several close 
homologues, and their alignment covered the highly conserved ATPase domain (Fig. 3.5 and 
see Section 1.2 of Introduction). High percentage identity of the overall sequences, as well 
as local alignment of each ATPase lobe (Table 3.1), allowed reliably to consider the 
remodellers from different subfamilies as modelling templates.  
No homology modelling was available for the terminal regions of LSH. Previously, ab initio 
modelling of the N-terminus LSH1-176 was performed by Simon Varzandeh (Simon Varzandeh, 
2016), however, two structures generated by I-TASSER and Phyre were dissimilar and were 
shown as a helical bundle or an elongated helical structure, respectively. In this study no ab 
initio modelling was performed. The basic patch (K855, R880 and K885) present in Snf2 that 
plays a role in the interaction with SHL-6 site on the nucleosome by acting as an electrostatic 
spring to direct the direction of translocation was not conserved in the other remodellers 
(Fig. 3.5). In LSH it is replaced by arginine, glutamine and histidine (R293, Q323, H328), 
therefore, there may still be a basic patch in LSH, despite the presence of uncharged 
glutamine (Fig. 3.10). In Chd1 it is unlikely to be present, with aspartate, arginine and serine 
in the respective positions. Ino80 and ISWI are still likely to have a partial basic patch, with 
lysine, alanine and lysine in Ino80 and asparagine, lysine and lysine in ISWI on the relevant 







Figure 3.5 Multiple sequence alignment of LSH and its homologues yeast Chd1, yeast Ino80, fly ISWI and yeast 
Snf2 from the Sf2 remodellers family. Alignment was performed with Clustal Omega and visualised in JalView. 
LSH domains are labelled as indicated, K237 is in green, basic patch (R293, Q323, H328) is in brown, Q682 
(murine LSH) is in red, arginine fingers R690 and R693 are in purple.  
 
Table 3.1 Chromatin remodellers used as the templates for homology modelling with their sequence identity 
percentages generated by BLAST Protein. Total query cover indicates the cover of LSH, % identity indicates the 
percentage of identical amino acids in the aligned sequences.  





















Chd1 S. cerevisiae 73% 47.6% 98% 42.5% 87% 56.2% 
Ino80  C. 
thermophilum 
80% 34.7% 98% 46.2% 87% 55.6% 
Snf2  S. cerevisiae 69% 42% 98% 46.4% 90% 49% 
Iswi S. cerevisiae 61% 42.5% 98% 50.6% 83% 54.7% 
 
Chd1 and LSH have 47.6% total identity and 42.5% and 56.2% identity for lobe 1 and 2, 
respectively (Table 3.1), which is a high enough similarity between the two proteins for 
homology modelling. Pairwise sequence alignment demonstrated extensive regions of 
identity in the ATPase region (Fig. 3.6). Interestingly, certain regions of the Chd1 fragment 
aligned to the LSH N-terminal coiled coil were identical (Fig. below). I then submitted this 







Figure 3.6 Pairwise sequence alignment of murine LSH and yeast Chd1. N-terminal coiled coil predicted by 
COILS server in yellow; LSH domains as indicated by ProSite: ATPase lobe 1 in blue, ATP-binding lysine K237 in 
green, ATPase lobe 2 in orange. Alignment was performed by EMBOSS Needle and visualised in JalView.  
 
 
The LSH model based on yeast Chd1 bound to the nucleosome and ADP-BeF and poised for 
catalysis is based on a cryo-EM structure with 4.8 Å resolution (Table 3.2), which is on the 
lower end of the resolution spectrum but sufficient for a rough estimation of the LSH model 
(Fig. 3.7). The model generated by Phyre2 has 100% confidence and 45% identity (Table 3.2), 
which indicates a good quality model.  
The superimposition of LSH on Chd1 demonstrated LSH bound to the nucleosome core particle 
(NCP) at SHL2 region, about 20 bp away from the dyad, which is a common binding site for 
chromatin remodellers (Fig. 3.7 A and B). The NCP used in the Chd1 structural study is an NCP 
containing 146 bp core with a single DNA linker of 14 bp on the entry side of the nucleosome. 
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In the template structure, Chd1 binds at this location on the tracking stand to move DNA in the 
3’ to 5’ direction (Farnung et al., 2017). The cryo-EM structure of Chd1 captures the detachment 
of DNA from the nucleosomal surface and rotation of the linker by about 60o  from the 
nucleosomal trajectory about the dyad axis (Farnung et al., 2017). LSH binds the NCP core and 
since no ATPase-flanking domains were modelled, it is impossible to evaluate the location of 
the LSH termini. There is the histone H4 tail in proximity to the ATPase lobes. In Chd1 H4 N-
terminus acts as an allosteric activator (Hauk et al., 2010) that interacts with the region outside 
of the chromodomains, presumably in the acidic pocket located in the lobe 2 through 
modifications of H4K16 and H4K20 (Farnung et al., 2017). Mutations in the chromodomains can 
affect the interaction between the N-terminus of H4 and nucleosome interface. Chd1 triple 
mutants KAK and AAA at positions E265, D266, E268 (an acidic region EDIE265-268) had a much 
higher affinity for a 16 bp dsDNA compared to the wild type in the absence of the H4 tail (Hauk 
et al., 2010).  
This region was not modelled for LSH (the model only covers the region corresponding to the 
residues 192-731 of LSH and 366-1011 of Chd1). LSH sequence inspection revealed a region 
EKLE98-101 in LSH that has a similar residue context to EDIE265-268 in Chd1. This sequence in 
LSH, however, contains a positively charged residue K99 and cannot be characterised as an 
acidic pocket. Besides that, this region is surrounded by lysine triplets on each side, making the 
region more likely to have an overall positive charge (Fig. 3.5).  
Checking the region proximal to the H4 N-terminus in the LSH model does not indicate the 
presence of any alternative acidic pockets (Fig. 3.7). The loop YMIEY at LSH558-562 corresponds 
to FMTREN in Chd1 and the α-helical portion at LSH609-617 (SMLDILMDYC) is similar to Chd1725-
730 (RMLDILGDYL). Even though these regions are similar, it is not clear what role they play in 
the NCP interaction and remodelling. These regions do not seem to have acidic pockets based 
on the residue sequence that would be expected to interact with a basic patch KRHR on H4 N-
terminus. However, the electrostatic model of LSH (Fig. 3.7 C) demonstrates this region as 
acidic (shown in red). Therefore, it is not clear if H4 N-terminus plays the same role in LSH-NCP 
interaction as with the other chromatin remodellers.  
When submitted to Phyre Investigator and assessed by ProQ2 server, the quality of the β-
sheet core of the ATPase lobes as well as the helical regions proximal to them were good, 
however, no further quantitative information was given in Phyre Investigator regarding the 
model quality (Fig. 3.7 E). When compared with PsiPred secondary structure prediction, the 
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modelled β-sheet from Phyre2 were in accordance with PsiPred data with a few exceptions: 
residues ILA and TLLY in lobe 1 and FSRL and FLFLVS in lobe 2 were modelled as loops (Fig. 
3.7 D).  
The Ramachandran analysis from Phyre Investigator (not shown) demonstrated that most 
residues in the model lied in favourable and good regions, including those containing 
important functional residues (Fig. 3.7 F).  
The Q682 residue in murine LSH relevant to ICF syndrome was shown to locate on the loop 
of a good-to-average quality (yellow), as indicated by ProQ2 (Fig. 3.7 E and F). When mutated 
to arginine, this residue has several disruptive possibilities: it may disrupt the interaction 
between lobe 2 and the loop in lobe 1 connecting two α-helices, may disrupt the location of 
the proximal α-helix in lobe 1 or may interfere with DNA gyre sliding (Fig. 3.7 D and 3.14). 
This lobe 1 loop also a good-to-average quality (yellow) (Fig. 3.7 E), which may indicate that 
is has a secondary structure other than a loop, without invalidating its location. Therefore, 
the ICF mutation may prevent the lobes from closing, thus compromising ATP binding are/or 









Figure 3.7 Phyre2 homology modelling of murine LSH ATPase domain based on yeast Chd1 template (PDB 
c5o9Gw). A) LSH ATPase (represented as spheres) bound to the nucleosome (represented as cartoon in cyan) 
at SHL2 site – top view; B) LSH ATPase bound to the nucleosome at SHL2 site – side view; C) Electrostatic 
surface representation of LSH model with histone H4 N-terminus located proximal to LSH ATPase lobe; basic 
residues- blue, acidic residues - red; D) Colour coding of the LSH model represented as cartoon; E) ProQ2 
model of the LSH ATPase model quality assessment generated in Phyre Investigator with the colour coding 
scale; F) close up of the LSH catalytic region.  
Table 3.2 LSH model information based on Chd1.  





Confidence % Id% Alignment coverage 
% (LSH aa) 
Chd1  5o9g, chain W 
(Farnung et al., 2017) 




Ino80 remodeller poised for catalysis in complex with the NCP was the next template for LSH 
modelling. Ino80 and LSH have high sequence identity overall (over 30%) and in the ATPase 
region (over 40% in lobe 1 and over 50% in lobe 2) (Table 3.2 and Fig. 3.8). Unlike LSH, Ino80 
has a long linker between the two lobes, however, its function is predominantly histone 
exchange, which LSH is unlikely to perform, since Ino80 is a part of a large complex, and LSH 
not being a part of a stable complex, may not produce enough force for such disruptive 






Figure 3.8 Pairwise sequence alignment of murine LSH and Ino80 from C. thermophilum. N-terminal coiled coil 
predicted by COILS server in yellow; LSH domains as indicated by ProSite: ATPase lobe 1 in blue, ATP-binding 
lysine K237 in green, ATPase lobe 2 in orange. Alignment was performed by EMBOSS Needle and visualised in 
JalView.  
 
In the model, based on a cryo-EM structure (Table 3.3) LSH is shown bound at SHL-6, with 
the ATPase lobe clamping DNA gyre (Fig. 3.9 A and B). The NCP superimposed from the Ino80 
structure demonstrates unwrapping of the DNA linker away from the nucleosomal core by 
15 bp, illustrating disruptive effect of Ino80 on the NCP (Eustermann et al., 2018).  
The quality of the model was assessed in Phyre Investigator. ProQ2 analysis agreed with the 
model quality based on Chd1: the core β-sheets in both lobes had the highest confidence 
with surrounding α-helices demonstrating good-to-average quality (Fig. 3.9 D). β-sheet 
location corresponded with PsiPred prediction (Fig. 3.1 and Fig 3.9 C). Ramachandran 
analysis was mostly favourable, with only a few surface loop regions indicated as disallowed 
(not shown).  
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The examination of the catalytic cleft of LSH demonstrated that Q682 faces the cleft and is 
located in a helical region, which contradicts the location in the Chd1-based model (Fig. 3.8 
F and Fig. 3.9 E). However, the disruptive role of the Q682R mutation is still relevant in this 
model. The loop in lobe 1 is in proximity to this residue, and the mutation may prevent 
efficient closure of the lobes. Examination of the helix sequence supports this hypothesis: 
LSH has an alanine stretch and two positively charged residues (K722, R723), which may 
cause electrostatic disruption when glutamine is mutated to arginine. However, it should be 
noted that the helix harbouring those residues was not modelled with high quality (Fig. below 
D), therefore, its location and secondary structure should be taken with caution. On the other 
hand, it may also disrupt the lobe 2 itself, which, in turn, prevents the translocase closure. 
Similarly, to the Chd1-based model, the linker connecting two ATPase lobes had low model 
quality due to low level of similarity of this region between the two proteins. 
 
 
Figure 3.9 Phyre2 homology modelling of murine LSH ATPase domain based on Ino80 from C. thermophilum 
template (PDB c6fml_G). A) LSH ATPase (represented as spheres) bound to the nucleosome (represented as 
cartoon in cyan) at SHL2 site – top view; B) LSH ATPase bound to the nucleosome at SHL2 site – side view; C) 
Colour coding of the LSH model represented as cartoon; D) ProQ2 model of the LSH ATPase model quality 





Table 3.3 LSH model information based on Ino80.  







Id% Alignment coverage 
% (LSH aa) 
Ino80  6fml, chain G 
(Eustermann et al., 2018) 
4.3, cryo-
EM 
100 49 64 (199-732) 
 
Yeast Snf2 bound to the NCP (Table 3.4) was another template used for LSH homology 
modelling due to high sequence identity: 42% overall, 46.4% in lobe 1 and 49% lobe 2 (Table 
3.3). The C-terminal region of LSH bears some similarity to the Snf2 region flanking lobe 2. 
Pairwise alignment of the C-terminal regions of LSH and Snf2 (Fig. below) in BLAST Protein 
reveal identity of 28%, which was too low to consider homology. This region of Snf2 is located 
on the surface of the remodeller (Ye et al. 2019) away from the NCP, therefore it is not clear 











Figure 3.10 Pairwise sequence alignment of murine LSH and yeast Snf2. N-terminal coiled coil predicted by COILS 
server in yellow; LSH domains as indicated by ProSite: ATPase lobe 1 in blue, ATP-binding lysine K237 in green, 
Snf2 basic patch (R293, Q323, H328) is in brown, ATPase lobe 2 in orange. Alignment was performed by EMBOSS 
Needle and visualised in JalView.  
 
The initial examination of the model based on the Snf2 structure in active state with the two 
core domains realigned showed 100% and 41% identity, as indicated by Phyre2 (Table 3.4). 
As in the case of the Chd1-based model of LSH (Fig. 3.7 C), the N-terminus of the histone H4 
is protruding towards the ATPase domain, however, its role in LSH interaction is unclear due 
to the absence of any acidic patches in that region of LSH.  
ProQ2 assessment, as in the models above, demonstrated high quality of the β-sheet cores 
of each ATPase lobe, and the α-helices surrounding them had lower but nevertheless 
relatively high quality, making this part of the model reliable for analysis (Fig. 3.11 D and E). 
As in the models above, the helices on the surface of the ATPase domain are of low quality, 
as indicated by ProQ2.  
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Ramachandran analysis as a part of Phyre Investigator (not shown) revealed that the majority 
of the residues were located in favourable regions, including those harbouring the Q682R 
mutation site. As in the previous models, ICF-relevant glutamine is located at the border of 
the helix facing the NCP-binding cleft (Fig. 3.11 F). The proximal lobe 2 helices had relatively 
low model quality, therefore, it is hard to determine whether Q682R mutation would disrupt 
the integrity of lobe 2.  
The basic patch that plays a role of an electrostatic spring in Snf2 and induces twist defects 
(Brandani et al., 2018) is located proximal to SHL-6 (not shown). In LSH these residues are 
R293, Q323, H328 (Fig. 3.10), and not all being positively charged they may not play the same 
role in LSH. Structural information would be required to test that.  
 
Figure 3.11 Phyre2 homology modelling of murine LSH ATPase domain based on yeast Snf2 template (PDB 
c5x0y_O). A) LSH ATPase (represented as spheres) bound to the nucleosome (represented as cartoon in cyan) 
at SHL2 site – top view; B) LSH ATPase bound to the nucleosome at SHL2 site – side view; C) Electrostatic surface 
representation of LSH model with histone H4 N-terminus located proximal to LSH ATPase lobes; basic residues- 
blue, acidic residues - red; D) Colour coding of the LSH model represented as cartoon; E) ProQ2 model of the LSH 
ATPase model quality assessment generated in Phyre Investigator with the colour coding scale; F) close up of 
the LSH catalytic region. 
Table 3.4 LSH model information based on Snf2.  




Confidence % Id% Alignment coverage 
% (LSH aa) 
Snf2   5x0y, chain O (Liu et al., 
2017a) 




Finally, the yeast ISWI cryo-EM structure was used as a template due to high overall sequence 
homology (when two full sequences were aligned) and ATPase-specific homology (Table 3.4 
and Fig. 3.12). Similarly to Chd1, a region of ISWI upstream lobe 1 showed some similarity to 
the coiled coil predicted in the LSH N-terminus (Fig. 3.12), however, COILS server did not 
predict any coiled coils in that region of ISWI (not shown).  
 
 
Figure 3.12 Pairwise sequence alignment of murine LSH and yeast ISWI. N-terminal coiled coil predicted by 
COILS server in yellow; LSH domains as indicated by ProSite: ATPase lobe 1 in blue, ATP-binding lysine K237 in 
green, ATPase lobe 2 in orange. Alignment was performed by EMBOSS Needle and visualised in JalView.  
 
ISWI-based model of LSH showed 100% confidence with 49% identity. The template is ISWI 
in activated, nucleosome-bound and ADP-BeF-bound state. ProQ2 assessment demonstrated 
good quality of the β-sheets at the core of ATPase lobes and slightly lower quality of the 
helices surrounding them, as it was in the models described above (Fig. 3.13 E). The 
Ramachandran analysis performed by Phyre Investigator indicated predominantly favourable 
locations of the residues in the model (not shown). The location of Q682 was in agreement 
with the other LSH models (based on Chd1, Ino80 and Snf2) and was shown to face the cleft 
between the lobes (Fig. 3.13 F). As in the models described above, Q682R mutation did not 
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appear to directly disrupt ATP binding, as it is located away from the arginine fingers and the 
ATP-binding lysine K237, however, it has the potential to interfere with ATP hydrolysis by 
preventing efficient closure of the lobes.  
 
Figure 3.13 Phyre2 homology modelling of murine LSH ATPase domain based on yeast ISWI template (PDB 
c6iro_L). A) LSH ATPase (represented as spheres) bound to the nucleosome (represented as cartoon in cyan) at 
SHL2 site – top view; B) LSH ATPase bound to the nucleosome at SHL2 site – side view; C) Electrostatic surface 
representation of LSH model with histone H4 N-terminus located proximal to LSH ATPase lobes; basic residues- 
blue, acidic residues - red; D) Colour coding of the LSH model represented as cartoon; E) ProQ2 model of the LSH 
ATPase model quality assessment generated in Phyre Investigator with the colour coding scale; F) close up of 
the LSH catalytic region. 
Table 3.5 LSH model information based on ISWI.  




Confidence % Id% Alignment coverage % 
(LSH aa) 
ISWI  6iro, chain L (Yan 
et al., 2019a) 
3.4, cryo-EM 100 49 65 (192-731) 
 
The ICF-related mutation located in lobe 2 may interfere with DNA strand electrostatic 
properties. To investigate that, I checked the position of Q682R mutation relative to the 
proximal DNA gyre (Fig. 3.14). Even though the models did not allow to estimate the position 
of the residue rotamers, it is possible to hypothesise regarding the disruptive potential of this 
mutation located in proximity to DNA. The Chd1-based model demonstrated proximal 
positioning of the arginine mutant with respect to DNA (Fig. 3.14 A). In the Ino80-based LSH 
model Q682 is located in proximity to the DNA strand, but does not seem to be in direct 
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contact with it (Fig. 3.14 B). The Snf2- and ISWI-based models appear to support the 
hypothesis of the disruptive effect Q682R mutation on DNA interaction (Fig. 3.14 C and D), 
even though rotamer positioning of a real structure may disprove the electrostatic effect of 
the mutation on LSH function. 
 
 
Figure 3.14 LSH models showing positioning of the Q682R mutation with respect to nucleosome DNA. A) Chd1-
based model of LSH (in cartoon) colour-coded as follows: N-terminus – green, ATPase lobe 1 – blue, ATPase lobe 
2 – orange, ATPase linker – yellow; residues shown as sticks: K237 - magenta, Q682 – red, Q682R – green; 
nucleosomal DNA strands shown as cartoon; Chd1 PDB ID 5o9g; B) Ino80-based model of LSH (in cartoon) 
colour-coded as in A; residues shown as sticks as in A; nucleosomal DNA strands shown as cartoon; Ino80 PDB 
ID 6fml;  C) Snf2-based model of LSH (in cartoon) colour-coded as in A; residues shown as sticks as in A; 
nucleosomal DNA strands shown as cartoon; Snf2 PDB ID 5x0y; D) ISWI-based model of LSH (in cartoon) colour-
coded as in A; residues shown as sticks as in A; nucleosomal DNA strands shown as cartoon; ISWI PDB ID 6iro.  
 
Recently solved structures of Snf2 bound to the nucleosome bound at SHL2 site in complex 
with NCP and in different transition states (has not been used by Phyre2 as a template, 
therefore I used them as templates for one-to-one threading. The cryo-EM structures have a 
medium resolution of 4.31 Å, 3.62 Å and 4.22 Å for the complex in apo, ADP-bound and ADP-
BeF-bound states, respectively (Li et al., 2019). The models show the similarities between the 
apo- and ADP-bound states, where they adopt an open conformation (Fig. 3.15 A, B and D, 
E) and the ATP analogue ADP-BeF3 locks the lobes in open conformation (Fig. 3.15 C and F). 
The models demonstrate the change in the location of Q682 residue relative to the helix in 
lobe 2 and the loop in lobe 1. Closure of the ATPase brings ICF-affected glutamine in close 
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contact with those regions of the ATPase. Therefore, it is feasible to assume that Q682R 
mutation (corresponding to Q699R in human) affects in vitro ATP hydrolysis but not ATP 
binding, since no disruption appears to occur in the region directly contacting ATP molecule 
– the arginine fingers and lysine K237 (Fig. 3.15 D, E, F).  
 
 
Figure 3.15 LSH homology modelling with yeast Snf2 bound to a nucleosome (Li et al. 2019) as a template. A) 
LSH model in complex with a nucleosome bound at SHL2 in apo state (template PDB ID 5z3l), LSH domains are 
colour-coded as follows: N-terminus – green, ATPase lobe 1 – blue, ATPase lobe 2 – orange, ATPase linker – 
yellow; residues shown as sticks: K237 - magenta, Q682 – red, Q682R – green; B) LSH model in complex with a 
nucleosome bound at SHL2 in ADP-bound state (template PDB ID 5z3o), LSH domains are colour-coded as in A; 
C) LSH model in complex with a nucleosome bound at SHL2 in ADP-BeF-bound state (template PDB ID 5z3v), LSH 
domains are colour-coded as in A; D) Close-up of the LSH nucleosome binding cleft (as a cartoon) as a part of a 
model of  LSH bound to a nucleosome in the apo state: as sticks - arginine fingers R690 and R693 in purple, 
lysine 237 in hot pink, glutamine Q682 mutated in ICF syndrome in red; E) Close-up of the LSH nucleosome 
binding cleft (as a cartoon) as a part of a model of  LSH bound to a nucleosome in the ADP-bound state, catalytic 
residues are colour-coded as in D; F) Close-up of the LSH nucleosome binding cleft (as a cartoon) as a part of a 
model of  LSH bound to a nucleosome in the ADP-BeF-bound state, catalytic residues are colour-coded as in D.  
 
LSH has a few poorly characterised homologues, including yeast Irc5, bread mould Mus30 
and a relatively well studied remodeller from A. thaliana DDM1 (Table 3.6 and Fig. 3.16). LSH 
and its homologues have relatively high percentage identity of the full sequences (30-40%) 
and even higher identity when only the ATPase regions were compared (50-60%) (Table 3.6 
and Fig. 3.16). Since DDM1 is a relatively well studied homologue, compared to the other 
two, to further verify modelling quality, I looked at the models of DDM1 to compare them 
with the ones of LSH. Like with the LSH models, all the models of DDM1 produced by Phyre2 





Table 3.6 LSH homologues with their sequence identity percentages generated by BLAST Protein. Total query 
cover indicates the cover of LSH, % identity indicates the percentage of identical amino acids in the aligned 
sequences.  




















DDM1 A. thaliana 97% 36.8% 98% 58.3% 90% 55% 
Irc5 S. cerevisiae 70% 44.5% 98% 59.8% 90% 53% 







Figure 3.16 Multiple sequence alignment of LSH and its homologues Irc5, Mus30 and DDM1. Alignment was 
performed with Clustal Omega and visualised in JalView. LSH domains are labelled as indicated, K237 is in 
green, Q682 (murine LSH) is in red, arginine fingers R690 and R693 are in purple. 
 
The model of DDM1 based on Chd1 bound to the nucleosome demonstrates high similarity 
to the LSH model and the RMSD value generated by PyMol after superimposition of the 
models was 0.000 Å with 390 Cα after outlier rejection (Table 3.7). The β-sheet core of the 
ATPase domain in both lobes again was the best modelled portion of the protein (Fig. 3.17 
C). The α-helical bundle surrounding the β-sheets were of average-to-high and average 
quality according to ProQ2 gradation (Fig. 3.17 C). The region connecting two ATPase lobes 
is shown as a mixture of α-helices and loops and is not present in other remodellers, 
however, the low model quality of this part does not allow to make conclusions about this 
region (Fig. 3.17 C).  The Q682 residue located at the centre of the ATPase lobe 2 and facing 
the DNA-binding cleft is located in a loop attached to an α-helix reinforcing the hypothesis 
that Q682R mutation would prevent effective closure of the lobe and, hence, may disrupt 
ATP hydrolysis.  
The outer α-helices of the ATPase domain have average model quality (Fig. 3.17 C), however, 
their exact role in the protein function is unclear, since they may also interact with the LSH 
terminal regions that have not been modelled. The biggest discrepancy between the models 
is the flexible loop belonging to the ATPase linker and located at the outermost part of lobe 
2, which has some helical elements in DDM1 but is only a loop in LSH, however, the model 
quality is the lowest in the whole model, therefore no conclusions can be drawn from this 
region (Fig. 3.17 A, B, C). The same is relevant for the N-terminus: in LSH it is absent but 
modelled as a loop in DDM1, however, the bad modelling quality makes this region unreliable 




Figure 3.17 Phyre2 homology modelling of murine LSH and A. thaliana DDM1 ATPase domain based on yeast 
Chd1 template (PDB ID 5o0g_W). A) LSH ATPase shown as cartoon with the labelled domains and Q682 residue 
shown in pink sticks; B) DDM1 ATPase shown as cartoon with the labelled domains and Q682 residue shown in 
sticks; C) ProQ2 model quality analysis of DDM1 generated in Phyre Investigator with the colour coding scale. 
 
Table 3.7 LSH and DDM1 model information based on Chd1-NCP complex and model alignment information. 
Protein  Protein 
template RDB 
ID  
Initial Cα atoms 
aligned 
Final Cα atoms 
aligned 
Cα RMSD (Å) 
Chd1-NCP   5o9g, chain W 426 390 0.000 
 
Ino80 in a complex with the nucleosome was the next template used for DDM1 modelling. 
The characteristics of the model bear similarities to the one based on Chd1 described above.  
The RMSD value between LSH and DMM1 was 0.001 Å with 397 Cα (Table 3.8). As in the 
previously described models, the β-sheet cores of both ATPase lobes have the highest 
modelling quality as estimated by ProQ2 (Fig. 3.18 C). The ATPase loop due to low homology 
has the lowest modelling quality. The Q682 residue is facing the DNA-binding cleft and 
similarly to the other models indicates possible ATP hydrolysis disruption or DNA-interaction 





Figure 3.18 Phyre2 homology modelling of murine LSH and A. thaliana DDM1 ATPase domain based on Ino80 
template (PDB ID 6fml_G) from C. thermophilum. A) LSH ATPase shown as cartoon with the labelled domains 
and Q682 residue shown in sticks; B) DDM1 ATPase shown as cartoon with the labelled domains and Q682 
residue shown in sticks; C) ProQ2 model quality analysis of DDM1 generated in Phyre Investigator with the 
colour coding scale. 
 
Table 3.8 LSH and DDM1 model information based on Ino80-NCP complex and model alignment information. 
Protein  Protein 
template RDB 
ID  
Initial Cα atoms 
aligned 
Final Cα atoms 
aligned 
Cα RMSD (Å) 
Ino80-NCP   6fml, chain G 452 397 0.001 
 
 
Snf2-based model of DDM1 shares high similarity with the LSH model. The RMSD value after 
outlier rejection was 0.001 Å with 412 Cα (Table 3.9). The highest quality of the model is 
again in the β-sheet region of the ATPase domain, however, this modelling quality is lower 
compared with the other models, according to ProQ2. The surface of the protein has low 
modelling quality, therefore, the exact location of the surface helices and loops are 
debatable. Since no terminal regions of LSH were modelled, the function implications of the 
protein surface and its interaction with the protein termini are only open to speculation, so 
far. Similarly, the lobe 1 helices harbouring the basic patch in Snf2 (Brandani et al., 2018) (not 
shown) have very low modelling quality, therefore, it is difficult to make assumptions about 




Figure 3.19 Phyre2 homology modelling of murine LSH and A. thaliana DDM1 ATPase domain based on yeast 
Snf2 template (PDB ID 5x0y_O). A) LSH ATPase shown as cartoon with the labelled domains and Q682 residue 
shown in sticks; B) DDM1 ATPase shown as cartoon with the labelled domains and Q682 residue shown in sticks; 
C) ProQ2 model quality analysis of DDM1 generated in Phyre Investigator with the colour coding scale. 
 
Table 3.9 LSH and DDM1 model information based on Snf2-NCP complex and model alignment information. 
Protein  Protein 
template RDB 
ID  
Initial Cα atoms 
aligned 
Final Cα atoms 
aligned 
Cα RMSD (Å) 
Snf2-NCP   5x0y, chain O 498 412 0.001 
 
 
The ISWI-based model of DDM1 is, again, similar to the LSH one with RMSD of 0.001 Å with 
385 Cα after outlier rejection (Table 3.10). The β-sheet cores and some helical regions 
surrounding them have high modelling quality, supporting the notion that the ATPase lobe 
core of LSH consists of parallel β-sheet, similarly to other Snf2-family remodellers. The 
modelling of Q682 region has average-to-high quality, along with the proximal loop on lobe 
1, however, the proximal perpendicular helix of lobe 2 has low modelling quality, making the 
mechanism of the culprit unclear. Again, the modelling does not rule out different 




Figure 3.20 Phyre2 homology modelling of murine LSH and A. thaliana DDM1 ATPase domain based on yeast 
ISWI template (PDB ID 6iro_L). A) LSH ATPase shown as cartoon with the labelled domains and Q682 residue 
shown in sticks; B) DDM1 ATPase shown as cartoon with the labelled domains and Q682 residue shown in sticks; 
C) ProQ2 model quality analysis of DDM1 generated in Phyre Investigator with the colour coding scale. 
 
Table 3.10 LSH and DDM1 model information based on ISWI-NCP complex and model alignment information. 
Protein  Protein 
template RDB 
ID  
Initial Cα atoms 
aligned 
Final Cα atoms 
aligned 
Cα RMSD (Å) 




Due to the lack of high-resolution structural data on LSH, homology modelling using the 
structures of chromatin remodellers from Snf2 family (Chd1 - PDB ID 5o9g, Ino80 - PDB ID 
6fml, Snf2 - PDB ID 5x0y, ISWI – PDB ID 6iro) was performed by Phyre2 (Kelley et al., 2015) 
to gain further insights into LSH possible structure and the functional aspects on the wild type 
and the ICF syndrome-associated mutant. 
PsiPred (Jones, 1999) prediction of the secondary structure revealed that full-length LSH has 
extensive α-helical regions with intermittent β-sheet regions and random coils (Fig. 3.1). The 
N-terminal part of LSH is predicted to harbour a coiled coil by the servers COILS and MARCOIL, 
implying either dimerisation or protein-protein interaction propensity of LSH (Truebestein 
and Leonard, 2016). It has previously been shown by SEC-MALS experiments (Simon 
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Varzandeh, 2016) that LSH is present in solution as a monomer, therefore, this coiled coil 
may be a site of protein-protein interaction rather than dimerisation. The binding partner of 
LSH CDCA7 (Jenness et al., 2018), through a tight DNA interaction via its zinc finger domain, 
may provide a docking site for LSH binding to the nucleosome, and the interaction between 
the two proteins is likely to occur through their coiled coil regions.  
Previously, the N-terminus of LSH was suspected to interact with the de novo DNA 
methyltransferase DNMT3B, presumably through the coiled coil (Myant and Stancheva, 
2008). This experiment utilised recombinant proteins, and an N-terminal GST-tag was fused 
to LSH N-terminus. S. Varzandeh could not detect LSH and DNMT3B interaction in vitro in the 
absence of the nucleosome (Simon Varzandeh, 2016). As observed in my experiments (see 
discussion on CDCA7), LSH has certain non-specific affinity for the GST-tag, therefore, this 
finding would require verification in a more reliable system. It should be noted that even 
though LSH may be functionally related to DNMT3B, this interaction was not detected in a 
mass spectrometry study of Xenopus laevis eggs (Jenness et al., 2018), indicating a possible 
transient nature of the interaction. Therefore, future experiments will require further 
optimisation of LSH truncations to elucidate the role of its N-terminus.  
Apart from the predicted coiled coil no further information could be deduced from the LSH 
N-terminal due to lack of homology with the other Snf2-family remodellers (Fig. 3.5). This is 
hardly surprising, since remodellers are unified by the highly homologous ATPase domain, 
however, other domains are accessory rendering each remodeller subfamily its unique 
characteristics. This can be the case for LSH, since it appears to have non-redundant functions 
in silencing heterochromatic repetitive elements (Yu et al., 2014). Unlike other remodellers 
that have N-terminal regulatory domain such as AutoN, HSA, post-HSA and chromodomain 
(Clapier and Cairns, 2012, Clapier et al., 2016, Yan et al., 2016, Hauk et al., 2010) with well-
studied functions, the N-terminus of LSH does not have such well-characterised domains. 
Recently identified conserved motif ppHSA present in human LSH64-85 (mouse LSH48-69) and 
other remodellers was shown to have an in vivo function and to stabilise the N-terminus by 
clamping it to ATPase lobe 2 in ISWI (Ludwigsen et al., 2017), which provides a room for 
speculation for this domain in LSH. 
Another Snf2/Swi2 related protein, Mot1 also has an extensive non-conserved but 
functionally important N-terminal region (Auble et al., 1997). Unlike other Snf2/Swi2 
remodellers, its primary interaction partner is not the nucleosome but TATA-binding protein 
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(TBP) and duplex DNA (Wollmann et al., 2011). In this context the N-terminal domain of Mot1 
binds to TBP and, while binding to DNA with Snf2/Swi2 ATPase domain, weakens the TBP-
DNA interaction (Wollmann et al., 2011). Rad54 utilises its unstructured N-terminus to bind 
Rad51 (Raschle et al., 2004). Similarly, LSH may utilise its N-terminus in a protein-protein 
interaction with a DNA-binding protein such as CDCA7, to compensate for the lack of a DNA-
binding domain in other regions apart from its ATPase domain. Another interacting partner 
of LSH N-terminus is the transcription factor E2F3, which has been found to specify LSH 
positioning at the transcription start site (von Eyss et al., 2012). 
Another important feature of N-terminus is its role in LSH stability. Previous attempts to 
express the ATPase core with various N-terminal truncations of LSH resulted in high level of 
protein degradation and chemical crosslinking demonstrated proximity of the N-terminus to 
the ATPase core (Simon Varzandeh, 2016). Therefore, the N-terminus appears to have an 
important role in LSH both in apo state and in complex with the nucleosome, however, its 
structural characteristics remain vague. Previously, ab initio modelling of the N-terminus 
LSH1-176 was performed by Simon Varzandeh (Simon Varzandeh, 2016). The two structures 
generated by I-TASSER and Phyre were a helical bundle and an elongated helical structure 
linked by loops, respectively. Optimisation of expression conditions would be required to 
biochemically elucidate the exact role of the LSH N-terminus.  
Homology modelling based on various Snf2 family remodellers (Chd1, Ino80, Snf2, ISWI) 
demonstrated that LSH is likely to have an ATPase domain structurally similar to the other 
Snf2 family ATPase (see Section 1.2), with the central parallel β-sheets surrounded by α-
helices harbouring the Walker A and B motifs (Ye et al. 2004). The orientation of the lobes 
and motif similarity to the well-studied remodellers allow to assume a similar remodelling 
mechanism in LSH. The lysine K237 residue of murine LSH has been shown to play an 
important role in ATP binding (Burrage et al., 2012; Ren et al., 2015; Termanis et al., 2016) is 
located in lobe 1 and is likely to interact with γ-phosphate on ATP (Ye et al. 2004). Lysine 
K237 forms an ATP-binding structure along with the arginine fingers located on lobe 2 (Fig. 
3.7 F, 3.9 E, 3.11 F, 3.13 F). Consistently with mutagenesis experiments (Burrage et al., 2012; 
Ren et al., 2015; Termanis et al., 2016), mutation of K237 abolishes cellular LSH activity, 
presumably via the lack of ATP binding.  
Homology modelling provided further insights into the role of the ICF-relevant mutation. 
Q682R mutation in murine LSH, which corresponds to Q699R in human LSH, is located away 
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from the ATP binding site (Fig. 3.7 F, 3.9 E, 3.11 F, 3.13 F), therefore, solely from the 
modelling it was not clear whether the ATP binding itself was affected by this mutation. The 
mutated residue is located in ATPase lobe 2 opposite the modelled loop in lobe 1 in LSH 
models based on different chromatin remodellers. Introduction of a positively charged and 
more protruding residue may disrupt conformation of lobe 2 and thus interfere with lobes 
closure upon ATP binding and chromatin remodelling. Alternatively, the mutation may 
disrupt lobes closure without introducing any deformation to lobe 2. Experiments in 
embryonic stem cells demonstrated that K237A mutant and deletion of DEAH box mutant 
could not restore methylation levels in repeat elements after introduction of those mutations 
to LSH-null cells, presumably via abrogated binding of de novo DNA methyltransferase 
DNMT3B (Ren et al., 2015). This indicates that LSH forms nucleosome-free areas that can 
then be accessed by DNMT3B, but not necessarily via direct protein-protein interaction and 
DNMT3B recruitment. Interestingly, LSH knock out was associated with reduced nucleosome 
occupancy at repeat elements (Ren et al., 2015), indicating that ATPase function of LSH is 
important for nucleosome positioning and not only forming nucleosome-free regions. These 
findings, however, do not specify whether ATP molecule was able to bind LSH. Thin layer 
chromatography (TLC) performed by Kevin Myant (Kevin Bryan Myant, 2008) demonstrated 
that LSH, albeit with low efficiency, could perform weak ATP hydrolysis both in the presence 
of free DNA and a nucleosome, compared to the lack of stimulus. This, however, still does 
not elucidate the requirements for LSH-ATP binding and the effects of Q682R mutation on it. 
Since it appeared that Q682 residue is located proximally the DNA gyre, it is feasible to 
suggest that an introduction of a positively charged residue could strengthen the 
electrostatic potential between LSH and DNA and prevent LSH from effective sliding along 
the strand. Furthermore, Q682R mutation is located two residues away from a conserved 
tryptophan (W679 in murine LSH), which inserts itself into the DNA duplex minor groove as 
shown in the Snf2 cryo-EM structure (Liu et al., 2017a). Mutation W1185A in Snf2 only 
reduces ATP hydrolysis but almost block remodelling activity (Liu et al., 2017a). It is not clear 
from the structural data how this mutation causes this effect but it is possible to assume that 
this tryptophan may provide a lever effect or an additional contact point necessary for the 
remodeller’s sliding across the DNA strand or a similarly critical contact point. In a similar 
manner, Q682R may not disrupt ATP binding and hydrolysis, but may prevent efficient sliding 
due to stabilisation of LSH on the phosphate backbone. Mutagenesis experiments with LSH 
would be required to determine that. For that the restriction enzyme accessibility 
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remodelling assay should be initially optimised for murine LSH and CDCA7, with LSH Q682 
and W679 residues subsequently mutated. Various residues, such as smaller and uncharged 
alanine or glycine, another positively charged residue such as lysine, or a bulky residue such 
as tryptophan, could be introduced at the position 682 to see the effects. Fluorescence 
resonance energy transfer (FRET) assay could be another project to dissect the roles of these 
LSH residues. However, this can only be achieved with a robust expression system and 
abundant protein yield. 
Homology modelling highlighted several similarities between the well-studied remodellers 
and LSH. One of them is remodeller binding location on a nucleosome. LSH models based on 
Chd1, Snf2 and ISWI were shown to bind at superhelical location 2 (SHL2) (Fig. 3.7 A and B, 
3.9 A and B, 3.11 A and B, 3.13 A and B) due to intrinsic instability at this site favouring 
translocation initiation (Li et al., 2019; Winger et al., 2018). SHL2 location around 20 bp away 
from the nucleosome dyad on the entry DNA gyre is a standard binding location for Snf2 
family remodellers (McKnight et al., 2011; Saha et al., 2005; Schwanbeck et al., 2004; Zofall 
et al., 2006). Recent studies showed that remodeller binding at SHL2 induces a DNA bulge, 
which then propagates across the histone octamer in a corkscrew-like manner resulting in 
translocation (Li et al., 2019; Winger et al., 2018; Yan et al., 2019b). This inchworm 
mechanism was contrasted to translocation via loop-formation (Zhang et al., 2006; Zofall et 
al., 2006). The LSH models based on transition states of Snf2 demonstrated how LSH fits into 
the structure, which adopts open conformation in apo or ADP-bound state, mimicking resting 
state before and after ATP hydrolysis and closed conformation when bound to an ATP 
analogue ADP-BeF (Fig. 3.15). This indicates a lack of major conformational change before 
ADP binding and after its release. Similarly to the recently identified mechanism, LSH is likely 
to be capable of pumping DNA towards the dyad in a two-step manner: first the DNA 
downstream SHL2 is pulled towards the remodeller once it is bound, this action creates 
under-twisting, which is then resolved at the step two following ATP hydrolysis (Li et al., 2019; 
Winger et al., 2018). Energy consumption of a twist defect formation is still unknown (Li et 
al., 2019) and it is unclear whether LSH being a relatively small protein compared to the 
known remodellers can induce this nucleosomal state, however, high similarity of the ATPase 
domain indicates that this mechanism can also be relevant to LSH.  
The LSH model based on Ino80 was bound to SHL6 (Fig. 3.9 A and B). Even though LSH and 
Ino80 share high identity of the ATPase domain (Table 3.1) and Phyre2 had good quality 
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parameters (Table 3.3), this localisation of LSH should be taken with caution. Ino80 is a part 
of a large megadalton multi-subunit complex (Tosi et al., 2013), whereas LSH has not been 
found in a complex (Myant and Stancheva, 2008). Ino80 ATPase was found to bind SHL6, 
whereas SHL2 was bound by Arp5-Ies6 – the proteins also present in Ino80 complex (Brahma 
et al., 2017). SHL6 is located closer to the entry site of the nucleosome and it is a good 
position to introduce significant disruptions into the nucleosome core, unlike a more subtle 
bulge formation induce at SHL2 due to its closer location to the edge of the nucleosome. 
Ino80 is known to perform histone variant exchange, form centrally positioned nucleosomes 
and was shown to induce major disruptions of ~15 bp, with auxiliary subunits were shown to 
act on SHL2 as a counter grip (Ayala et al., 2018; Eustermann et al., 2018). Even though the 
exact mechanism of LSH remodelling has not yet been elucidated, it is unlikely that is acts 
similarly to Ino80 due to its physical capacities. Interestingly, Liu et al. and Li et al. also found 
that Snf2 was able to bind the 601-containing nucleosome at SHL6 position in a subset of 
samples, however, biological relevance of this interaction was not investigated in those 
studies (Li et al., 2019; Liu et al., 2017a).  
Remodelling potential of Snf2 family proteins is ensured not only by the ATPase domain, but 
additional interaction with the nucleosome. This was reflected in LSH homology modelling, 
which shows histone H4 tails protruding towards the ATPase lobes (Fig. 3.7 C, 3.11 C, 3.13 
C). In the relevant remodellers the H4 tail contains an important nucleosomal epitope – the 
basic patch – which plays a role in remodelling, remodeller auto-inhibition, recruitment and 
orientation, linker-length sensitivity and nucleosomal array formation (Clapier, 2002; Clapier 
et al., 2001; Clapier and Cairns, 2012; Dang et al., 2006; Hwang et al., 2014). LSH was not 
found to contain any similar acidic pockets, nevertheless, its N-terminus is abundant in 
glutamates, which may provide contact points with the H4 basic patch, however, their 
potential functions can only be determined experimentally.  
Histone H3 tail is another significant binding partner for Snf2 family remodellers, 
predominantly via its modifications (Mansfield et al., 2011; Santos-Rosa et al., 2003). H3 tail 
acetylation was shown to increase affinity of SWI/SNF and RSC for the nucleosome through 
their bromodomains (Chatterjee et al., 2011). SANT domain present in subunits of those 
remodelling was also found to play a role in H3 tail binding (Boyer et al., 2004).  
Chromodomains of Chd1 interact with methylated H3 tail and their deletion impairs binding 
and remodelling of the nucleosome (Flanagan et al., 2005). In LSH homology modelling H3 
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tail is located away from the modeller ATPase domain and no obvious contacts were present 
in any of the models (Fig. 3.7 A, 3.9 A, 3.11 A, 3.13 A). However, the domains lacking in the 
LSH models may be relevant for this interaction, even though no bromodomains and 
chromodomains have been identified in LSH. Histone interaction may be an important 
feature of an LSH binding partner, such as CDCA7, however, this hypothesis is not yet 
substantiated by evidence.   
Additional nucleosomal epitope relevant to remodelling was recently described in molecular 
modelling simulation of Snf2. It has been found that the basic patch (K855, R880 and K885) 
in lobe 1 of Snf2 directs the orientation of the remodeller by acting as an electrostatic spring 
(Brandani et al., 2018). This portion of lobe 1 is located in the similar position in LSH and can 
potentially have a similar function. On examination on the LSH sequence, the relevant site 
was represented by R293, Q323, H328, which does not make it a bona fide basic patch. 
However, this site can be examined experimentally by mutating RQH to KRK to mimic the 
Snf2 basic patch. Along with this, mutating all three residues to alanine would provide 
additional insights and a potential negative control.  
Additional information about LSH can be gained from its distant homologues DDM1, Irc5 and 
Mus30 (Alvaro et al., 2007; Basenko et al., 2016; Jeddeloh et al., 1999). Irc5 was recently 
been found to facilitate cohesin loading on the centromeres via its ATPase domain activity 
(Litwin et al., 2017), indicating functions independent of DNA methylation. It would be 
interesting to evaluate this function in LSH profile and to explore the mechanisms alternative 
or linked to DNA methylation. Recent findings demonstrated the role of chromatin 
remodelling in cohesin loading: the remodelling complex RSC was found to not only to 
generate nucleosome-free regions but also independently from its remodelling function act 
as a docking site for Scc2-Scc4 cohesin loading complex (Muñoz et al., 2019). 
Mus30 has been linked to ubiquitylation via its association with a E3 ubiquitin ligase 
homologue WDR76 (Basenko et al., 2016). These functions were, however, outside the scope 
of this homology modelling.  
Irc5 and Mus30 do not have extensive experimental information, therefore, DDM1 was 
chosen for homology modelling. The resulting models based on the same templates as for 
LSH were highly similar to the LSH models (Fig. 3.17, 3.18, 3.19, 3.20). Even though LSH and 
DDM1 are present in very different organisms, they both participate in DNA methylation of 
heterochromatic regions (Tan et al., 2018). Activity of DDM1 was shown as a requirement to 
100 
 
bypass linker histone H1 as a barrier to silencing in heterochromatin as well as providing 
nucleosome-free regions for establishment of DNA methylation (Lyons and Zilberman, 2017; 
Zemach et al., 2013). Both LSH- and DDM1-containing cells exhibit 10 bp methylation 
periodicity (Jimenez-Useche et al., 2013), which is lost in their respective mutants (Lyons and 
Zilberman, 2017), which could arise from DNA loop formation on the surface of the 
nucleosome or methylation on the linker DNA, which is then shifted to the nucleosomal core. 
These findings provide further insight into the ability of LSH to methylate heterochromatic 
regions, which, as in the absence of DDM1, can also be performed by other remodellers 
(Lyons and Zilberman, 2017). This propensity of LSH towards heterochromatin may be related 
to the more compact size of LSH compared to other remodellers, which are also often a part 
of large multi-subunit complexes.  
Homology modelling, although providing some information in the absence of high resolution 
structural data, has obvious limitations. As mentioned before, the terminal regions of LSH 
could not be modelled due to low or lacking homology (Fig. 3.5). More fine details, such as 
DNA bulge formation observed in other remodellers (Li et al., 2019; Winger et al., 2018) could 
be speculated but not reliable extrapolated to LSH, since it is not clear what force is required 
for this DNA translocation mode and if it requires additional force from interactions with 
nucleosomal epitopes and auxiliary domains and subunits. Additionally, only experimental 
and structural data would allow to test the common features of LSH and other remodellers, 
such as α13 gating helix, which stabilises the tracking DNA strand and prevents it from 
backward motion (Li et al., 2019). Mutations of this region impair remodelling, without 
compromising ATP hydrolysis (Li et al., 2019). This portion of the LSH model had low quality, 
as indicated by ProQ2 (Fig. 3.11), therefore, functions of this LSH region are not clear. 
To conclude, homology modelling of LSH not only provided some insights into LSH structure 
and functions but also highlighted limitations of this approach and reinforced the importance 








4. EXPRESSION AND PURIFICATION OF LSH 
4.1 Introduction 
LSH is a poorly studied member of the chromatin remodelling family and its function is 
implicated in development of ICF syndrome. To gain further insights into LSH structure and 
functions by carrying out biochemical and structural studies I needed to produce the protein 
in the amount and purity adequate for structural and biochemical studies. Previously, LSH 
has been attempted to be expressed in E. coli, however, this expression system was not 
adequate for the murine LSH (Kevin Bryan Myant, 2008). Therefore, all subsequent 
purification attempts have been carried out in the insect cell system, which allows to 
generate proteins with the current post-translational modifications (PTMs).  
Previously, LSH has been expressed by Simon Varzandeh (Simon Varzandeh, 2016), however, 
the closer examination of the remaining stocks produced by him, revealed that to carry out 
high-resolution structural studies (e.g. cryo-EM) the protein purity could be increased. 
Therefore, I attempted to further optimise the purification process of LSH.  
 
4.2 Cloning and expression of LSH and LSHK237Q 
As per previous expression attempts, murine LSH could not be expressed in bacteria. Hence, 
an insect cell expression system using baculoviral infection was utilised. The system differs 
from E.coli in that it takes advantage of the insect eukaryotic protein expression machinery, 
ensuring proper folding and post-translational modification (PTM) allocation of the 
expressed protein (Sørensen, 2010).  
Wild-type murine LSH and LSHK237Q had been previously cloned by Simon Varzandeh into a 
pFL plasmid, with a C-terminal 6xHis tag without a TEV cleavage site between the tag and the 
protein’s N-terminus. The LSHK237Q has a mutation in its ATPase domain, which results in the 
DNA methylation abolished as revealed by cell studies (Termanis et al., 2016). Since I was 
planning to carry out a nucleosome remodelling assay, using WT LSH and CDCA7, LSHK237Q 
would act as a useful negative control. The WT LSH construct also contained the gene ORF of 
a de novo DNA methyltransferase DNMT3B. Since my experiments did not include DNMT3B, 
I needed to reclone LSH-6xHis into another pFL plasmid. Full-length LSHWT was amplified by 
PCR from the pFL-LSH-6xHis-DNMT3B construct using Q5 polymerase and primers containing 
SalI and BamHI restriction sites (see Section 2.1.2.1 of Materials and methods). I digested 
both an empty pFL plasmid and LSH PCR product using SalI and BamHI enzymes and ligated 
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using a standard protocol (see Section 2.1.2.4 of Materials and methods), so that the LSH 
gene was inserted downstream of a polH promoter (MSC2, Fig. 4.1). Correct clones were 
confirmed by Sanger sequencing (see Section 2.1.2.7 of Materials and methods).  
 
 
Figure 4.1 Cloning of the LSH construct. A) LSHWT and LSHK237Q construct schematics. B) 
Transformation and transposition processes in preparation of a bacmid.  
 
For transfection into Sf9 insect cells, bacmids were generated using the MultiBac expression 
system (Fitzgerald et al., 2006). The system requires a two-step process. First, a transfer 
plasmid (in this case, pFL) was generated by cloning (see Section 2.1.2 of Materials and 
methods and Fig. 4.1). It contains two promoters – polyhedron (polH) and p10 – allowing for 
cloning of two gene ORFs. LSH was inserted downstream of the polH promoter. Second, 
competent E. coli DH10 strain containing the EMBacY baculoviral genome with transposition 
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sites and lacZ gene that allows to utilise blue-white screening. LacZ encodes β-galactosidase, 
which is induced by a lactose analogue IPTG (isopropyl β-D-1-thiogalactopyranoside). β-
galactosidase can then break down a dye-linked substrate X-gal present in the agar, 
producing blue pigment. In the event of successful transposition, lacZ gene is disrupted and 
X-gal is not broken down, resulting in white (positive) colonies. EMBacY competent cells are 
transformed with a transfer plasmid, and Tn7 transposition takes place, which should disrupt 
lacZ gene.  
Unlike the MultiBac backbone, the EMBacY backbone also encodes yellow fluorescent 
protein (YFP) (Fig. 4.1) under the control of the polH promoter. YFP expression conveniently 
allows detection of the expressed protein using a microscope with a UV-lamp with an 
emission filter of 520 to 550 nm transmission range. The caveat here is that the protein of 
interest and YFP are expressed under separate polH promoters, and it is difficult to estimate 
the levels of protein expression by YFP intensity, however, in this study, it reliably correlated 
with the presence of the protein of interest.  
Successful production of the resulting bacmid constructs was verified by PCR using a pair of 
primers, one of which is complementary to the inserted gene ORF, and the other is 
complementary to the EMBacY backbone (see Section 2.1.2.1 of Materials and methods). In 
the case of LSH cloning, the forward primer was complementary to the N-terminus of LSH 
and the reverse primer was the universal M13 reverse primer (M13 R) complementary to the 
lacZ gene (Fig. 4.2). The expected sizes of LSHWT and LSH K237Q were 2.5 kb and 3 kb, 
respectively (note, the difference in sizes was due to different forward primers used to 




Figure 4.2 Schematic representation of bacmid with primers used for veryfication PCR after tranfer 
plasmid insertion into EMBacY DNA. Top - The part of the transfer plasmid that is transposed into 
the EMBacY DNA. Middle  – Transposition site of the EMBacY DNA. Bottom – resulting construct of 
the transfer plasmid inserted into the EMBacY DNA. 
 
It should be noted that the quality of the PCR product (smears present in the amplicons, Fig. 
4.3 A,B) did not correlate with the subsequent levels of protein expression (see below), and 
even though the PCR product of LSH shows poor amplification compared to that of LSHK237Q, 









   
Figure 4.3 PCR verification of LSH bacmid. A) Schematic representation of the bacmid PCR approach 
used to verify LSH wide-type and mutant. Amplified regions of LSH, pFL plasmid and EMBacY DNA 
are indicated. B) LSHQ237K-containing transfer plasmid previously made by Simon Varzandeh was 
used as a positive control for the LSHWT clones; C) LSHQ237K bacmids verified by PCR. The sizes of the 
amplicons correspond to the portions or the genes of interest, transfer plasmids and the 
transposition-related portions of EMBacY backbone. (CDCA7 data not relevant to this section cut out 
these lanes and leave a gap between the marker and the LSH mutant clones).   
For a good expression of the protein of interest it is important to avoid freeze-thawing of 
bacmids, therefore they should be aliquoted for a single usage and stored at -20oC (see 
Section 2.1.3.2). Even though DNA is a stable molecule, bacmids are large DNA fragments, 
and freeze-thawing and above 0oC temperatures may have a negative effect on its integrity. 
Another important point is the viability of insect cells. It is not advised to perform 
transfections and infections if cell viability is below 95%. Passage number is also an important 
factor, and in the present experiments I tended to only use Sf9 below passage 20 for 
transfections and below passage 30 for infection and large scale expressions. It is also 
important to bear in mind that the cell viability does not guarantee high expression levels, at 
least in the case of Sf21 cells.  
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Bacmid #3 LSHWT and #1 LSHK237Q (Fig. 4.3 A, B) were used for transfection into Sf9 cells using 
a 6-well plate (see Section 2.1.3.3 of Materials and methods). After 48h, a YFP signal could 
be detected, peaking at 72h, at which point supernatant containing baculoviral particles was 
pooled from the wells as the V0 viral generation. This was followed by infection of 50 ml of 
Sf9 at 1-1.5 million/ml at 1:20 (v:v) V0 to Sf9 ratio to produce V1. Again, at 72h fluorescent 
signal reached ~90-95%, supernatant was collected and the pellet (10-50 ml) was used for a 
pull-down and Western blot. At this point, V1 was used directly for expression tests (in this 
case, the volume of the prior viral infection should be 100 ml) or for further generation of V2. 
In both cases, a ratio of 1:50 (v:v) V1 to Sf9 was used. Expression tests with V2 required 1:75 
or 1:100 ratio (v:v) V2 to Sf9. For expression tests fluorescence and viability were monitored 
after 24h. Generally, 72h was the time point of cell harvesting, with the highest YFP signal 
and a reasonable viability (85-95%). Generally, Sf9 cells are used for virus generation and 
High Five are used for expression, as the latter produce higher amounts of protein. However, 
in this case no High Five cells were available, therefore, I used Sf9 for all steps of protein 
production.  
 
Figure 4.4 Evalution of LSH expression by pull-down and Western blot.  
A) Coomassie stained 12% SDS-PAGE gel of Ni-NTA pull-down confirming LSH expression. The 
samples shown are uninfected Sf9 (lane 2), LSH total lysate (lane 3) , LSH supernatant (soluble 
fraction) (etc) and the fraction bound to the resin. 
B) Western blot of LSH after wet transfer onto neutrocellulose membrane, with anti-LSH 1ry 
antibody and visualisation of Licor IR800-conjugated 2ry anti-mouse antibody.  SN – supernatant. 




Expression of LSH was verified by Protein expression was verified by a Ni-NTA pull-down (to 
ensure that the expressed proteins can be visualised by Coomassie staining) and by Western 
blot (Fig. 4.4 B). It should be noted that LSHK237Q did not express well in this instance, 
however, subsequent tranformation (not shown) solved that problem.  
 
4.3 Purification of LSHWT  
The presence of  6xHis tag on the N-terminus of LSH allows to utilise a robust approach of 
immobilised metal affinity chromatography (IMAC) as a first step of LSH purification, in which 
a spherical bead is attached to a chelating ligand nitrilotriacetic acid (NTA), charged with Ni2+ 
that, in turn, binds histidines in the 6xHis tag. Ni-NTA resin can be used as a slurry or as a 
packed column. Initially, as a test purification, LSH was incubated with the resin for 2-3h and 
then the resin was washed and the protein eluted through centrifugation steps, as detailed 
in Materials and Methods (see Section 2.1.3.8). However, that resulted in a lot of residual 
contaminants (not shown). Therefore, after incubation, the resin was packed into a gravity 
column for washes and elution (Fig. 4.5 A). The eluted protein was still heavily contaminated, 
due to insufficient number of washes and low concentration of imidazole in the wash buffer 
(10 mM). As the second purification step, LSH was applied on a HiTrap Heparin HP 1 ml 
column (Fig. 4.5 B). Heparin columns are routinely used for purification of DNA-binding 
proteins, through anionic sulphated glucosaminoglycans, which mimic negatively charged 
DNA. The electrostatic interaction is disrupted by an increase in ionic strength, making the 










Figure 4.5 Crude LSH purification from Sf9 cells with Ni-NTA resin as the first step, followed by the 
heparin column and SEC.  
A) Coomassie stained 12% SDS-PAGE gel of LSH that partially isolated from the total lysate. Three 
washes with 10 mM imidazole were performed, followed by elution with 500 mM imidazole. Wash 
and elution buffers contained 500 mM NaCl. 2% of each sample volume loaded per well. SN – 
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supernatant, FT – flow-through, W1-3 – washes, E1-5 – imidazole elutions, Ni-NTA – Ni-NTA resin 
after elution.  
B) Chromatogram of LSH from HiTrap Heparin HP 1 ml column with UV detection (280 and 260 nm) 
and % of high salt elution buffer B (containing 1M NaCl, for details see Section 2.1.3.8).  
C) Coomassie stained 12% SDS-PAGE gel of LSH after HiTrap Heparin HP 1 ml column. 2% of each 
sample volume loaded per well.  
D) Chromatogram of LSH from Superdex200 10/30 24 ml column with UV detection (280 and 260 
nm). 
E) Coomassie stained 12% SDS-PAGE gel of LSH after Superdex200 10/30 24 ml column. 2% of each 
sample volume loaded per well.  
 
Ni-NTA purification step was performed in a buffer containing 500 mM NaCl and the protein 
was eluted using 500 mM imidazole, making this ionic strength incompatible with binding to 
the heparin column. Therefore, an overnight dialysis step into a lower ionic strength buffer 
(150 mM NaCl) was required. That, however, resulted in significant precipitation of LSH, 
possibly caused by the combination of the protein concentration in the sample and the 
presence of impurities. The sample was spun down to pellet the precipitate, and the 
supernatant was applied on the heparin column.   
150 mM NaCl allowed protein binding to the column, and separation of a portion of 
impurities, released in a flow-through (Fig. 4.5 B). The elution step with the top concentration 
of 1 M NaCl allowed release of LSH from the column at 78.3% of buffer B concentration (780 
mM NaCl, 39.8 mS/cm conductivity), however, the gradient was only 10 CV, or 10 ml. 
Extending the gradient to 20 CV would allow better separation of LSH and other impurities.  
Finally, the sample was applied to a Superdex200 10/300 24 ml column. It allowed further 
separation from impurities, with LSH eluting as a main peak at 14.3 ml, but the final protein 
was around 80% pure, which is sufficient for functional assays but not pure enough for 
structural studies (Fig. 4.5 D and E). Around 0.6 mg of LSH at 1.3 mg/ml was purified from a 
600 ml culture, with a large fraction of LSH lost at the dialysis step.   
In the attempt to increase LSH purity, I used a HiTrap IMAC HP (high performance) 1 ml on 
the ӒKTApure system, with subsequent imidazole washes of 20 mM for 30 CV and 40 mM for 
15 CV (Fig. 4.6 A). That resulted in LSH of around 80% (Fig. 4.6 B). However, I had to switch 
to a HiTrap IMAC FF (fast flow) 1 ml column, since the HP columns have a smaller bead size, 
which allows for improved purification at the cost of loading efficiency. A 1 ml HP column 
was not sufficient for loading 150 ml lysate and resulted in column clogging and an increase 
in column pressure. Therefore, the rest of the sample was loaded on a HiTrap IMAC FF 1 ml 
column (Fig. 4.6 C). The eluted protein had more impurities compared with a HiTrap IMAC 
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HP 1 ml column (Fig. 4.6 D). Since I was planning to do subsequent purification steps, this 
was not considered a problem.  
   
 
 
Figure 4.6 LSH purification using HiTrap IMAC HP and FF 1 ml columns.  
A) Chromatogram of LSH applied on HiTrap IMAC HP 1 ml with UV detection (280 nm) and % of 
elution buffer B (see Section 2.1.3.8).  
B) Coomassie stained 12% SDS-PAGE gel of LSH after HiTrap IMAC HP 1 ml. 2% of each sample volume 
loaded per well.  
C) Chromatogram of LSH applied on HiTrap IMAC FF 1 ml with UV detection (280 nm) and % of elution 
buffer B (see Section 2.1.3.8). 
D) Coomassie stained 12% SDS-PAGE gel of LSH after HiTrap IMAC FF 1 ml. 2% of each sample volume 
loaded per well. 
 
To avoid the time-consuming and potentially detrimental dialysis step, I instead used the 
HiPrep 26/10 desalting column packed with Sephadex G-25 fine resin for a quick (10-15 min) 
buffer exchange. A Desalting column is a type of gel filtration column with pores too small 
for protein and peptide partitioning, thus inhibiting only salt and other small molecules. The 
Elution buffer contains the desirable salt concentration. Since previously dialysis resulted in 
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a lot of protein precipitation, I attempted to avoid a drastic decrease in ionic strength and 
chose 250 mM NaCl as the final salt concentration. LSH did not seem to precipitate and 
appeared as a single peak in the void volume immediately at the start of elution (Fig. 4.7 A).  
After desalting, instead of a second step heparin column, the sample was applied on a 
Resource S column, which acts as a strong cation exchanger, binding positively charged 
proteins. It has superior properties compared to standard ion exchange resin due to 
homogeneous size and distribution of resin particles. 
The theoretical pI of LSH is 8.2, indicating an overall positive charge in a buffer close to 
physiological pH (7-7.5). After LSH was applied on the Resource S column, it appeared in the 
flow-through (Fig. 4.7 B). It is, however, not uncommon that some proteins predicted to be 
positively charged, in fact, bind to anion exchange resin, instead of cation exchange, possibly 
through some negatively charged pockets or surfaces. However, a more plausible 
explanation for the lack of binding is the excessive ionic strength. Therefore, I diluted the rest 
of the sample to bring the NaCl concentration to 150 mM, which allowed LSH binding as 
indicated by a test run (Fig. 4.7 C). Then the rest of the sample was loaded on the column 
allowing separation of the main peak from minor impurities (Fig. 4.7 D, E).  
As a final step, LSH was applied on the Superdex200 10/300 24 ml column to perform size 
exclusion chromatography (Fig. 4.7 F, G), which allowed separation of LSH (peak 2) from 
minor impurities (peak 1). Around 0.2 mg of protein that was close to 100% purity was 
obtained. That was an improvement from previous LSH purification approaches, and the 













Figure 4.7 LSH purification using HiPrep 26/10 desalting, Resource S ion exchange and Superdex200 
10/300 gel filtration columns.  
A) Chromatogram of LSH applied on HiPrep 26/10 desalting column with UV detection (280 and 260 
nm) and eluted with 250 mM NaCl-containing buffer.  
B) Chromatogram of test application of LSH in 250 mM NaCl-containing buffer on Resource S column 
with UV detection (280 and 260 nm) and % of elution buffer B (1 M NaCl). 
C) Chromatogram of test application of LSH in 150 mM NaCl-containing buffer applied on Resource 
S column with UV detection (280 and 260 nm) and % of elution buffer B (1 M NaCl). 
D) Chromatogram of large-scale application of LSH in 150 mM NaCl-containing buffer applied on 
Resource S column with UV detection (280 and 260 nm) and % of elution buffer B (1 M NaCl). 
E) Coomassie stained 12% SDS-PAGE gel of LSH after Resource S column. 2% of each sample volume 
loaded per well. 
F) Chromatogram of LSH gel filtration on Superdex200 10/300 24 ml column with UV detection (280 
and 260 nm) showing separation of impurities (peak 1) and LSH (peak 2). 
G) Coomassie stained 12% SDS-PAGE gel of LSH after Superdex200 10/300 24 ml column. 2% of each 
sample volume loaded per well. 
 
4.4 Purification of LSHK237Q 
LSHK237Q is an ATPase-inactive mutant with a disrupted ATP binding site. The construct was 
previously cloned by Simon Varzandeh and was meant to be used in the nucleosome 
114 
 
remodelling assay replicated from Jenness et al. (Jenness et al., 2018). Since the mutant 
would not be used in any structural studies, I did not aim for the highest purity of final 
material and followed the same approach as for LSH WT but with minor alterations.  
As the first step, I used the HiTrap IMAC FF column with imidazole washes as high as 40 mM 
(Fig. 4.8 A). That allowed to obtain a semi-pure protein upon elution (Fig. 4.8 B). That was 
followed by the HiPrep 26/10 desalting column to remove imidazole (Fig. 4.8 C) and, finally, 
Superdex200 10/300 (Fig. 4.8 D, E). The final protein was over 90% pure (Fig. 4.8 E) with a 


















Figure 4.8 LSHK237Q purification using HiTrap IMAC FF 1 ml, HiPrep 26/10 desalting and Superdex200 
10/300 gel filtration columns.  
A) Chromatogram of LSHK237Q applied on HiTrap IMAC FF 1 ml column with UV detection (280 nm) 
and % of elution buffer B (500 mM imidazole).  
B) Coomassie stained 12% SDS-PAGE gel of LSH after HiTrap IMAC FF 1 ml column. 2% of each sample 
volume loaded per well. 
C) Chromatogram of LSHK237Q applied on HiPrep 26/10 desalting column with UV detection (280 and 
260 nm) and eluted with 500 mM NaCl-containing buffer.  
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D) Chromatogram of LSHK237Q gel filtration on Superdex200 10/300 24 ml column with UV detection 
(280 and 260 nm) showing separation of impurities (peak 1) and LSH (peak 2). 
E) Coomassie stained 12% SDS-PAGE gel of LSHK237Q after Superdex200 10/300 24 ml column. 2% of 
each sample volume loaded per well. 
 
4.5 Conclusions   
Previously LSH has been successfully expressed using baculovirus expression system, 
however, purification process could be further optimised for potential high-resolution 
structural studies. LSHWT and LSHK237Q were successfully recloned into pFL vectors for insect 
cells expression and expressed in Sf9 cells. I utilised chromatography columns for each 
purification step instead of incubation with resin (in this case, Ni-NTA), since it provided 
purity superior to resin. I also added the ion exchange step using Resource S column. 
Resource columns have smaller matrix beads with homogenous size, which allows to 
efficiently separate impurities. The final step of gel filtration resulted in LSH of over 95% 
purity, albeit at a low yield (200 µg), which still would be sufficient for a cryo-EM study. The 
yield could be improved by expressing LSH in HighFive insect cells, however, during the 
present expression work the cells were not available to me. Overall, murine LSH expression 
and purification has been optimised to a level adequate for structural work.  
The ATPase inactive mutant LSHK237Q was expressed in the similar fashion to LSHWT, however, 
the Resource S step has been omitted, since the mutant was going to be used to recapitulate 
the remodelling assay performed by Jenness et al. (Jenness et al. 2018), and resulting 85-90% 











5. INTERACTION BETWEEN LSH AND THE MONONUCLEOSOME 
5.1 Introduction  
Chromatin remodellers exert their enzymatic functions by interacting with the chromatin 
units, nucleosomes, and free DNA and proteins, as in the case of Mot1. LSH was previously 
shown to interact with free DNA and a mononucleosome containing a DNA linker protruding 
from of the sides of the nucleosomal core particle (NCP), but not a mononucleosome without 
any linkers (see Simon Varzandeh’s thesis), impying that LSH contains a domain that binds 
extranucleosomal DNA. Here, I wanted to test whether LSH binding to the nucleosome is 
dependent on the presence of DNA linkers or a type of a histone octamer. I used recombinant 
mononucleosomes made up of X. laevis histones, which were formed into histone octamers, 
and a synthetic DNA sequence Widom 601 (see Section 2.2.1.4 of Materials and methods). 
These recombinant nucleosomes are a standard system for investigating chromatin units and 
proteins that interact with them. Here, I used 601 DNA with linkers of various length to 
estimate what length is optimal for LSH binding. I also used different octamers – wild type, 
an octamer containing H3 with 27 aa truncation on the N-terminus and an octamer 
containing mutations in the acidic patch (see below) – to check if LSH interacts with the 
nucleosomal core. 
5.2 Expression and purification of histones from Xenopus laevis 
To make mononucleosomes, recombinant histones derived from frog Xenopus laevis were 
expressed in E. coli, isolated as part of inclusion bodies and purified by ion exchange 
chromatography (IEC) (Fig. 5.1). As histones are small proteins completely lacking tryptophan 
residues and having only a few tyrosine residues, it is challenging to accurately determine 
their concentration. This, however, is a critical step, since the success of octamer formation 
depends of the equimolarity of histones mixed. Hence, a range of methods, such as Bradford 
assay, measurement of absorbance at 280 nm and densitometry, was used. A truncated 
version of H3 histone (H3T lacking first 27 residues from the N-terminus that constitute the 
histone tail protruding from the nucleosomal core) was added to the histone set to be 
potentially used in experiments with DNMT3B – a putative LSH interaction partner that has 
been shown to bind the N-terminus of H3 (Rondelet et al., 2016). In the initial experimental 
plan, LSH-DNMT3B complex would have been assessed with and without the 





Figure 5.1 Purified histones form Xenopus laevis. 20% SDS-PAGE.    
 
 
5.3 Octamer formation and purification by gel filtration 
To prepare octamers, histones were mixed at equimolar ratios, each at the concentration 
around1 mg/ml, with a slight excess of H2A and H2B to ensure successful reconstitution and 
dialysed into octamer refolding buffer (10 mM Tris pH 8, 1 mM EDTA, 2 M NaCl, 5 mM β-
mercaptoethanol). During dialysis, histones transform from disordered aggregates to H2A-
H2B dimers and H3-H4 tetramers and subsequently to histone octamers, which are stable at 
2 M NaCl. To separate octamers from any aggregates or any smaller species that might have 
formed during reconstitution, gel filtration was used. The principle of gel filtration is based 
on separation of the species in a sample based on their hydrodynamic radius, which in turn 
affects their partitioning into the solid phase of the column’s resin. Smaller and globular 
particles will partition into the pores more readily, compared with larger and more elongated 
particles, therefore, the former will be eluted later, i.e. at a higher elution volume. Hence, 
the elution volume depends on the size and shape of a molecule. A calibration curve based 
on globular proteins of known sizes is used to determine the elution profile for each column. 
From the previous experiments in the Voigt lab, it was known that octamers containing these 
particular histones have expected molecular mass of around 108 kDa and elute at 12.4 ml on 
Superdex200 24 ml column. In the present run, the main peak, supposedly containing histone 
octamers eluted at 12.8 ml (Fig. 5.2A), which indicates smaller molecular size compared to 
the run in the Voigt lab. However, the columns were physically different, and the present run 
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was done on a slightly compressed column, therefore, the total column volume was less than 
the manufacturer’s specifications. Hence, it is possible to assume that the main peak is, 
indeed, the wild type histone octamer, which was subsequently confirmed by 20% SDS-PAGE, 
where each histone could be seen and all histones have comparable band intensity (Fig. 5.3, 
lanes labelled oct.-WT and oct.-H3T). An octamer previously purified in the lab was used as 
a control, however, as it turned out to contain a mixture of frog and human histones, the 
pattern of histone migration is slightly different (Fig. 5.3 lane labelled oct.-H.s./X.l.).  
In the present run, a peak eluted in the void volume at around 8ml. The presence of 
aggregates indicated that either the dialysis conditions were suboptimal, e.g. transition into 
refolding buffer was not gradual enough, or, more likely, that the ratio of mixed histones was 
not equimolar, which is plausible, considering the difficulty of their accurate quantification. 
A smaller peak at ~15.2ml indicated the presence of smaller species, such as histone 
tetramers or dimers (Fig. 5.2A). The octamer containing the truncated version of H3 
(predictably eluted later than the wild type octamer, at 13.1 ml (Fig. 5.2 B), reflecting the 
difference of approximately 5 kDa between the octamer types (108.8 kDa – wild type, 103.1 
kDa – truncated version). 
 
 
Figure 5.2 Size exclusion chromatography of histone octamers. Octamers containing wild type 
histones A) and N-terminally truncated H3 B) from Xenopus laevis were purified by isocratic elution 
with octamer refolding buffer. Peak 1 represents histone aggregates and peak 2 represents 





Table 5.1 Elution profile following SEC of octamers.  
Peak # Peak description WT oct. elution 
V (ml) 
H3T oct. elution 
V (ml) 
Molecular mass (kDa) 
1 Aggregates 8.2 7.9 - 
2 Octamers 12.8 13.1 108/102 
3 Tetramers or 
dimers 
15.2 15 ~60  
 
 
Figure 5.3 Purified histones from Xenopus laevis and reconstituted octamers containing wild type 
and N-terminally truncated H3. Samples were separated on 20% SDS-PAGE at 250 V for 120 min for 
enhanced resolution. Individual histones are labelled H2A, H2B, H3 and H4 for the wild types and 
H3T for the H3 truncation; Oct. WT – octamer with Xenopus laevis wild type histones; Oct.-H3T - 
octamer with Xenopus laevis truncated histone 3. Oct.-H.s/X.l. - octamer with a mixture of Homo 
Sapience and Xenopus laevis histones (made by Simon Varzandeh).   
 
5.4 Nucleosome reconstitution and quantification 
Being basic units of chromatin, nucleosomes are complexes of histone octamers and DNA 
wrapped around them. They are naturally present in the form of arrays, but to study a 
chromatin remodeller’s mode of action, mononucleosomes are sufficient, since a 
remodeller-mononucleosome complex allows to capture the details of the interaction. To 
form a mononocleosome, a synthetically derived strong positioning DNA sequence termed 






remodellers’ activity can be dependent on the presence of a DNA linker extending from the 
nucleosome core particle (NCP). LSH, the protein investigated in this study, has a poorly 
characterised mode of interaction with a mononucleosome, and it cannot be ruled out that 
it also requires a linker for efficient engagement with NCP. Previous experiments performed 
by Simon Varzandeh suggested that LSH requires at least 26 bp DNA linker for binding and it 
could not bind a nucleosome without any linkers.  
Hence, 601 sequence was amplified with a range of shorter DNA linkers: 0W0 (601 Widom 
sequence without any linkers), 6W0 (601 with a 6bp linker on the 5’-end of the 601 
sequence), 12W0 (601 with a 12bp linker on the 5’-end of the 601 sequence) and 25W0 (601 
with a 25bp linker on the 5’-end of the 601 sequence) (see Section 2.2.1.3 of Materials and 
methods for oligo sequences). The reverse primer amplifying 3’ of the 601 sequence without 
a DNA linker was conjugated to IR800 fluorophore. It was ensured that the linkers did not 
contain any palindromic restriction sites in their sequences, as it can result in secondary 
structure formation in the linker sequence and, therefore, artefactual results.  
Successful nucleosome reconstitution results in formation of mononucleosomes with 
minimal amounts of free DNA or octamers. The optimal ratios were determined empirically 
for each new DNA and octamer preparation, for example, the 25W0 fragment was titrated 
with the fixed amount of the octamer to determine the optimal reconstitution ratio (Fig. 5.4 
A). Reconstituted mononucleosomes were run alongside the free DNA fragment to verify 
successful reconstitution by the shift on a native TBE gel (Fig. 5.4 B). Generally, in my octamer 
reconstitution set-ups the DNA-octamer ratios of 0.5:1 or 0.7:1 resulted in minimal amounts 




Figure 5.4 Nucleosome reconstituted with X.l. octamers and the 601 sequence with various linkers 
resolved on 6% TBE native PAGE and visualised as an IR800 signal on Licor Osyssey scanner. A) 
Titration of 25W0 DNA fragment with the wild type and H3T octamers to determine the optimal 
reconstitution ratio; molar ratios are shown. B) DNA fragments with various linker lengths mixed 
with the wild type octamers at 0.5:1 molar ratio. NCP – nucleosome core particle. 
It is worth noting that the 601 sequence is known for its uniform positioning of the octamer 
(Lowary and Widom, 1998). Other sequences, such as alpha-satellite DNA or 5S RNA, may 
wrap around the octamer in a variety of ways, which results in different nucleosomal species 
visible on a gel (Luger et al., 1999). When different nucleosomal species are present due to 
non-uniformal positioning, a heating step helps to obtain molecules with uniform DNA 
positioning. This problem should not occur with the 601 sequence, since it is a synthetically 
generated fragment with enhanced affinity for the octamer, compared with naturally 
occurring sequences. However, in the present study, nucleosome reconstitution resulted in 
two bands present when H3T-containing octamer was used (Fig. 5.4 A, lanes H3T oct.). 
Similarly, an extra band was present after 25W0 NCP WT octamer reconstitution (Fig. 5.4 B, 
lane 25W0 NCP), however, this pattern was not observed in subsequent reconstitutions, 
even though the preparation method was the same. Taq polymerase, which was used to 
make Widom 601 DNA, has relatively low proofreading activity may introduce errors, 
however, it is unlikely for small fragments, such as the ones used in this study. Nevertheless, 
potential mutations may weaken the affinity of the DNA fragment for the octamer, resulting 
in non-uniform positioning.  
Nucleosome quantification is complicated by the fact that the molecules contain both DNA 
and proteins, therefore, it was rationalised that A260 will give a mixture of DNA and protein 
absorbance and will not be accurate, therefore, I used three approaches to NCP 











quantification: measurement at A260 by Nanodrop, scanning of fluorescence signal and DNA 
staining with SYBR Safe. Since all the DNA fragments used here (0W0, 6W0, 12W0 and 25W0) 
contained the same 3’ fluorescent IR800 label, it was expected that the concentration of 
NCPs would be directly proportional to the fluorescence intensity. To check that, all four DNA 
fragments of the same concentration determined by Nanodrop were separated on a 6% TBE 
native PAGE alongside a standard curve based on 6W0 samples of known concentrations and 
NCPs of unknown concentrations and visualised either using IR800 fluorescent signal and 
SYBR Safe (Fig. 5.5 A and 5B, respectively) and the standard curve based on 6W0 SYBR Safe 
staining signal (Fig. 5.5 C).  
 
 
Figure 5.5 Evaluation of NCP reconstitution. NCPs were visualised on a 6% TBE native PAGE using A) 
IR800 fluorescence intensity or B) SYBR Safe staining. C) Standard curve was generated from 6W0 
titration visualised by SYBR Safe. 
The comparison of the visualisation and quantification methods demonstrated that 
fluorescence intensity was not directly proportional to the nucleosome concentration but 
SYBR Safe staining was more consistent with Nanodrop measurements (Fig. 5.5 A and B, 
respectively). Predictably, dilution of the 6W0 DNA fragment (Fig. 5.5, from 75 down to 9 

























nM) and staining with SYBR Safe generated a nearly linear standard curve (Fig. 5.5 C), 
indicating correct dilution, which did not translate into the IR800 signal (Fig. 5.5 A). This result 
demonstrated that fluorescence intensity should be evaluated cautiously, and Nanodrop 
quantification was selected as more accurate and quick.  
Measurement of the nucleosomes at 260nm on a Nanodrop spectrophotometer 
demonstrated A260/280 ratio of 1.8, which corresponds either to a DNA sample free of protein 
contaminants or to a DNA sample containing proteins lacking aromatic groups, which are the 
main source of absorbance at 280 nm. Histones have a few tyrosine residues that give a 
weaker absorbance at 280nm and a few phenylalanines that absorb very weakly at 260nm. 
Hence, histones were not anticipated to interfere with DNA absorbance, and its estimated 
concentration by Nanodrop divided by the MW of the DNA fragment was used to estimate 
molarity of each nucleosome.  
 
5.5 LSH binding to the NCP was not affected by various DNA linker present 
on the NCP    
It has previously been established that LSH can bind both free DNA and a nucleosome (Simon 
Varzandeh, 2016). However, from the previous experiments, it was not clear whether LSH 
requires a linker extending from the nucleosome core particle (NCP). Previous 
electrophoretic mobility shift assays (EMSA) demonstrated conflicting findings, wherein an 
NCP lacking a linker (0W0) could not be shifted by increasing concentrations of LSH in some 
experiments (Kevin Bryan Myant, 2008; Simon Varzandeh, 2016) but was shifted in other set 
of experiments (Laura FitzPatrick’s MSc report, University of Edinburgh). It should be noted 
that S. Varzandeh used an octamer that contained a mixture of human and frog histones, 
however, the human histones are highly homologous to the frog histones and the differences 
in the octamers are unlikely to account for the difference in the shift. In attempt to resolve 
this discrepancy and to establish whether LSH required linker DNA to bind an NCP, EMSA was 
performed in triplicate with fixed amount of the nucleosome containing four different DNA 




Figure 5.6 EMSA with 10nM of NCP with various linkers and increasing concentrations of LSH. Shift 
assay on 0.5% agarose gel visualised by IR800 fluorescence intensity for the nucleosomes containing 
DNA fragments A) 0W0; B) 6W0; C) 12W0; D) 25W0. 
 
From the EMSA experiments in this study, it appears that LSH does not require a DNA linker 
to bind to a nucleosome, as indicated by the shift of the 0W0 NCP. A shift occurs with all 
fragments used in this study, however, the 12W0 NCP demonstrated a clear double shift (Fig. 
5.6 C), which may indicate either oligomerisation of LSH or a more likely possibility that it 
binds NCP at the two locations – super-helical location 2 (SHL2) and super-helical location -2 
(SHL-2) (see Section 2.1). There may be a slight double shift with the other NCP fragments, 
however, it was hard to distinguish a clear double shift from a smear (Fig. 5.6 A, B, D). 
However, it is unlikely that LSH binds 12W0 in a way that differs from the other NCPs in this 
experiment. If LSH, like the other chromatin remodellers, binds through its ATPase lobes at 
the SHL2 and SHL-2, this should be done irrespective of the linker DNA.  
This is not entirely unpredictable as chromatin remodellers have a propensity to bind an NCP 
at SHL2, which ensures an adequate placement of mechanical force for DNA translocation 
along the octamer. This mechanism was observed in the mode of action of Snf2, the closest 
126 
 
LSH homologue from yeast (Liu et al., 2017b). Snf2 was also shown to interact with an NCP 
at SHL6, located roughly opposite SHL2 (Liu et al., 2017b). That would explain the super-shift 
clearly observed in the case of 12W0 NCP-LSH interaction (Fig. 5.6 A). Other remodellers, 
such a CHD1, which has two DNA-binding domains, have a higher affinity for an NCP in the 
presence of DNA linker (Nodelman et al., 2017). It cannot be ruled out that LSH interacts both 
with a nucleosomal DNA and a linker DNA, perhaps, recognising the linker DNA through the 
same mechanism as free DNA. Nevertheless, the exact mode of interaction between LSH and 
an NCP cannot be elucidated solely based on EMSA experiments.  
 
5.6 LSH-NCP complex with free DNA and nucleosomal mutants  
Next, I wanted to check if the octamer itself influences LSH interaction with the NCP. To do 
that, various types of free DNA (a short double-stranded 12-mer fragment, a double-stranded 
159-mer fragment) and the nucleosome (containing 0W0 or 12W0 DNA in a complex with 
the wild type octamer (WT oct.), H3 N-terminal 27 aa truncation (H3T oct.) and an acidic 
patch mutant (AP-M) octamers) were used. The acidic patch mutant contained the following 
alanine substitutions: H2A (E65A E90A E91A) and H2B (E105A).  Even though LSH is not 
expected to interact with H3 N-terminal tail, as seen from homology modelling (see Section 
3.1 of Results). However, I decided to test this octamer variant to gain experimental data 
regarding the effects of H3 N-terminus truncation on LSH-NCP interaction and to substantiate 
LSH-NCP homology modelling. 
Comparing the short DNA fragment with a long one would show if LSH binds DNA in a 
particular location or if it just recognises double-stranded DNA nonspecifically. The octamer 
variants would elucidate whether LSH interacts with the octamer core during its interaction 
with the NCP. As indicated from the previous experiments performed by Simon Varzandeh 
(Simon Varzandeh, 2016), LSH binds free DNA, therefore, it is not clear whether its shift of 
the NCP is due to the recognition of the nucleosomal fold or simply the recognition of the 
double-stranded DNA.  
Preparation of Nucleosome core particles containing variant histones proceeded as 
previously: I performed initial octamer titration into 100 nM of 601 DNA to obtain the 
appropriate reconstitution ratios (Fig. 5.7 A, B). For all of the variants, After almost no free 
DNA was present at 1:2 DNA:octamer molar ratio (Fig. 5.7 A, B). Then, using 1:2 ratio 
obtained from the test reconstitution, I performed a scale up to 500 nM 601 DNA (Fig. 5.7 
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C). Double-stranded oligonucleotide 12-mer was obtained by annealing two ss12-mer 
fragments (IR800-F-12mer-non-hairpin: GTTGCGTGCTTT, R-12mer-non-hairpin: 
AAAGCACGCAAC) (Fig. 5.7 D). All samples were resolved on a native PAGE.  
 
Figure 5.7 Reconstitution of various nucleosome core particles (NCPs) containing the wild type (WT) 
histone octamer, the octamer with a truncated H3 variant (H3T) and an acidic patch mutant octamer 
(AP-M) used for EMSAs. A) Test reconstitution of 0W0 601 DNA fragment with different octamers, 
ratios are DNA:oct.; B) Test reconstitution of 12W0 601 DNA fragment with different octamers, 
ratios are DNA:oct.; C) Scale up (100 µl) of successful (1:2 DNA:oct. in all octamer variants) 
reconstitution reactions. D) Annealing of 12-mer.  
 
Following reconstitutions, validation and quantification of the DNA fragments (ds12-mer and 
ds159-mer) and NCPs (0W0 and 12W0 with WT, H3T and AP-M octamers), they were 
incubated with increasing amounts of LSH and binding was analysed by EMSA (Fig. 5.8). 
Incubation of LSH with the ds12-mer resulted in a shift, confirming that LSH is capable of 
recognising and binding short DNA fragments (Fig. 5.8 top). The shifts at 100 and 150 nM of 
LSH may represent a 1:1 stoichiometry and a relatively small complex, however, at 200 and 
250 nM LSH the complex appeared larger and some of it was inhibited in wells (Fig. 5.8 top), 
which may be due to LSH aggregation or oligomerisation.  
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Comparison of ds12-mer oligo to the ds159-mer fragment demonstrated a similar pattern, 
however, it appeared that LSH was more efficient in shifting the longer DNA fragment (Fig. 
5.8 top). This can be due to the presence of some ssDNA in the ds12-mer sample. LSH has 
not been shown to bind ssDNA, therefore, some residual ssDNA may result in the smear on 
the left hand side gel but not on the middle gel (Fig. 5.8 top). The shift pattern of ds159-mer 
and 12W0-NCP-WT appeared similar (Fig. 5.8 top, middle, right), indicating that the presence 
of dsDNA rather than NCP folds is the key for LSH binding.  
When LSH was incubated with the NCPs containing 0W0 DNA and different octamers (WT, 
H3T or AP-M), all the nucleosomal variants were shifted (Fig. 5.8 B), demonstrating that 
difference in octamers does not affect LSH binding to different 0W0 NCPs. There is a double 
shift similar to the one that was clearly observed after incubation with 12W0 NCP (Fig. 5.6 
C), which reinforces the notion that LSH preferentially binds at two nucleosomal locations 
(most likely SHL-2 and SHL2), regardless of the presence of DNA linker. The fact that in the 
previous EMSA experiment it was not clearly observed may be due to the quality of the gel 
in the previous experiment (Fig. 5.6 A). The smeary pattern may also indicate that there is a 
variety of locations along the nucoleosome where LSH can bind. There is an apparent slight 
reduction in affinity with acidic patch mutations (Fig. 5.8 B), with the shift occurring at slightly 
higher LSH concentrations (250 nM LSH was enough to completely shift 0W0 NCP-WT 
whereas some NCP remained unshifted at 250 nM LSH with 0W0 NCP-AP-M, Fig. 5.8 B, C), 
which may indicate that LSH uses the regions flanking the ATPase domain to interact with 
the octamer. This pattern was also observed with the 12W0 NCP fragments (Fig. 5.8. C), 
further reinforcing the hypothesis that LSH does not rely on any DNA linkers for binding the 
nucleosome and interacts only with the nucleosomal core. 
The nucleosomes containing 12W0 DNA and different octamers (WT, H3T and AP-M) were 
also incubated with LSH, which resulted in a similar result to that of 0W0-containing 
nucleosomes. As previously, a step-wise shift was observed (Fig. 5.8 C), hinting at LSH binding 
at two different locations. Similarly to the 0W0-contaning NCPs, acidic patch mutant 
appeared to reduce LSH affinity for the NCP, with the WT NCP being completely shifted by 
200 nM LSH (Fig. 5.8C left), whereas the AP-M NCP was shifted by 250 nM LSH (Fig. 5.8C 
right). 
H3T octamer did not appear to make a drastic change to LSH binding for the NCP containing 
either 0W0 or 12W0 DNA (Fig. 5.8 B, C), but there may be a slight increase in affinity, since 
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the bands of the shifted NCPs at 200 and 250 nM of LSH appear more compact compared to 
the WT NCPs, however, like with the wild type, the shift occurred at 200 nM of LSH, indicating 
that the difference in band appearance may be due to the resulting shape of the nucleosome 
contributing to the migration pattern, rather than due to the difference in affinity (Fig. 5.8 B 
left and middle, 5.8 C left and middle). The nucleosomes containing acidic patch mutated 
octamers appeared distinct from the wild type and H3 histone truncated octamers (Fig. 5.8 
B, C), with the shifted bands appearing more smeary than the wild type. Additionally, the 
complete shift did not seem to occur even at the highest concentration of LSH, 250 nM, 
indicating that the patch may play a role in LSH interaction with the nucleosome. One of the 
terminal regions of the protein may form interactions with this nucleosomal area, however, 
their exact orientation could not be deduced from homology modelling (see Section 3.2) and 
chemical crosslinking experiment did not capture any obvious intermolecular protein-protein 







Figure 5.8 EMSA with various DNA fragments and NCPs and LSH titration. A) LSH titrated with 10 
nM 12-mer DNA fragment, 159-mer (12W0) DNA fragment and 10nM 12W0 NCP. B) 10 nM of 0W0 
NCP with indicated octamers (WT - wild type, H3T – N-terminally truncated H3, AP-M - acidic patch 
mutant) with LSH titration; C) 10 nM of 12W0 NCP with indicated octamers (WT - wild type, H3T – 
N-terminally truncated H3, AP-M - acidic patch mutant) with LSH titration. 0.5% agarose gel, Tris-
CAPS buffer pH 9.4 run at 4oC and visualised through IR800 fluorescent signal. 
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It is known that LSH recognises acetylated chromatin and histone deacetylation through 
inhibition of HDAC by trichostatin A (TCA) abolishes LSH association with it (Yan et al., 2003), 
indicating that acetylation is a requirement for LSH binding to chromatin in cells. 
Recombinant NCPs used in the present experiments do not have post-translational 
modifications (PTMs) and LSH is still capable of binding them indicating that here LSH relies 
only on recognition of NCP itself rather than any histone tail modifications. To check whether 
LSH has an altered affinity to NCPs containing recombinant octamers compared to the native 
ones, I reconstituted NCPs with native octamers isolated from HeLa cells (native octamers 
were isolated and purified by Dr. Alba Abad, Arulanandam lab). These NCPs were used to 
perform an EMSA experiment to compare the shift patterns between the NCPs containing 
recombinant and native histone to determine whether PTMs influence LSH binding in vitro.  
and performed EMSA.  
 
Figure 5.9 EMSA experiment of LSH binding to NCPs containing 12W0 601 DNA fragment and 
recombinant or native octamers. 0.5% agarose gel, Tris-CAPS buffer pH 9.4 run at 4oC. 
 
The presence of any PTMs on HeLa cell histones did not appear to improve LSH affinity to the 
NCPs in vitro and even make the affinity slightly lower (Fig. 5.9, recombinant vs. native 
octamers). This may be due to the presence of different PTMs on the histone tails since they 
were isolated from asynchronous cells. A clearer comparison would be possible by chemically 
adding specific PTMs, namely acetylation, on the tails of recombinant histones, which might 
have improved affinity between NCPs and LSH, however, this assumption was not tested in 
the present study. The H3T-containing octamer could be used to add an N-terminal tail with 




5.7 NCP-LSH complex was not detected by SEC-MALS at room 
temperature  
To characterise the LSH-NCP complex detected by EMSA, size-exclusion chromatography-
multiple angle light-scattering (SEC-MALS) was then used. SEC-MALS is a technique that 
allows separation of molecules based on its hydrodynamic radius and measurement of their 
molecular masses. It is more reliable for protein and complex characterisation than standard 
gel filtration, since the results from a gel filtration run rely on comparison of the protein’s 
elution profile with a standard set of that consists of mostly globular proteins, such as 
aprotinin, ovalbumin and conalbumin 
(https://www.gelifesciences.co.jp/catalog/pdf/28407384.pdf). Gel filtration relying on a 
globular protein standard can provide some insight but may be misleading since the protein 
migration through the matrix also depends on the protein shape or conformation. Elongated 
proteins are less likely to partition into the pores, hence, they elute earlier than would a 
globular protein, and appear larger. SEC coupled with MALS allows to overcome this caveat 
and to obtain the absolute molecular weight of a molecule, without relying on calibration, by 
passing the protein of interest through a chamber that is illuminated by a laser (Meier and 
Heinzmann, 2017) (Fig. 5.10). Protein concentration is determined by the refractive index 
(RI) detection, which allows determining molecular weight across the sample peak (Wyatt, 
1993). Once the laser has passed through the sample, the protein absorbs the energy from 
the incident beam. The resulting intensity of light scattered by the protein is then captured 
by detectors surrounding the chamber. The light scattering allows to determine the 
dimensions of the protein (or any other macromolecule) through the mean square radius of 




Figure 5.10 Schematic representation of a MALS detector. Grey rectangles represent 21 detectors 
located at the angles according to the number on each detector. Flow represent the sample flow 
following separation by gel filtration. Laser passes through the sample resulting in energy 
scattering, this energy is then captured by the detectors. Figure from Meier and Heinzmann 2017.  
All these advantages make SEC-MALS a useful technique for determining not only the size of 
the components of a potential complex, but also allow determining the absolute mass of the 
complex, thus, elucidating its stoichiometric characteristics.  
A few things should be taken into consideration when comparing analysis of LSH-NCP 
complex formation by EMSA and by SEC-MALS. First, even though both experiments were 
performed at 150 mM NaCl, the EMSA experiments (Fig. 5.6 and 5.8) were performed at 4⁰C 
but the SEC-MALS instrument set up was only possible at the room temperature. Increase in 
temperature is a factor affecting complex stability. To test if the complex can survive those 
altered conditions, I repeated the EMSA analysis of LSH-NCP complex formation at room 
temperature and at two NaCl concentrations – 150 mM and 250 mM (Fig. 5.11). It appeared 
that the increase in salt slightly changed the affinity of the components and resulted in 
incomplete shift of NCP as well as the increase in temperature affected affinity of LSH for the 
NCP (compare with Fig. 5.8C), however, the differences between the experiments at 4oC and 




Figure 5.11 EMSA experiment with 10 nM 12W0 NCP and increasing concentrations of LSH. 0.5% 
agarose gel, Tris-CAPS buffer pH 9.4 run at room temperature. 
 
Second, the amount of material used in the SEC-MALS study differed from that in EMSAs. In 
the case of EMSAs, the amount of NCPs was 10 nM and the highest LSH concentration was 
250 nM, making the ratio to shift the NCP 1:25 NCP to LSH. As was visually estimated from 
the EMSA experiments, the qualitative Kd for the LSH-NCP interaction is around 100 nM LSH 
(Fig. 5.11) and the highest amount of the complex in the EMSA set up would be 10 nM, 
however, this amount would not be detected by the instrument. The purified LSH stock 
(prepared by Simon Varzandeh) was 10 mg/ml, or 104 µM. This high concentration would 
allow to dilute LSH to a desired concentration, however, scaling up NCP proved to be more 
problematic, and typically the highest NCP concentration did not exceed 10 µM. Therefore, 
the highest NCP concentration that could be injected was around 5 µM. Since the samples 
undergo further dilution of around 14-fold from the initially injected concentrations (Table 
5.2) while migrating through the column, the complex that might have been formed could 
undergo partial or complete disintegration. The limiting component of the complex is the 
NCP concentration, therefore, the highest amount of the complex would be 5 µM at the 
present NCP molarity. If the complex has a 1:1 or 1:2 stoichiometry of NCP to LSH and the 
estimated Kd is around 100 nM, injecting 5 µM NCP and 26 µM of LSH would allow to detect 
the complex. This amount of LSH was chosen due to an attempt to inject as much LSH as 
possible within the 100 µl of injected volume to capture the complex formation.  
When the components (5 µM 12W0 NCP and 26 µM LSH) were applied on Superdex200 24 
ml column separately, their molecular masses measured by the instrument were close to 
their expected molecular masses (observed 205 kDa for NCP and 99 kDa for LSH, Table 4.2) 
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(Fig. 5.12 A, B). NCP 12W0 eluted as a single peak at 11.3 ml and with 80% recovery (MALS 
data, not shown), indicating that 150 mM NaCl was sufficient to disrupt any potential non-
specific interaction with the column matrix (Fig. 5.12 A). LSH (Fig. 5.12 B), on the other hand, 
displayed a poor recovery of only around 28% (MALS data), which was unexpected since 
previously this non-specific interaction had not been observed. This may be due to the lower 
salt concentration in this experiment compared to previous LSH runs on Superdex 200, since 
previously all LSH purification steps were performed at 500 mM NaCl. There was an 
additional peak that eluted after LSH (Fig. 5.12 B) but it was outside the column volume 
indicating that the particle was very small. It was not possible to investigate what it was, since 
fractions could not be collected on this instrument.  
 
 
Figure 5.12 12W0 NCP-LSH SEC-MALS chromatograms. A) Elution of 12W0 NCP with absorbance at 
280 nm and molecular mass indicated on the left and right hand Y axes respectively; B) Elution of 
LSH with absorbance and molecular mass indicated on the left and right hand Y axes respectively; C) 
12W0 NCP and LSH following their mixture and a 30 min incubation at 4oC with absorbance and 





Table 5.2 Characteristics and parameters of the 12W0 NCP-LSH SEC-MALS run.  
 
12W0 NCP LSH 12W0 NCP and LSH together 




0.5 mg/ml (5 µM), 2.5 mg/ml 
(26 µM) 
Elution volume (ml) 11.3 13.3 11.4, 13.3 
 UV 260/280 1.8 0.5 1.8, 0.5 
Expected MM (kDa) 205 96 
 
Observed MM (kDa) 205 99 211, 102 
 
When the NCP and LSH were mixed at 5 µM and 26 µM, respectively, incubated at 4oC for 30 
min and injected on the column in a total of 100 µl, the components eluted separately and 
no shifts were observed, indicating that the complex did not form or that it formed but did 
not survive the run (Fig. 5.12C). The elution volumes of NCP and LSH were 11.3 ml and 13.3 
ml, respectively, when injected separately, and these values did not change after injection of 
the mixture, indicating the lack of a shift due to the absence of the complex. The increase in 
the temperature compared to the original EMSA performed at 4oC (Fig. 5.6) should not have 
affected the complex as indicated by the EMSA performed at room temperature (Fig. 5.11). 
It should also be noted that the incubation volume was 100 µl, whereas the samples undergo 
roughly a 14-fold dilution as they pass through the column. This dilution may interfere with 
the kinetics of the complex and cause complex dissociation, even though the nanomolar 
affinity predicted by EMSAs should be sufficient to overcome this dilution. This discrepancy 
may be explained by the overestimation of affinity by EMSA. EMSA is notorious for its 
limitations, creating an environment where the components behave differently compared to 
the solution. Once the complex is applied on the gel it is stabilised by the caging effect of the 
gel, hence, showing an overestimated affinity (Fried and Bromberg, 1997; Hellman and Fried, 
2007). Therefore, the SEC-MALS method was not adequate to detect NCP-LSH interaction.  
 
5.8 Gradient fixation trials of LSH-NCP  
Since the ultimate step in the LSH-NCP complex investigation would be examination via 
electron microscopy (EM), optimisation of the complex preparation was explored. Gradient 
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fixation (GraFix) is a common step in preparation for single-particle EM. The sample is 
ultracentrifuged into an increasing gradient of glycerol or sucrose and a fixative, such as 
formaldehyde or glutaraldehyde (Kastner et al., 2008a; Stark, 2010). Sucrose provides a 
cushioning effect for the sample that migrates through the gradient and is simultaneously 
being fixed in increasing concentration of glutaraldehyde. The centrifugal forces disrupt any 
aggregates, whereas the fixative at a low concentration provides intramolecular cross-links. 
This results in a stabilised complex that is structurally more homogeneous and can endure 
longer adsorption times on the EM grid, resulting in improved resolution of the sample and 
reduced noise. Labile samples, such as spliceosomes and 70S ribosome, have been 
successfully visualised using cryo-EM combined with GraFix. The structure of a nucleosome, 
both free and in a complex with a protein, have also been solved by combining these methods 
(Liu et al., 2017a; Nguyen et al., 2013). Therefore, GraFix was selected as a promising 
approach to stabilise the complex and to improve the sample quality.  
Following methods reported in the literature, 10-30% (w/v) sucrose and 0.2% (v/v) 
glutaraldehyde gradients were chosen to crosslink LSH to an NCP (see Section 2.6.1). 
Glutaraldehyde is an amine-reactive homobifunctional crosslinker (has identical reactive 
groups on each side of the molecule) and the preferred reagent in crosslinking for electron 
microscopy. It is a larger molecule compared to another fixation reagent formaldehyde, 
therefore, it is less prone to introducing artefacts. The initial approach was to check how 
these conditions affect the fixation of 0W0 NCP, to make sure that no intermolecular cross-
linking occurs. A 100 μl of 0W0 NCP sample at 100 nM was added to 10-30% sucrose gradients 
with or without 0.2% glutaraldehyde.  Following an 18h centrifugation at 35,000 rpm 0W0 
with and without glutaraldehyde were manually fractionated and analysed on a native 6% 
TBE PAGE (Fig. 5.13 A, B). 
The comparison of fixed and unfixed NCPs demonstrated two bands at the bottom of the 
gradient in the unfixed sample and one band species in the fixed sample, indicating that 
centrifugation introduced some aggregation to the NCPs (Fig. 5.13 A). This extra band was 
not present in the fixed sample, indicating that fixation might have crosslinked the NPCs and 
they were pulled to the bottom of the gradient leaving the mononucleosomes in the middle 
of the gradient (Fig. 5.13 B). The weaker signal of the fixed sample may indicate that some 
fraction of the NCP has aggregated due to crosslinking or that glutaraldehyde caused some 
IR800 quenching (Fig. 5.13 B).  The comparison of input (NCP before loading on the gradient), 
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fixed and unfixed NCPs demonstrated that the bands present in the fixed and unfixed 
samples, indeed, corresponded to the input NCP (Fig. 5.13 C).  
To check for successful fixation, the samples were assessed by 15% SDS-PAGE (Fig. 5.13 D). 
The input and unfixed samples have a similar migration pattern, whereas the fixed sample 
was not visible on the gel. This may be due to two possibilities: either the sample was cross-
linked, therefore, being too big to enter the gel of this percentage, or the denaturing 
conditions further affected the fluorophore, making the sample even less detectable. The 
presence of faint low molecular weight traces of unknown origin in the fixed sample lane may 
indicate that the sample could not enter the gel. Future experiments will require optimisation 
of each GraFix step and include introduction of molecular weight marker mix run on a 
gradient, gradient preparation and fractionation and different approach to the final product 
detection.   
The analysis of the gels has a few caveats. First, the fractionation was done manually, which 
is likely to introduce error, and the sedimentation pattern cannot be used to estimate 
molecular weight of the sample. Second, manual fractionation is more time consuming, and 
the gradients were likely to undergo some dissipation following centrifugation. These two 
factors are likely to explain the broad sedimentation profile of the samples.  
 
 
Figure 5.13 PAGE analysis of GraFix tests on 0W0 NCP. Native PAGE of ulatracentrifuged A) Unfixed 
NCPs. B) Fixed NCPs. C) Comparison of 0W0 DNA (lane 1), input, fixed and unfixed NCPs, Lanes 2,3 
and 4, respectively D) Comparison of input, fixed and unfixed NCP migration patterns under 




- glutaraldehyde + 0.2% glutaraldehyde 15% SDS-PAGEA B C D
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samples were visualised by fluorescence intensity of IR800. Fr. – fraction. Note: only every other 
fraction was run on the gels.  
 
5.9 LSH-NCP complex was not detected by chemical crosslinking   
To further explore the ways to capture LSH-NCP complex, I tried chemical crosslinking with 
BS3 and EDC/sulfo-NHS (see Section 2.6.2). Crosslinking is a process where a chemical with a 
specific reactive group interacts with a functional group on a protein or other molecule, such 
as DNA, thus forming a covalent bond. BS3 (bis(sulfosuccinimidyl)suberate) is a 
homobifunctional amine-to-amine crosslinker at each end of its 11.4 Å spacer arm (Fig. 5.14). 
It reacts with primary amines on N-termini of the protein and on lysine residues.  
 
Figure 5.14 Chemical structure of BS3 (bis(sulfosuccinimidyl)suberate) crosslinker (from Thermo 
Scientific Crosslinking Technical Handbook).  
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride) is a carbodiimide 
crosslinker that conjugates carboxyl groups to primary amines. Sulfo-NHS (N-
hydroxysulfosuccinimide) is added to the EDC reaction to activate carboxylic group (-COOH) 





Figure 5.15 Crosslinking reaction with EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride) and sulfo-NHS (N-hydroxysulfosuccinimide). Carboxylic group reacts with EDC to form 
an unstable O-acylisourea conjugate, which then reacts with sulfo-NHS forming stable and amine-
reactive intermediate. This intermediate is later used to form an intramolecular or intermolecular 




Homology modelling and EMSAs of LSH in a complex with NCP indicated that interaction with 
nucleosomal DNA would be the most likely contact between two molecules. However, the 
N- and C-termini of LSH could not be reliably modelled due to low levels of homology with 
the other chromatin remodellers. The EMSA experiment with acidic patch-mutated octamer 
showed a slight decrease in affinity (Fig. 5.8 B, C). Hence, even though LSH may not form 
functional interaction with NCP, its flexible termini may be in close proximity to histone tail 





Figure 5.16 Crosslinking reaction between LSH and NCP. A) Crosslinking reactions of 4.8 µg of LSH 
(2.5 µM) with and without 1 µg of NCP (0.5 µM) and the indicated amounts of BS3; B) Crosslinking 
reactions of 4.8 µg of LSH (2.5 µM) with and without 1 µg of NCP (0.5 µM) and the indicated amounts 
of EDC and sulfo-NHS.  
 
4.8 µg of LSH (2.5 µM) was incubated with and without 1 µg of NCP (0.5 µM) for 30 min on 
ice, and a crosslinker was added to the mix and further incubated for 2h at 4oC. The 
crosslinked products were resolved on 4-20% precast gradient gels. BS3 crosslinking 
appeared to be more efficient than EDC-sulfo-NHS, since a larger portion of LSH and NCP was 
shifted to the crosslinked position on the gel. However, the patterns of LSH and LSH-NCP 
appeared almost identical indicating that no new crosslinked species were formed following 
the addition of NCP. Hence, the crosslinking experiment was not pursued further.  
 
5.10 Discussion  
To further investigate the LSH-nucleosome interaction I used a common system of a 
recombinant mononucleosome made of Xenopus histones and 601 Widom DNA sequence. 
The aim was to evaluate if LSH required a DNA linker for binding an NCP or if it binds directly 
to nucleosomal core. Along with this question I wanted to check if the addition of octamer 
variants, such as truncated H3 or mutated acidic patch on the octamer, affects LSH affinity 
for the NCP.  
Compared with the other remodellers, LSH does not appear to have a DNA-binding domain, 
apart from its ATPase domain, however, this role may be carried out by its N- or C-termini. 
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As mentioned earlier, the N-terminus of LSH harbours a ppHSA motif, common to other 
chromatin remodellers and found to interact with lobe 2 in ISWI to stabilise the protein, 
without contributing to its catalytic activity (Ludwigsen et al., 2017). However, this motif is 
not expected to interact with DNA.  
Previous EMSA experiments performed by Simon Varzandeh (Simon Varzandeh, 2016) 
indicated that LSH required a 25-bp DNA linker to bind the nucleosome and binding was not 
detected when only a nucleosomal core containing 147 bp was present. This finding was not 
confirmed in the present study.  
To determine which DNA linker minimal length is required for LSH binding, I reconstituted 
nucleosomes containing no linker DNA or a 6-bp, 12-bp or 25-bp linker on one side (Fig. 5.6). 
From the EMSA experiments performed with nucleosomes with variable DNA linkers it 
appeared that LSH does not require a DNA linker for binding to the NCP, with similar shifts 
present in all samples. This reinforced the hypothesis that LSH predominantly binds 
nucleosomal DNA and does not require linker DNA for binding in vitro. This is consistent with 
the homology modelling data showing LSH binds the nucleosome at SHL2, however, future 
work elucidating the positions of LSH termini on the nucleosome will be required to verify 
any potential contacts with the linker DNA.  
Different chromatin remodellers have various requirements for DNA linkers. For example, 
CHD2 required ~40 bp (Liu et al., 2015), ISW2 was shown to require at least 20 bp for binding 
and remodelling (Brehm, 2000; Kagalwala et al., 2004; Zofall et al., 2004) and around 75-80 
bp for efficient association and remodelling (Dang et al., 2006; Deindl et al., 2013). On the 
other hand, there was evidence that ISWI remodeller can bind nucleosomal core without 
requiring a linker DNA (Whitehouse et al., 2003), however, linker DNA was indeed required 
for ISWI ATPase activity, with progressively longer linker resulting in more ATP hydrolysis 
(Whitehouse et al., 2003). Sth1 subunit of the RSC complex could bind dsDNA of at least 15 
bp but required 15-85 bp for increasing and optimal ATPase activity (Saha, 2002). Since LSH 
remodelling activity has been detected (Jenness et al., 2018), but its ATPase activity has not 
been dissected, it is still unclear whether LSH requires a linker for efficient ATP hydrolysis, 
even though it can bind nucleosomal core. It should be noted that Jenness et al. used 
symmetrical 20-bp linkers, and linker-free nucleosome has not been probed for a remodelling 
assay. Since the remodelling experiment that they used relied on a PstI restriction site that 
was initially protected by nucleosomal core and did not necessarily require linker DNA on 
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both sides, it would be interesting to check if this remodelling could be performed on no-
linker or a single-side linker DNA to see their effect on ATPase activity of LSH.  
Next, LSH binding to the nucleosome resulted in a double shift, which was clearly observable 
in case of 12-bp linker DNA but is not very clear with other linkers or the no-linker core (Fig. 
5.6). This can be due to several reasons. It is established that LSH can bind free dsDNA (see 
below), but the minimal DNA length is not known. It is possible that in the case of linker-free 
nucleosome LSH binds the core at the superhelical location 2 (see Section 3.2), which is a 
preferred site for chromatin remodellers (Hauk et al., 2010; Li et al., 2019; Liu et al., 2017a; 
McKnight et al., 2011; Schwanbeck et al., 2004; Zofall et al., 2006). However, even at that 
location LSH can bind SHL2 on two surfaces on the nucleosomal disc, which requires two 
binding events, however, it is not clear how discrete they are and if in the present study the 
first shift corresponds to the single or double SHL2 binding. Another possible binding location 
is SHL6 (Eustermann et al., 2018), however, Ino80 is the only remodeller that preferentially 
binds this location with known biological functions. Snf2 was observed to bind SHL6 with 
unknown implications (Li et al., 2019; Liu et al., 2017a). Therefore, it is feasible to assume 
that LSH can bind all four of those locations (two SHL2, two SHL6) in vitro via its ATPase 
domain, as well as the linker DNA, when it is present. Structural studies would be required to 
elucidate LSH binding pattern to the nucleosome.   
This non-specific pattern of LSH binding was observed when free and nucleosomal DNA were 
compared. The initial experiment comparing the binding to 12-mer, 159-mer or a 12W0 NCP 
did not reveal any obvious differences, indicating that LSH can bind short fragments of free 
DNA, as well as longer fragments. Therefore, LSH does not rely on nucleosomal curvature for 
binding and can recognise free duplex DNA. Moreover, the EMSA shift pattern between 159-
mer and 12W0 NCP, which contain the same DNA fragments, but the latter is present in the 
mononuclesomal context, appeared very similar indicating that LSH is predominantly 
interacting with the nucleosomal DNA and not the octamer, however, EMSA experiments 
should not be overinterpreted due to the inherent limitations of this technique.  
Previous experiments with an HDAC inhibitor trichostatin A abolished LSH binding to 
chromatin (Zhou et al., 2009), indicating that LSH may be dependent on histone post-
translational modifications. However, this was not the case in vitro, as indicated by 
comparison of LSH binding to nucleosomes containing native and recombinant octamer. 
Therefore, the main driver of LSH-NCP interaction is still more likely to be solely DNA itself. 
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Nevertheless, when LSH was incubated with a nucleosome lacking N-terminal H3 tails, the 
migration pattern appeared distinct from the wild-type, and the shifted bands appear more 
compact, even though there is no difference in nucleosomal band disappearing upon LSH 
concentration increase (Fig. 5.8 B and C). Whereas predominant point of interaction of H3 
with chromatin remodellers is through its post-translational modifications (Chatterjee et al., 
2011; Flanagan et al., 2005; Mansfield et al., 2011; Santos-Rosa et al., 2003), LSH indeed may 
form distinct contacts with the nucleosome upon H3 tail deletion. However, the biological 
implication for LSH interaction with unmodified H3 tail is unclear and would require further 
investigation. In would be interesting to explore the effects of histone modifications such as 
acetylation, methylation and ubiquitylation (Krajewski, 2018; Levendosky et al., 2016) on LSH 
interaction with the nucleosome. As it appears in other chromatin remodellers, histone 
modifications are important for orientation and specificity but not for binding per se, hence, 
would not necessarily be detected by EMSA.  
Furthermore, histones play an important role in a formation of a nucleosomal epitope 
termed the acidic patch (Kalashnikova et al., 2013). Symmetrical acidic patches and SHL2 site 
symmetry on each side of the nucleosomal disc and provide a basis for distinct chromatin 
remodelling patterns for different remodellers, which use DNA linker as the nucleosomal cue 
for end-to-centre or centre-to-end positioning (McKnight et al., 2011; Ilana M. Nodelman et 
al., 2017; Patel et al., 2013; Schwanbeck et al., 2004; Whitehouse et al., 2003). The acidic 
patch has been shown to act as a remodelling activator in Ino80 and ISWI, in the latter by 
counteracting the inhibitory AutoN an NegC motifs (Gamarra et al., 2018). Mutations of the 
acidic patch on just one side of the nucleosome resulted in disruption of DNA linker sensing 
by Snf2h and shifting the histone octamer towards the shorter DNA linker, as opposed to the 
longer one (Dann et al., 2017; Levendosky et al., 2016; Levendosky and Bowman, 2019), 
indicating that the acidic patch is an important factor in insuring remodelling directionality. 
In vivo acidic patch mutations disrupting nucleosome regularity by ISWI have been associated 
with cancer (Dao et al., 2019).  
Here the nucleosomes were reconstituted with mutated H2A (E65A E90A E91A) and H2B 
(E105A), and, therefore, contained symmetrical acidic patches on each side, whereas Snf2h 
studies relied on H2A residue mutations (E61A/E64A/D90A/E92A) (Levendosky and Bowman, 
2019), highlighting variations in potential experimental set-ups. In the EMSA experiments 
performed here the nucleosomes appeared completely shifted, as indicated by the 
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disappearance of the IR800-labelled nucleosome band in a manner compared to the wild-
type and the nucleosome containing truncated H3 tail histones (Fig. 5.8 B and C). The 
difference was again, however, in the compaction of the band in the acidic patch mutants, 
which produced a smeary migration pattern. Whereas this may indicate the difference in LSH 
binding to the nucleosome, this result should not be overinterpreted, as the different 
appearance can be due to difference in electrostatic potential explained by the reduction of 
the negative charge after alanine mutations. Therefore, rigorous structural data, along with 
biochemical remodelling assays exploring acidic patch variant in LSH remodelling potential 
should be explored.  
Since the LSH-nucleosome complex was detected by EMSA with qualitatively estimated Kd of 
~100 nM, even though proper quantification was not successful due to smeary appearance 
of the bands (Fig. 5.6). This affinity was comparable to some other remodellers to 20-40 bp 
dsDNA with calculated Kd, for example, ISWI had Kd of ~18 nM (Al-Ani et al., 2014) and Chd2 
had Kd of ~160 nM (Liu et al., 2015). However, these results cannot be directly compared to 
the affinity for the nucleosome and a rigorous kinetic study would be required for LSH-
nucleosome affinity. However, LSH appeared to bind the nucleosome with nanomolar 
affinity, which should produce a stable complex. Assuming that the complex formed during 
the 30 minute incubation of LSH and NCP mix prior to SEC-MALS run, it appears that the 
complex disintegrated during migration through the column. The injected amounts of LSH 
and NCP (26 µM and 5 µM, respectively) should have been sufficient for complex formation, 
if the Kd estimated from EMSA was reliable. Nevertheless, EMSA experiments may 
demonstrate overestimated affinity, possibly due to caging effect of the gel. It is likely that 
LSH binding to NCP is transient and is stabilised by interaction with additional proteins, such 
as CDCA7.  
As previously demonstrated by K. Myant and S. Varzandeh who used sucrose gradient 
sedimentation and SEC-MALS, respectively (Kevin Bryan Myant, 2008; Simon Varzandeh, 
2016), LSH is not present in a protein complex or as a dimer. This was confirmed in my SEC-
MALS experiment (Fig. 5.12, Table 5.2), where LSH migrated through the column as a 
monomer. Dimerisation of chromatin remodellers, even though not relevant to all of them, 
plays an important part in chromatin architecture. For example, Snf2h (part of the ACF 
complex) dimerises on the nucleosome, occupying two SHL2 sites and, by alternating its 
conformations (Armache et al., 2019; Leonard and Narlikar, 2015), produces alternating 
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motions that result in central positioning of the nucleosome (Racki et al., 2009), however, 
from that EM structure it was not apparent if two Snf2h molecules physically interact with 
each other and would form a dimer without the bridging nucleosome. Nevertheless, when 
Snf2h molecules were covalently linked, remodelling was accelerated, indicating that 
physical interaction between two monomers are functionally important (Leonard and 
Narlikar, 2015). This can also be the case for LSH, a hint of which was observed by EMSA in 
the form of a double shift (Fig. 5.6), however, it is still unclear whether these multiple binding 
events have functional relevance. On the other hand, Chd1 was shown to perform 
bidirectional sliding as a monomer (Qiu et al., 2017).  
The attempts to stabilise the complex using crosslinking with glutaraldehyde and 
ultracentrifugation (GraFix) (Kastner et al., 2008b) or chemical crosslinking using BS3 and 
EDC+sulfo-NHS have not been successful. In the first instance, NCP on its own appeared to 
be crosslinked, as indicated by its lack of migration through denaturing gel compared with 
uncrosslinked NCP. However, LSH on its own was not observed on the gel, indicating either 
that it aggregated and could not migrate through the gel or that the migrated amount was 
not sufficient to be detected by Coomassie staining. GraFix, however, is extensively utilised 
for cryo-EM studies for chromatin remodeller-nucleosome complexes (Li et al., 2019; 
Machida et al., 2018; Winger et al., 2018).  
In the second instance, neither of the chemical crosslinking approaches resulted in an 
obvious band distinct from the LSH-only control. It is hardly surprising, since LSH is more likely 
to interact with DNA rather than the octamer core. Nevertheless, LSH terminal regions should 
be close enough to certain histone tails, for example H4 and H3 that are positioned close to 
SHL2 site (Luger et al., 1997b), and this proximity was likely to be captured by the long range 
BS3 crosslinking. It should be noted that recently identified motif ppHSA in the N-terminus of 
LSH is not expected to interact with H4 (Ludwigsen et al., 2017). Considering that the histone 
tails, as well as LSH termini, are flexible and may not form enough of crosslinks of the same 
entity to be observed on the gel. Chemical crosslinking may require further optimisation, a 
crucial part of which would be scaling up LSH and especially NCP. Optimised crosslinking 
experiment with LSH and octamer wild-type would be a good starting point for the 
experiments involving truncated histone tails.  
Another possibility to capture LSH-nucleosome complex would be site-specific UV 
crosslinking of DNA and protein, which involves modification of DNA with 5-Iodouracil (Flett 
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et al., 2018). This sophisticated approach, however, requires lengthy optimisation and would 
require initial labelling of a simpler system with a short dsDNA fragment.  
Overall, the LSH-NCP complex appeared to form, predominantly due to LSH-DNA interaction 
through the LSH ATPase domain, however, the affinity could be in µM rather than nM range, 
which would require more material to detect it. Additionally, CDCA7 could be a stabilising 





















6. BIOINFORMATICS ANALYSIS, CLONING, EXPRESSION AND 
PURIFICATION OF CDCA7 
6.1 Introduction  
CDCA7 has been recently identified to be a binding partner of LSH, however, information 
available on CDCA7 is very limited. With the ultimate goal of expressing and purifying murine 
CDCA7 for biochemical and structural studies and to evaluate its binding to LSH, I initially 
utilised a host of bioinformatic tools to evaluate the sequence characteristics and associated 
biochemical properties of CDCA7. One of the aims of this part of work was to produce mg 
amounts of CDCA7 to carry out biochemical and biophysical characterisation studies of 
CDCA7. For that, I attempted to express the protein in two different systems – insect and 
bacterial cells. Murine CDCA7 has proved to be difficult to purify, as high amount of nucleic 
acid contamination was present following various purification protocols.  
 
6.2 CDCA7 bioinformatics analysis 
Being a DNA-binding protein, murine CDCA7 has a high isoelectric point (theoretical pI 8.94 
as indicated in ProtParam), which indicates it has extensive positively charged regions 
participating in protein-DNA or protein-protein interactions.  
 
Figure 6.1 Schematic representation of CDCA7 domains, adapted from Pfam server. Grey boxes represent 
disordered regions, LC – low complexity, CC – coiled coil, ZF-4CXXC-R1 – zinc finger domain. Amino acid numbers 









Table 6.1 CDCA7 amino acid regions and their charachteristics as predicted by Pfam (visualised on Fig. 6.1). 
Region (amino acids) Characteristics  
1-28 Disorder  
29-42 Low complexity  
32-127 Disorder 
82-115 Low complexity 
131-253 Disorder 
181-192 Low complexity 
203-223 Coiled coil 
203-213 Low complexity 
273-371 ZF-4CXXC-R1 
 
As can be seen from the Pfam domain prediction (Fig. 6.1, Table 6.1), CDCA7 has extensive 
regions of structural disorder and can be characterised as an intrinsically disordered protein 
(IDP). Those disordered regions include highly conserved parts of the protein, indicating they 
likely have a biological function. There are several proteins that transition from disordered 
to folded state upon binding their biological target. Alternatively, disordered domains can 
function as flexible linkers crucial for proper folding and functioning of their juxtaposed 
regions (Dyson and Wright, 2005). Biological rationalisation for such regions is their increased 
specificity, since the target is required for proper folding, and that they can be an easier 
target for degradation, which is an additional fine-tuning mechanism for their interactions 
and biological functions, such as in signalling and transcription regulation, where fast binding-
unbinding mode is utilised (Dunker et al., 2000; Oldfield et al., 2005). Additionally, disordered 
proteins may bind in a “fly-casting mechanism”, in which initial weak contacts are formed 
away from the biding site, and the protein gradually folds upon approaching its bona fide 
bidning site (Shoemaker et al., 2000). The main driving force for protein folding is 
hydrophobic interactions, which are weak intermolecular forces, but their cumulative action 
ensures protein stability. Propensity for hydrophobic interaction formation can be deduced 
from the protein sequence. IDPs can be identified by their amino acid composition, which is 
biased towards polar charged residues that provide repulsion. Due to the lack of stable 
structural features, IDPs are notoriously hard to crystallise and to conduct structural studies 
on. IDPs are predominantly studied by computational approaches, such as molecular 
dynamics simulations, and by biophysical techniques, such as surface plasmon resonance and 
electron paramagnetic resonance (Na et al., 2018; Stanley et al., 2015). 
150 
 
CDCA7 has four (two of them located close to each other and can be counted as one) 
predicted regions of low complexity (CDCA729-42, 82-115, 181-192, 203-213) (Fig. 6.1). Low complexity 
regions (LCRs) are those that have simple repetitive patterns of amino acid composition 
(Coletta et al., 2010). They can contain a few amino acid types or just one amino acid. Coletta 
et al. found that LCRs located in the central part of a protein tend to be predominantly related 
to transcription processes based on Gene Ontology terms (Coletta et al., 2010). This 
correlates with the central LCR of CDCA7 that flanks the c-Myc interacting domain. It was also 
found that LCR-containing proteins tend to be a part of highly connected interaction 
networks (Coletta et al., 2010). Interestingly, CDCA7 has two runs of glutamates – one (E10) 
in the second predicted low complexity region (CDCA7106-115) and another one (E11) 
downstream the last low complexity region (CDCA7204-215), although E11 is predicted to be a 
part of the coiled coil (CDCA7203-223) (see below). Glutamate stretches, or runs, were more 
frequently found in human proteins, however, in general such stretches are more common 
in fly (Karlin et al., 2002). Human proteins containing such stretches are often implicated in 
diseases(Karlin et al., 2002). It should be noted that these glutamate stretches are not well 
conserved, as indicated by the multiple sequence alignment (MSA) (Fig. 6.4).  
CDCA7 has predicted sites for post-translational modifications (PTMs). PTMcode2 is a 
database of known and predicted PTMs of proteins (Minguez et al., 2015). It showed that 
murine CDCA7 has three predicted phosphorylation sites – T170, T203 and S225. T170 
corresponds to T163 in human, which is a site of 14-3-3 protein interaction (Gill et al., 2013) 
(see Section 1.4 of Introduction). UniProt also lists S197 as an additional PTM. These sites 
were predicted by similarity with human CDCA7, in which the PTMs were discovered during 
a proteomics study of HeLa cells (Zhou et al., 2013), or, as in the case of S225, during 
phosphoproteomics of mouse tissues (Huttlin et al., 2010).  
UniProt predicts a coiled coil (CC) at positions 203-223. CCs are formed by supercoiling of two 
or more α-helices through close packing of their side chains (Truebestein and Leonard, 2016) 
and have highly versatile biological functions, including self-oligomerisation and protein-
protein interaction (Burkhard et al., 2001). Even though there are rules guiding which 
residues are to form the heptad repeat of a CC, sequences can be highly variable. Pfam 
predicted one CC203-223 flanking the zinc finger domain (Fig. 6.1). However, the ExPASy server 
COILS predicted two CCs – one consistent with the Pfam prediction and another one that 
partly overlaps with the middle LCR (residues 100-150 and 200-225) (Fig. 6.2). It should be 
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noted that a simple visual analysis of CDCA7 sequence does not allow to observe any obvious 
heptad repeats, which is expected, since CCs can be highly discontinuous (Lupas and Gruber, 
2005). The COILS server used for identification of putative CCs is based on Parry matrices of 
residue frequencies that analyse asymmetric distribution of the heptad segments within 
defined windows (Parry, 1982). Both CCs predicted by COILS include the glutamate stretches. 
These CCs are potential regions of interaction with LSH (which has a predicted CC in its N-
terminus 14-96), if such an interaction exists. 
 
Figure 6.2 Prediction of coiled coil patterns in the sequence of murine CDCA7 by the server COILS. Windows 
represent the number of amino acids scanned at a time (14,21, 28).  
The server MARCOIL (Delorenzi and Speed, 2002) predicts coiled coils in the same regions as 
COILS, adding more confidence to this prediction. In the first predicted coiled coil, the core 
position at a include a mixture of charged and hydrophobic residues, whereas position d 
accommodates negatively charged residues followed by small hydrophobic isoleucine and 
leucines (Fig. 6.3 A). The solvent-facing positions (b, c, e, f, g) predominantly contain polar 
and charged residues (Fig. 6.3 A). The second coiled coil is also dominated by hydrophobic 
and charged residues in the core a and d positions and the solvent-facing positions are 
occupied mostly by charged and polar residues (Fig. 6.3 B). Therefore, predicted coiled coils 




Figure 6.3 N-terminal region (residues 99-147 and 197-231) of murine CDCA7 with two heptad repeat patterns 
as indicated by MARCOIL server. Core positions a and d are in red, surface positions are in blue. Percentage 
probability to form coiled coil is in brackets. A) First and B) second coiled coil predicted.  
 
CDCA7 has several orthologues in mammals and more distant species such as clawed frog 
and zebrafish (Fig. 6.4). UniProt entries of the orthologues, although mostly unreviewed, 
include such classes as Actinoprerygii (ray-finned fishes) and Avis (birds). The most distant 
orthologues have around 50% identity to the murine CDCA7, as indicated by a BLAST search 
on UniProt. The ICF syndrome-associated mutations (R274C/H, G294V, R304H in human 
corresponding to R285, G304, R315 in mouse) are all located in the zinc finger domain and 
are all highly conserved (Fig. 6.4). The species present in the alignment were selected based 
on their curated status in UniProt (mammalian species). The non-mammalian species (X. 
laevis, D. rerio, X. tropicalis), although unreviewed, were selected to check the conservation 




Figure 6.4 Multiple sequence alignment of CDCA7 orthologues performed in ClustalOmega and visualised in 
JalView. Domains are labelled as follows: C-Myc interacting domain (yellow) and zinc finger domain (green) are 
indicated on UniPro; coiled coiled regions (blue) were predicted by the COILS server. Relevant murine residues 
(R285, G304, R315) mutated in ICF syndrome in human LSH are in red.   
MSA in ClustalOmega revealed extensive conserved regions in CDCA7. Server COILS predicted 
two coiled coils, that are 50-60% conserved across the species used in the present alignment 
(Fig. 6.2). The c-Myc interaction domain does not appear to be highly conserved across the 
species but about a half of it is conserved in the mammalian species present in the alignment 
(human, mouse, bull), namely the region PRRRTFPGVATR (Fig. 6.4). The C-terminal zinc finger 
domain is highly conserved. None of the CDCA7 orthologues have structural information in 
the Protein Data Bank, therefore studying CDCA7 by homology modelling would not give 
reliable information. Nevertheless, sequence analysis can provide some insight into the 
protein profile.  
The server PONDR (Garner et al., 1999; Peng et al., 2006; Romero et al., 1997) indicates the 
overall percentage disorder to be 49%, which echoes the result from Pfam, which predicted 
extensive regions of disorder in CDCA7. The ordered region corresponds with the ZF-4CXXC 
domain (Fig. 6.1 and 6.5). Interestingly, there are two disordered regions predicted with high 
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confidence in the middle part of the protein that overlap with the predicted CCs (Figs. 6.1, 
6.2 and 6.5). The black lines covering the threshold region indicate possible transition from 
disordered to ordered state (residues 70-123 and 157-219) in the presence of binding and/or 
stabilising partners. This analysis is confirmed by the disorder prediction tool IUPred2A 
(Dosztányi, 2018; Mészáros et al., 2018) and the predictor of binding regions in disordered 
proteins ANCHOR2 (Dosztanyi et al., 2009; Mészáros et al., 2009). There are several described 
zinc finger proteins (e.g. the ones with the Cys2His2 motif) that undergo conformational 
changes in their 3D folds in the presence of DNA and adopt structural characteristics required 
for their biological functions (John H Laity et al., 2000). Examples include the AT-hook 
containing HMG (high mobility group) and ETS (E26 transformation specific) transcription 
factor proteins (Levy et al., 2007; Ozturk et al., 2014). CDCA7 may follow a similar mechanism 
of folding and activity.  
 
Figure 6.5 CDCA7 disorder profile as indicated by A) PONDR and B) IUPred2A. In A, the black lines covering the 
threshold region indicate possible transition from disordered to ordered state. In B, ANCHOR2 represents 




PsiPred (Jones, 1999) prediction of secondary structure demonstrated extensive regions of 
random coil (Fig. 6.6), which corresponds with the results from PONDR and IUPred2A (Fig. 
6.5). Both predicted coiled coils correspond to the mostly helical regions, with both 
glutamate stretches located in those regions, and only a few short β-sheets (Fig. 6.6). The c-
myc interaction domain is predicted to be a random coil, which agrees with the disorder 
prediction (Fig. 6.5). The ICF syndrome-associated mutations (Thijssen et al., 2015) are 
located in ZF domain, either in the random coil or the end of an α-helix (Fig. 6.6). 
 
Figure 6.6 Secondary structure prediction by PsiPred. Numbers on each side are amino acid positions in the 
protein. Pink – helix, yellow – strand, grey – random coil. CDCA7 domains are labelled as follows: coiled coils 
predicted by COILS server – blue, c-myc interaction domain - yellow box, zinc finger domain - green, ICF-
associated mutations for the murine sequence: R285, G304, R315 are in red boxes.  
 
A close homologue of CDCA7, CDCA7L (CDCA7-like), is a protein found to have a monoamine 
oxidase inhibitor function (Chen et al., 2005). Pairwise sequence alignment in EMBOSS 
Needle demonstrated that the two proteins have high percentage sequence identity in the 
coiled coil 1 and zinc finger domain (ZFD), as was confirmed by the alignment in Blast Protein. 
However, the second coiled coil present in CDCA7 is not present in CDCA7L (Fig. 6.7, Table 
6.2). The N-terminal part of CDCA7L not present in CDCA7 harbours a specific interaction 
domain (SID) with LEDGF (lens epithelium-derived growth factor)/p75 – a binding target for 
HIV integrase (Bartholomeeusen et al., 2007). The ZFD of CDCA7L was found to harbour a 





Figure 6.7 Pairwise sequence alignment of murine CDCA7 and CDCA7L performed in EMBOSS Needle and 
visualied in JalView. Domains are labelled as follows: C-Myc interacting domain (yellow) and zinc finger domain 
(green) are indicated on UniPro; coiled coiled regions (blue) were predicted by the COILS server. Residues 
mutated in ICF syndrome are in red.   
Table 6.2 Percentage identity (%Id.)  in amino acid sequences of murine CDCA7 and its homologue murine 
CDCA7L as indicated by BLAST Protein.  
 Species  Total 
% id. 
Coiled coil 1 
% id. 
Coiled coil 2 
% id. 
ZF % id. 




In vivo yeast one-hybrid assay demonstrated that CDCA7L had a putative DNA-binding 
activity by directly binding the sequence 5’-ccg gac gcg cag ccc cgc ccg ccc gcc tac gcg cag-3’ 
found in monoamine oxidase A core promoter, which contains Sp1 transcription factor 
binding sites (Chen et al., 2005). This is in line with the propensity of many zinc finger 
containing proteins to bind CG-rich sequences (Paillard, 2004), however, RING ZFD are more 
likely to bind proteins than nucleic acids (Borden and Freemont, 1996). 
Currently there is no high resolution structural information, for either CDCA7 or CDCA7L. 
Therefore, the possibility of homology modelling was tested in Phyre2, but only 
demonstrated the lack of templates with >30% identity. Therefore, ab initio modelling in 
Phyre2 and I-TASSER (Kelley et al., 2015; Yang et al., 2015) were attempted.  
Ab initio structure prediction is utilised if a protein does not have known homologues or none 
of its homologues have structural data. Small proteins (<120 residues) are better candidates 
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for this task rather than large proteins (Lee and Skolnick, 2007). I-TASSER models are 
constructed by iterative fragment assembly simulations which removes steric clashes and 
constructs models of correct topology even if clashes are present in the threading templates 
(Lee and Skolnick, 2007; Wu et al., 2007). Phyre2 uses an extended list of templates, which 
are then used for generating models and the missing fragments are constructed by simplified 




Figure 6.8. Ab initio modelling of the zinc finger domain of murine CDCA7. A) CDCA7 zinc finger domain with 4 
cysteine pairs. All cysteines present in ZF are labelled in bold and underlined. ICF-associated mutations are 
labelled in red. Zinc finger labelling adapted from Chen et al. 2005. B) CDCA7 cartoon model predicted by I-
TASSER: cysteines  participating in the zinc finger domain are in blue sticks, residues R285, G304, R315 mutated 
in ICF syndrome are in red sticks; C) Close-up on the zinc finger 1 by I-TASSER: ICF mutations R285C/H, G304V, 
R315H are in yellow sticks superimposed on the non-mutated residues in red sticks; D) Close-up on the zinc 
finger 2 by I-TASSER: ICF mutations R285C/H, G304V, R315H are in yellow sticks; E) CDCA7 cartoon model 
predicted by Phyre2: cysteines  participating in the zinc finger domain are in blue sticks, residues R285, G304, 
R315 mutated in ICF syndrome are in red sticks; F) Close-up on the zinc finger 1 by Phyre2: ICF mutations 
R285C/H, G304V, R315H are in yellow sticks superimposed on the non-mutated residues in red sticks;; G) Close-




To simplify modelling only the zinc finger domain was submitted covering CDCA7272-371 wild 
type murine sequence. Both modelling programs produced structures consisting of α-helices 
connected by loops (Fig. 6.8 B and E). The I-TASSER model has a C-score of -1.99, which 
indicates it is a model of an average confidence with -5 being the lowest C-score and 2 the 
highest (Yang et al., 2015). The TM-score of the I-TASSER model is 0.48, which is close but 
below the cut-off of >0.5 for a model of correct topology (Zhang and Skolnick, 2004). Phyre2 
generated a model with confidence value of >90% and 77% of the submitted sequence 
modelled. Phyre2 does not provide further information on model quality and the Phyre 
Investigator option is not available for intensive modelling.  
The two models do not appear to have similar shapes (Fig. 6.8 B and E), however, due to the 
abundance of disordered region, the absence of a bound ligand and bound zinc atoms a 
distinct shape would not be expected. Even though there are few short β-sheets fragments 
predicted by PsiPred (Fig. 6.6), no such secondary structure was predicted in either model 
(Fig. 6.8 B and E). In the I-TASSER model only the sequence GPCLRNR was predicted to be an 
α-helix, the rest were either partially or completely loops (Fig. 6.6 and 6.8 B). The Phyre2 
model showed the sequences GPCLRNR and VLVYLAKY as an α-helix, the rest were loops (Fig. 
6.6 and 6.8 E).  
Initial inspection of both models showed correct orientation of the zinc finger-participating 
residues, which fold into pockets that can potentially coordinate one zinc ion per pocket (Fig. 
6.8 B and E). However, the orientation of the cysteines  folds the domain in a way more 
resembling LIM configuration, rather than RING or PHD (Fig. 6.8 B and E), since LIM domain 
fold relies on continuous cysteine orientation, whereas RING and PHD folds have a central 
criss-cross orientation of the central cysteines , which participate in neighbouring zinc 
coordinating pockets (Cassandri et al., 2017). Moreover, examination of the ZFD sequence 
does not show any histidines located away from the cysteine residues (Fig. 6.8 A). There are 
histidine residues immediately neighbouring the cysteines, therefore, it is not clear whether 
or how they participate in Zn2+ coordination. It is also possible to assume that the cysteines 
form two neighbouring classic C2H2 ZFD, since the sequence does not appear to provide a 
clear answer.  
The residues mutated in ICF (R285C/H, G304V, R315H) are located right next to the Zn2+-
coordinating cysteines in ZF1, therefore, it is viable to suggest they interfere with ion binding 
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through imidazole ring introduction (Fig. 6.8 A, C, F). However, this was not determined in 
this present ab initio modelling due to inability to superimpose the models onto known 
structures, so that the zinc atoms locate to the relevant areas within the zinc binding pocket. 
The ZF2 is located away from the ICF mutations, however, in the native conformation it could 
also be affected by these mutations through altered folding of the domain (Fig. 6.8 A, D, G). 
Finally, it is still not clear whether the main interacting partner of CDCA7 ZFD is DNA or 
protein, and if the ICF mutations introduce conformational changes without disrupting zinc 
ion binding but interfering with CDCA7’s rigidity or topological parameters, which causes 
disruption of binding to its target molecule.  
I-TASSER also uses the TM-align algorithm, which performs structural alignment based on 
structural similarity by scanning all structures in the PDB library (Zhang and Skolnick, 2005). 
The top two hits for structural similarity with the constructed model were DNA 
methyltransferase-like protein DNMT3L in complex with H3 peptide (Ooi et al., 2007 PDB ID 
2PVC) and the ADD domain of de novo DNA methyltransferase DNMT3A in complex with H3 
peptide (Otani et al., 2009 PDB ID 3A1B). Both proteins are predicted to have GATA-1-like 
and PHD ZFDs (UniProt O88508 and Q9CWR8 for DNMT3A and DNMT3L, respectively).  
 
 
Figure 6.9 Crystal structures of DNMT3A, DNMT3L and EGF1 zinc finger domains. A) DNMT3A ZFD (PDB ID 3A1B) 
with the domains labelled is indicated. Structure adapted from Otani et al. 2009; B) DNMT3L ZFD (PDB ID 2PVC) 
with the domains labelled is indicated. Structure adapted from Ooi et al. 2007; C) EGF1 (PDB ID 1ZAA). Structure 
adapted from Pavletich and Pabo 1991. In all structures, zinc-coordinating cysteines are in red sticks, zinc atoms 
are shown as grey spheres.  
 
Even though both DNMT3A and DNMT3L are known to have a PHD ZFD, they are distinct 
from classic PHD domain containing histidine, and instead their three zinc atoms are 
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coordinated by six pairs of cysteines  (Fig. 6.9 A and B), of which one zinc atom is coordinated 
by the GATA-1-like domain with cysteine residues located continuous along the peptide 
backbone, and two are coordinated by the PHD domain and have the classic criss-cross 
orientation of cysteines  in zinc coordination (Fig. 6.9 A and B). A classical C2H2 zinc finger 
protein EGF1 bound to DNA (Fig. 6.9 C) is shown as a comparison to demonstrate DNA-
binding mode of a zinc finger domain. Here, pairs of cysteines and histidines coordinate each 
zinc atom, and the α-helix-β-sheet tandems insert themselves into the DNA major groove 
(Pavletich and Pabo, 1991). EGF1 has 28% identity with CDCA7 in their ZFD, which was too 
low to be used as a homology modelling template. 
Taken together, ab initio modelling of CDCA7 did not show its ZFD as a classic RING domain 
due to the orientation of cysteine residues. Therefore, the modelling confirms the propensity 
of the C-terminal region to coordinate bivalent cations, such as zinc, but does not elucidate 
the type of molecule CDCA7 ZFD is likely to bind.  
 
6.3 Insect cell expression of CDCA7 
6.3.1 CDCA7 cloning into pFL vector  
Initially, I planned to clone full-length insect-cells codon optimised CDCA7 with an N-terminal 
MBP (Maltose Binding Protein) tag to keep the construct close to the one used in the Jenness 
paper (Jenness et al., 2018). MBP tag is a large tag of approximately 42 kDa that can improve 
protein stability and solubility. To do that I used a plasmid that contained an MBP ORF and 
tried to create a construct for a fusion protein using overlapping PCR and then Gibson 
assembly. In the initial approach with overhanging PCR and traditional ligation-based cloning, 
I tried using BamHI and SalI and then NheI and SphI restriction sites, however, the attempts 
to insert the resulting amplicon into the pFL plasmid were not successful with any of the 
approaches. Even though the plates contained a large number of evenly spread colonies, all 
checked clones turned out to be incorrect, with restriction digest showing fragment of wrong 
sizes (not shown). One of the reasons for that may have been non-specific recombination 
due to the lack of recA1 gene in DH5α strain.  
In parallel with MBP tag cloning, I tried using a vector for ligation independent cloning (LIC) 
containing an N-terminal GST-tag. Insertion of murine CDCA7 with LIC-compatible overhangs 
into pFL-GST vector with a 3C cleavage site resulted in production of a correct clone, which 
was verified by Sanger sequencing (clone pFL-GST-CDCA7). The GST tag has an additional 
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caveat of forming dimers, which can be problematic in stoichiometry and binding studies, 
however, I was planning to cleave the tag after the first step of purification with GSH resin, 
so the tag dimerization would not affect downstream processes.  
 
6.3.2 CDCA7 expression and purification in Sf9 cells 
After generating pFL-GST-CDCA7 plasmid, inserting it into EMBacY cells and verifying the 
resulting bacmid by PCR (see Section 2.1.2.2), I transfected Sf9 cells with GST-CDCA7 
construct, according to the protocol described in Materials and Methods (see Section 
2.1.3.4). 50 ml culture infected for 96h using V2 were lysed and incubated with GSH resin for 
3h and eluted with the buffer containing 20 mM GSH. Even though a fraction of GST-CDCA7 
was removed from the resin, the majority was not eluted (Fig. 6.10), indicating non-specific 
interaction. Therefore, I decided to displace the protein from the resin by cleaving off GST 
tag with 3C.  
 
 
Figure 6.10 GST pull-down of GST-CDCA7 from Sf9. Unsuccessful elution from the resin was 
attempted using 20 mM GSH. Coomassie stained 12% SDS-PAGE, 0.5% of the total sample loaded. 
It is a common practice to use 3C fused to a GST tag, allowing the protease to be inhibited on 
the resin through binging to GSH to avoid downstream contamination of the sample. 
However, available 3C-GST has a MW close to that of CDCA7 (~44 kDa). Therefore, I chose to 
use 3C fused to a His tag, resulting in a 22 kDa construct that can subsequently be separated 
by gel filtration. After an overnight incubation the resin-bound protein with 3C, CDCA7 
appeared in the flow-through indicating successful cleavage (Fig. 6.11 A, lane FT). Along with 
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the full-length CDCA7, two extra bands also appeared in the flow-through (Fig. 6.11 A). 
Initially, it was assumed that the predicted high degree of disorder inherent to the protein 
renders it unstable and results in degradation products of around 29-30 kDa in size. However, 
a Western blot against CDCA7 epitopes revealed that the fragments are either not CDCA7 
degradation products or they are but are lacking the relevant epitopes (Fig. 6.11 B).  
 
Figure 6.11 Test purification of murine CDCA7 expressed in Sf9 cells: A) GST pull-down of GST-CDCA7 
with subsequent cleavage by 3C. 0.5% of total sample volume was loaded and stained with 
Coomassie. B) Western blot of GST pull-down: same samples as for the Coomassie stain were used. 
The membrane was probed with anti-CDCA7 primary polyclonal antibody raised in rabbit and anti-





Figure 6.12 Gel filtration of CDCA7. A) Chromatogram of gel filtration on Superdex200 10/300 24 ml 
column. B) Coomassie stained 12% SDS-PAGE of CDCA7 GF, 0.5% of the total sample loaded; the 
bands in blue frames were excised from the gel and processed for MALDI-TOF mass spectrometry. 
After GSH resin, the sample was applied on a Superdex200 10/30 24 ml column to further 
separate CDCA7 from contaminants by size exclusion chromatography (SEC). Even though 
prior to gel filtration the sample appeared ~80% pure, the chromatography run revealed a 
more complex sample with multiple contaminating bands (Fig. 6.12 A). An SDS-PAGE showed 
that the second peak that consisted of a purified protein (A260/280 was 0.6) was CDCA7 with 
the same smaller bands present in the input, as well as extra contaminants (Fig. 6.12 B). The 
bands were present in the sample before SEC, however, as can be seen in the input, CDCA7 
and the smaller bands were the dominating proteins in the sample, but after SEC the portion 
of CDCA7 was reduced compared to the contaminants (Fig. 6.12 B). This may indicate non-
specific interaction of CDCA7 with the dextran-agarose matrix. Another observation from SEC 
was the elution volume of CDCA7, which in the present run was 14.4 ml. 96 kDa LSH that was 
previously purified on this column and eluted at 14.2 ml, whereas 44 kDa CDCA7 eluted at 
14.4 ml, indicating a negligible difference between the protein sizes. This indicates that either 
CDCA7 formed dimers of around 88 kDa or it co-eluted as a complex with the smaller MW 
contaminants. If those contaminants were the smaller bands of around 27-29 kDa present 
on SDS-PAGE, a complex with CDCA7 would be of around 100 kDa. However, this number is 
an approximation, since SEC elution volume does not directly depend on molecular mass but 
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rather on the hydrodynamic radius of a protein, nevertheless, an estimation can be made 
that CDCA7 eluted in a complex with smaller MW proteins.    
Therefore, it was decided to confirm the presence of CDCA7 and to reveal the identity of the 
bands by mass spectrometry (Fig. 6.12). Tryptic digest of the CDCA7 and the smaller bands 
was followed by MALDI-TOF (see Section 2.4.1). Peptide spectrum of the CDCA7 band was, 
indeed, matching that of murine CDCA7 as revealed by the ProteinProspector database (not 
shown). However, that smaller bands turned out not to match that spectrum. Therefore, 
Mascot software was used for identification of those proteins by a probabilistic scoring 
algorithm (Pappin et al., 1993). It revealed that the smaller bands were 14-3-3-ε (epsilon) and 
14-3-3-ζ (zeta). Since CDCA7 is predicted to be mostly disordered and ab initio modelling did 
not demonstrate a distinct globular shape, its elution profile on SEC (Fig. 6.12) followed the 
parameters of a globular protein, therefore, it can be hypothesised that in complex with the 
14-3-3 proteins CDCA7 adopts a more compact globular structure or formation of extensive 
contacts, which may also explain its resistance to extraction even with higher salt (Fig. 6.11) 
and to elution with 20 mM GSH (Fig. 6.10). 
This result is consistent with the earlier finding by Gill et al., who identified 14-3-3 bound to 
CDCA7 when the latter was phosphorylated at T163 (Gill et al., 2013). This interaction 
sequesters CDCA7 into cytoplasm (Gill et al., 2013). 14-3-3 is a family of adapter proteins with 
a multitude of binding partners and a range of signalling functions. The fact that CDCA7 is 
tightly bound to 14-3-3 proteins may indicate that it is phosphorylated, as would be expected 
following insect cell expression, and that is may have a specific conformation or state 
relevant for cytoplasmic but not necessarily nuclear environment. However, this hypothesis 
would require empirical evidence.  
In an attempt to remove contaminating bands, I tried to purify CDCA7 on the ӒKTApure 
system, which would allow a more stringent purification process with less protein loss. Prior 
to loading the sample onto a GSTrap column, the cell pellet was lysed at 300 mM NaCl 
concentration and incubated with 25 U/ml benzonase for 1.5h to digest DNA and RNA 
present in the sample. Following that, the sample was slowly loaded on a GSTrap FF 1 ml 
column at 100 µl/min and then incubated overnight with 3C for on-column cleavage. 
Following elution of the protein from the column, it was washed with 20 ml of 20 mM GSH-
containing buffer. The resulting trace revealed extensive contamination with nucleic acids 




Figure 6.13 Purification of CDCA7 on GSTrap column. A) Chromatogram of a GSTrap run showing 
application of 40 ml lysate with subsequent column wash, incubation with 3C overnight and 20 ml 
wash with 20 mM GSH.B) Magnified section of the chromatogram shown on A. Peaks 1 and 2 
correspond to CDCA7, as revealed by Coomassie stain, peak 3 corresponds to GST eluted from the 
column. C) Coomassie stained 12% SDS-PAGE of CDCA7 GSTrap run, 0.5% of the total sample loaded. 
 
Since the previous purification attempts demonstrated nucleic acid contamination, it was 
decided to increase the NaCl concentration at the lysis stage to disrupt interactions with the 
contaminants. I chose 500 mM and 1 M NaCl. As can be seen from GST pull-downs, CDCA7 
was present in the soluble fraction and bound to the resin, indicating that high salt did not 
cause protein precipitation at either concentration or regardless of glycerol presence (Fig. 
6.14 A, B). Since it was not possible to measure the extent of nucleic acid contamination from 
a pull-down, I decided to use 1 M NaCl in the lysis buffer in the large-scale prep to increase 
the chances to disrupt any interactions with contaminants. I also decided to keep the GST tag 
and to attempt elution with 20 mM glutathione following a rationale that high salt may 
release the protein from contaminants that provided protein stability, therefore, it would be 




Figure 6.14 12% SDS-PAGE of fractions from GST pull-down of CDCA7 at NaCl concentration indicated 
above each gel. 15 ml of Sf9 culture following a 72h test expression with V1. L+D – lysate incubated 
with DNAseI for 30’, SN – supernatant, P – pellet, FT – flow-through.  
As in the previous attempt to elute GST-CDCA7 using 20 mM GSH (Fig. 6.10), the protein 
could be eluted only partially (Fig. 6.15 A). Nevertheless, the elution fractions were pooled 
(~10 ml in total) and concentrated using PES concentrators to 1 ml. However, I came across 
two problems: either due to high salt or due to protein’s electrostatics, it got stuck to the 
concentrator membrane, and then the rest got stuck to the column (elution was in 1 M NaCl), 
so the protein peak on the chromatogram represents only GST (Fig. 6.15 C). This may be due 
to other contaminants being present on the column from previous runs or the way protein 
behaves on this resin.  









Figure 6.15 GST resin purification step and gel filtration of CDCA7. A) Sf9 lysate was processed and 
incubated with GSH resin for 2h and subsequently with 3C overnight. L+D – lysate incubated with 
DNAseI for 30’, SN – supernatant, P – pellet, FT – flow-through, GSH E1-4 – GSH elutions, GSH-r b/3C 
– GSH resin before 3C cleavage, 3C FT – flow-through after 3C cleavage, GSH-r a/3C – GSH resin after 
3C cleavage. B) Chromatogram of GST-CDCA7 gel filtration on Superdex200 10/300 24 ml column. B) 
Coomassie stained 12% SDS-PAGE of CDCA7 GF, 0.5% of the total sample loaded. 
Since there was a concern that 1M salt may cause protein precipitation and the usefulness 
of such high salt for removing contaminating DNA was not established form the previous 
purification attempt, I used 500 mM NaCl in the next purification and this time to repeat GST 
tag cleavage (Fig. 6.16). Following an overnight incubation with 3C, CDCA7 was present in 
the flow-though and on the resin. However, this time pooling the fractions was avoided, since 




Figure 6.16 CDCA7 purification with GSH resin and 3C cleavage of GST tag at 500 mM NaCl 
concentration. L+D – lysate incubated with DNAseI for 30’, SN – supernatant, P – pellet, FT – flow-
through, W – wash, GSH-r b/3C – GST resin before 3C incubation, GSH-r a/3C – GST resin after 3C 
incubation.  
 
Measurement of the UV absorption of the sample at 260 nm and 280 nm (using the 
Nanodrop) again indicated nucleic acid contamination (A260/280 ~2), therefore, I decided to 
repeat incubation with DNAseI, rationalising that an additional incubation may be more 
efficient due to removal of extra contaminants that might have prevented DNAseI from 
efficient digest. Therefore, a fraction of semi-pure CDCA7 sample was incubated with DNAseI 
for 30’ on ice (Fig. 6.17), however, that did not affect A260/280, indicating that DNA may either 
be an important stabilising component of CDCA7 or it binds non-specifically. There was a 
band of around 25 kDa that initially appeared as a small contaminant, but with additional 
DNAseI incubation its proportion in the sample increased (Fig. 6.17). DNAseI has MW of 
around 30 kDa and is more likely to be the band the one running at 35 kDa just above 14-3-
3 proteins. Therefore, that smaller band could be a degradation product of either CDCA7 or 












Another attempt to remove contaminating nucleic acid was to use a heparin column. After 
the initial GSH resin step (not shown) the sample was applied on a HiPrep 26/10 desalting 
column (not shown) to reduce NaCl concentration from 500 mM to 150 mM and then on a 
HiTrap Heparin HP 1 ml column (Fig. 6.18 A). Reduction in ionic strength allowed to remove 
a contaminant, which on a Coomassie-stained SDS-PAGE gel turned out to be 14-3-3 (Fig. 
6.18 B). However, A260/280 was still around 1, indicating that nucleic acids were not efficiently 
removed. Comparison of the input and eluted CDCA7 indicated that the protein was not 
inhibited on the column (Fig. 6.18 B).  




Figure 6.18 CDCA7 run on a HiTrap heparin HP 1 ml column. A) Chromatogram of CDCA7 eluted with 
gradient 0.15-2M NaCl. B) Coomassie stained 12% SDS-PAGE following the run on HiTrap heparin HP 
1 ml column.  
 
Since GSH purification step resulted in a protein that was around 90% pure, I decided to only 
use that step to avoid any potential problems with downstream purification steps. I repeated 
preparation of Sf9 lysate, incubation of the soluble fraction with GSH resin for 2h and then 
with 3C-His overnight at 4oC. As previously, 3C cleavage was efficient and resulted in CDCA7 




Figure 6.19 Coomassie stained 12% SDS-PAGE of partial CDCA7 purification. A) L+D – lysate 
incubated with DNAseI for 30’, SN – supernatant, P – pellet, FT – flow-through, GSH-r b/3C – GST 
resin before 3C incubation, W 1-2 – washes, GSH-r a/3C – GST resin after 3C incubation. B) CDCA7 
quantification using BSA standard.   
 
Since Nanodrop reading was not reliable due to nucleic acid contamination, I used a BSA 
standard for CDCA7 quantification (Fig. 6.19 B). A BSA titration from 2 to 0.063 mg/ml was 
ran alongside different loading volumes of CDCA7 on an SDS-PAGE gel. Following a thorough 
destaining, the gel was scanned, and band intensities quantified using ImageJ software. 
CDCA7 amounts were derived from the BSA standard curve (not shown). According to this 
quantification approach, 128 µg of CDCA7 were obtained from 3.9 g of wet pellet, with final 
concentration 0.043 mg/ml and molarity 1 µM (higher concentration could not be achieved 
due to the problem with PES concentrator). This relatively low yield demonstrated the need 
for CDCA7 expression optimisation, however, the lack of time did not allow to do this within 
the present project. This low yield also prevented a mass spectrometry identification of post-
translational modifications, therefore, I could not confirm whether CDCA7 was, indeed, 
phosphorylated.  
 
6.4 CDCA7 cloning, expression and purification in E. coli 
6.4.1 CDCA7 cloning for E. coli expression  
Along with the expression and purification attempts in Sf9 cells, I decided to try expressing 
CDCA7 in E. coli, since yields from bacterial expression are often better than from insect cells. 
For that expression, I used ligation-independent cloning (LIC) technique to produce three 
constructs:  full length CDCA7 (GST-CDCA7_FL) and two truncated versions – GST-CDCA7_T1 
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and GST-CDCA7_T2, all with an N-terminal GST tag (Fig. 6.21). The truncations were designed 
based on predicted domain boundaries from UniProt and COILS (see Section 5.1 of Results). 
The first truncation (GST-CDCA7_T1) was missing the first 63 residues, which comprise a long 
disordered region (see Section 6.2). The truncation removes two N-terminal α-helices and is 
located in a disordered region, as predicted by PsiPred (Fig. 6.6). These regions often 
contribute to protein instability, since they are one of the main sites for protease activity. 
Hence, I hypothesised that removing the N-terminus may result in a more stable protein with 
all putative functional domains intact. However, this truncation still leaves a disordered 
region leading up to the first coiled coil predicted by COILS and MARCOIL (Fig. 6.2 and 6.3), 
which may also be targeted by proteases. Therefore, various truncation boundaries, in which 
the optimal region upstream the first coiled coil is remove, can be tested in further studies. 
The second truncated version (GST-CDCA7_T2) was lacking a further 87 residues and in which 
the first coiled coil has been removed (Fig. 6.21). The rationale behind this truncation was 
that it may serve as a control for potential interaction studies using LSH, since the second 
coiled coil was still in place and it may also participate in the interaction with LSH, hence, 
removing one of the CCs would allow to dissect their roles in protein-protein interaction. 
According to PsiPred, the N-terminal part of this truncation falls into a disordered region (Fig. 
6.6).  
I also planned to clone only the zinc finger domain, which would be a crucial negative control 
for any protein-protein interaction studies but cloning of that construct was unsuccessful 
(not shown). The disordered region upstream the zinc finger domain could be further tested 
for the optimal truncation boundaries, with potential incorporation of the upstream α-helix 
E258-I264 (Fig. 6.6), but the exact boundaries would have to be determined empirically. 
Nevertheless, in the future studies it would be important to check whether this part interacts 
with either protein or DNA and if it is capable of facilitate chromatin remodelling by LSH. The 
three constructs in Fig. 6.21 were verified by Sanger sequencing and used for bacterial 
transformation.  
The disorder profile of these truncations from PONDR and IUPred2A would also be consistent 
with potential functional regions: the first truncation (Δ1-63) would abrogate the disordered 
N-terminus, which was not predicted to contact any protein bindings regions, the second 
truncation (Δ1-150) would remove first predicted region for protein-protein interaction and 
173 
 
third truncation (Δ1-271) would have removed the second region (Fig. 6.5) leaving only the 
zinc finger domain.  
 
Figure 6.21 Schematic representation of the GST-CDCA7 constructs used in these expression tests 
and their domain predicted by Pfam. The numbers under the constructs indicate the amino acid 
residues.   
 
6.4.2 CDCA7 test expression in E. coli  
One of the main challenges in bacterial expression process is a potentially long expression 
optimisation process. Selection of an appropriate competent cell strain may have an effect 
of protein expression. BL21(DE3) is a strain widely used for recombinant protein expression, 
therefore, it was selected for a test expression, as well as its derivatives C41(DE3) and 
C43(DE3) that were selected as mutant host strains of BL21(DE3) are suitable for expression 
of recombinant proteins that can be potentially cytotoxic (Dumon-Seignovert et al., 2004).  
Initially, I selected CDCA7_T1 for a test expression (Fig. 6.22), and followed a standard 
protocol, with an overnight induction at 16oC using 0.5 mM IPTG. The expected MW of the 
protein was 37 kDa without a GST tag and 62 kDa with the tag. A band of that size appeared 
in a GST pull-down, however, the sample was dominated by a more prominent band of 
around 35 kDa (with the tag, since it was present in the GST pull-down). This result appeared 





Figure 6.22 CDCA7_T1 test expression GST pull-down after test expression in the indicated strains. 
UI – uninduced, I – induced, SN – supernatant, P – pellet, FT – flow-through. Unlabelled arrows 
indicate the most prominently expressed fragment. CDCA7_T1 was identified by a Western blot on 
Fig. 5.20.  
To reveal the identity of the bands, a Western blot was performed on the samples from the 
test expressions using an anti-CDCA7 polyclonal antibody (Fig. 6.23). Unexpectedly, 
CDCA7_T1 was detected in the lanes corresponding to BL21(DE3) expression, albeit with a 
molecular weight of around 52 kDa instead of the expected 62 kDa (Fig. 6.21, 6.23). A large 
portion of the protein was present in the pellet. Some soluble CDCA7_T1 was detected in the 
BL21 (DE3) sample. The large bands visualised by Coomassie staining was not detected by 
the antibody, indicating that it was either not CDCA7_T1 or that smaller degradation product 




Figure 6.23 Western blot of CDCA7_T1 following test expression in three E. coli strain. Primary 
antibody – rabbit polyclonal α-CDCA7, secondary antibody – anti-rabbit Licor IR800-conjugated. 
 
Since CDCA7 was detected, although not as an expected fragment, I continued optimisation 
using a shorter induction time, which could alleviate protein degradation process. This time 
I tested all three constructs, also adding 0.1% of Triton X-100 (a non-denaturing non-ionic 
detergent), since previously a lot of CDCA7 was present in the insoluble fraction, which might 
have been due to incomplete cell lysis. This may be due to only sonication was being used for 
this preparation, whereas cell disruptor generally provides better yields. Whereas 0.1% 
Triton X-100 improved samples’ purity (Fig. 6.24) and it was decided to incorporate it into 
the lysis and purification process, the bands of incorrect sizes persisted. However, CDCA7_T2 
sample contained a smaller band of around 52 kDa, which corresponded to the expected size 




Figure 6.24 GST-CDCA7 full length and the truncations 1 and 2 test expression with and without 0.1% 
Triton X-100 added to the lysis buffer. UI – uninduced, I – induced, SN – supernatant, P – pellet, FT – 
flow-through. A) GST-CDCA7_FL was induced in BL21(DE3) at 30oC for 3h; B) GST-CDCA7_T1 was 
induced in BL21(DE3) at 30oC for 3h; C) GST-CDCA7_T2 was induced in BL21(DE3) at 30oC for 3h. 
Expected positions of CDCA7 truncations are indicated by red arrows with expected molecular 
weights.  
 
In order to test more conditions, I also tried expressing the proteins in an E. coli strain B843 
(DE3) (Fig. 6.25 B, C). This strain is auxotrophic, i.e. it cannot synthesise certain organic 
compounds, such as amino acids, in this respect methionine, which should be added to the 
growth medium. A supplement of choice in X-ray crystallographic studies is 
selenomethionine, which, when incorporated into the protein of interest, provides improved 
diffraction data. The aim of this expression was not to produce a selenomethionine-
containing protein, but simply to test which strains can produce desirable proteins, 




Figure 6.25 GST-CDCA7 expression test at different conditions. UI – uninduced, I – induced, SN – 
supernatant, P – pellet, GSH – GSH resin. A) Indicated constructs in BL21(DE3) induced with 0.5 mM 
IPTG at 16oC overnight; B) Indicated constructs in B843(DE3) induced with 0.5 mM IPTG at 30oC for 
3h; C) Indicated constructs in B843(DE3) induced with 0.5 mM IPTG at 16oC overnight. The constructs 
of expected sizes are indicated with red arrows: CDCA7_FL 69 kDa, CDCA7_T1 62 kDa, CDCA7_T2 52 
kDa.  
 
This expression test, however, resulted in the bands of around 35-40 kDa on the GST resin 
lanes (Fig. 6.25). No bands of expected sizes were observed with different strains, induction 
times or incubation temperatures. To elucidate their identity, the bands indicated with a red 
asterisk on Fig. 6.25 B were excised from the gel, trypsin-digested and processed for MALDI-
TOF mass spectrometry. The resulting spectra were compared to the GST-CDCA7 sequence 
using Protein Prospector and the presence of CDCA7 was confirmed (Fig. 6.26), despite the 




Figure 6.26 Confirmation of full-length (FL), truncation 1 (T1) and truncation 2 (T2) of GST-CDCA7 by 
MALDI-TOF mass spectrometry with peptide coverage. Identified peptides are in bold.  
There are a few possible reasons for the low coverage of the matched peptides. First, trypsin 
digestion may have been insufficient, therefore, no peptides were present. Second, trypsin 
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digestion was too efficient. CDCA7 has many lysine and arginine residues, making them highly 
likely digestion sites (Fig. 6.27). 
 
 
Figure 6.27 Mapping of lysine and arginine residues in Mus musculus CDCA7 full length sequence. 
Lysines are shown in yellow, arginines are shown in green.  
 
Since the boundaries of the trypsin-digested sample could not be identified by MALDI-TOF, 
the intact sample was subjected to electrospray ionisation mass spectrometry (ESI-MS) to 
determine the exact molecular mass of the fragments, which would allow to determine which 
part of the protein was expressed. However, no meaningful data was obtained (not shown) 
due to insufficient amount of the protein and its contaminated state.  
In the attempt to scale up protein production for a more rigorous purification and for 
subsequent ESI-MS, I repeated CDCA7 expression scaling up to 1 L culture volumes. This time, 
instead of cleaving the GST tag with 3C, I tried eluting the protein using 20 mM GSH. This 
elution was more successful compared with the insect cell sample (Fig. 6.28 A, B), however, 





Figure 6.28 Indicated GST-CDCA7 constructs 1L scale up expression. UI – uninduced, I – induced, SN 
– supernatant, P – pellet, FT – flow-through, GSH E1-3 – elution with 20 mM GSH.  
 
Since the samples from Fig. 6.28, both GSH eluted and cleaved with 3C protease, still had a 
lot of contaminants present, I attempted to remove the impurities by gel filtration (Fig. 6.29 
A, C and Fig. 6.30 A, B) using Superdex200 10/30 24 ml column. All samples were 
concentrated using PES concentrators before applying the samples the column. The shorter 
version of CDCA7_T1 (35 kDa) eluted at 11 ml in the first peak, indicating that it eluted in a 
complex with a larger than 100 kDa molecule, presumably DNA, as indicated by Nanodrop 
absorbance ratio A260/280 of 2, confirming nucleic acid contamination (Fig. 6.29 A, B). The 
larger version of CDCA7_T1 (~52 kDa) eluted at around 17 ml in the second peak (A260/280 1.9), 
in a very dilute state, however, there was another band of 10 kDa of unknown origin, which 
might have been the main species in the peak 2 (Fig. 6.29 B). The discrepancy between the 
sizes of the two proteins and their elution volumes indicates that the smaller protein may 
interact with DNA, oligomerise or aggregate. It seems counterintuitive, since I would expect 
the larger fragment, which presumably retained some ZF domain to interact with DNA and 





Figure 6.29 GST-CDCA7_T1 and CDCA7_T1 purificaiton by gel filtration. A) Chromatogram of GST-
CDCA7 following elution with 20 mM GSH; B) 12% SDS-PAGE of GST-CDCA7 following gel filtration, 
0.5% of total sample was loaded; C) Chromatogram of GST-CDCA7 following cleavage with 3C 
protease; D) 12% SDS-PAGE of 3C-cleaved CDCA7 following gel filtration, 0.5% of total sample was 
loaded. 
A similar situation was observed in CDCA7_T2 gel filtration (Fig. 6.30 A), however, it was not 
possible to discern any CDCA7_T2 constructs on the gel. Therefore, as with the insect cell 
sample, CDCA7 expressed in bacteria seemed to interact with the resin, and Superdex200 




Figure 6.30 GST-CDCA7_T1 and CDCA7_T1 purificaiton by gel filtration. A) Chromatogram of GST-
CDCA7 following elution with 20 mM GSH; B) Chromatogram of GST-CDCA7 following cleavage with 
3C protease; C) 12% SDS-PAGE of 3C-cleaved CDCA7 following gel filtration, 0.5% of total sample 
was loaded. 
 
Since it was not possible to express any CDCA7 variants of the correct size, and this time- and 
labour-consuming did not result in improved yields, I decided to return to the full-length 
CDCA7 expressed in insect cells and use it for protein characterisation studies.  
 
6.5 Discussion   
Little understanding of structural and functional aspects is available for CDCA7, but in the 
light of the recent findings of its interaction with LSH, this information is crucial for 
understanding its role in chromatin remodelling (Jenness et al., 2018). Therefore, the first 
step was to examine its sequence. The N-terminal part of CDCA7 has two coiled coil domains 
predicted by the servers COILS and MARCOIL (Fig. 6.2 and 6.3). These regions are conserved 
across the CDCA7 orthologues, however, the close homologue CDCA7L does not appear to 
harbour the second predicted coiled coil (Fig. 6.7), indicating a distinct role for that region in 
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CDCA7. As mentioned earlier, LSH also has a predicted coiled coil in its N-terminus and it is 
the main candidate region for protein-protein interaction in LSH.  
Human CDCA7 was predicted to contain a leucine zipper region upstream its phosphorylation 
sites (serine-142, threonine-163, serine-190 in human CDCA7) that promote interaction with 
14-3-3 proteins (Gill et al., 2013). This leucine zipper location corresponds with the first coiled 
coil predicted by the both coiled coil prediction servers for murine CDCA7 analysis (Fig. 6.2 
and 6.3), and since a leucine zipper is a subtype of a coiled coil (Reger et al., 2014; Truebestein 
and Leonard, 2016), this strengthens the probability that this prediction is valid, highlighting 
the potential of CDCA7 to participate in homo- and heterodimerisation. The homologue 
CDCA7L has been found to interact with LEDGF/p75 (Chan et al., 2016), a host factor 
participating in HIV integration through interaction with DNA via its AT-hook motif 
(Cherepanov et al., 2003). Therefore, it is not clear whether CDCA7L also interacts with DNA 
or solely assists LEDGF through protein-protein interaction in stabilising it or in forming 
contacts with other proteins. CDCA7L-LEDGF complex has been implicated in PI3K/AKT 
signalling in promoting aggressive medulloblastoma (Chan et al., 2016), however, the roles 
of CDCA7L domains in this interaction have not yet been dissected.  
The C-terminal region of both CDCA7 and CDCA7L was predicted to harbour a zinc finger 
domain (ZFD) (Fig. 6.1) (Bartholomeeusen et al., 2007; Gill et al., 2013). The ZFD of CDCA7L 
was predicted to belong to the RING ZFD class, as identified through SMART database, and 
addition of 70-90 µM of ZnCl2 increased pull-down efficiency for LEDGF/p75 interaction 
(Bartholomeeusen et al., 2007). This domain was termed 4CXXC-R1, where C is a cysteine, X 
is any amino acid and R1 is an alternative name for CDCA7L (Chen et al., 2005).  
About a half of eukaryotic zinc finger domains share a consensus sequence (F/Y)-X-C-X2−5-C-
X3-(F/Y)-X5-ψ-X2-H-X3−5-H, where X represents any amino acid and ψ is a hydrophobic residue, 
which comprises a classical zinc finger domain (Wolfe et al., 2000). The classic C2H2 ZF 
domain has a common conserved motif TGEKP connecting adjacent ZFs (John H Laity et al., 
2000) and transitioning from disordered to ordered state upon binding to DNA (J. H. Laity et 
al., 2000). Zinc finger proteins rely on CG-rich sequence specificity and sequence-specific DNA 
deformation with nanomolar binding affinities between ZFD and DNA (Elrod-Erickson et al., 
1996; Lisowsky et al., 1999; Paillard, 2004). Some interactions are non-specific and have 
micromolar affinities (von Hippel and McGhee, 1972). An example of zinc finger-DNA binding 
was elucidated by X-ray crystallography. The transcription factor EGF1/Zif268 contains the 
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classical zinc finger domain C2H2 which coordinates three zinc ions and fits α-helices into the 
major groove, as indicated by its crystal structure (Elrod-Erickson et al., 1996; Pavletich and 
Pabo, 1991).  
It has been observed that RING ZFD target binding molecules are proteins, rather than nucleic 
acids (Borden and Freemont, 1996; Ravasi, 2003), which is contrary to the findings by Chen 
et al. that CDCA7 could bind DNA (Chen et al., 2005). The findings from my CDCA7 purification 
experiments indicate high CDCA7 affinity for DNA, however, this can be due to their non 
sequence- or base-specific affinity through the extensive positive surface charge of CDCA7 
(Gamsjaeger et al., 2007), therefore, the nature of the CDCA7-DNA interaction and its role in 
LSH-mediated chromatin remodelling is not clear. In vivo yeast one-hybrid assay 
demonstrated that CDCA7L had a putative DNA-binding activity by directly binding the CG-
rich sequence 5’-ccg gac gcg cag cCC CGC CCG CCC GCC tac gcg cag-3’ found in MAOA core 
promoter, which contains Sp1 transcription factor binding sites (Chen et al., 2005). This 
finding is the only one showing the capacity of the ZFD common to CDCA7 and CDCA7L to 
bind DNA, and it cannot be ruled out that the result was a false positive, which is a common 
caveat of this method (Reece-Hoyes and Marian Walhout, 2012). Alternatively, the DNA 
binding activity of CDCA7L may be due to a region distinct from the RING ZFD. Previously, a 
Polycomb-group related protein Mel-18/bmi-1 containing a RING domain was shown to bind 
DNA in a sequence-specific manner (Kanno et al., 1995), however, the study used a full-length 
protein, and the roles of its domains have not been dissected, therefore, it is feasible to 
suggest that RING domain is not necessarily the one participating in DNA interaction.  
Due to the lack of close homologues with structural data, ab initio molecular modelling of 
murine CDCA7 ZFD272-371 was performed using the programmes I-TASSER and Phyre2 (Fig. 
6.8). Among the top threading templates selected by I-TASSER were the crystal structures of 
the TRIM37 E3 ligase RING domain, the ADD domain of DNA methyltransferase DNMT3A, the 
E2-E3 ubiquitylation complex and the DNMT3A-DNMT3L complex, which strengthens the link 
of CDCA7 with RING domain containing proteins. The top model from I-TASSER had average 
quality parameters (see Section 6.2) but was used to examine possible structural 
characteristics of the ZFD and to compare it with the ab initio model from Phyre2 (Fig. 6.8). 
The most obvious discrepancy between the known RING domains and CDCA7 models was 
the location of cysteine pairs within the structure: if described structures of RING ZFDs 
showed a cross-brace arrangement of cysteines (Miyamoto et al., 2017), both CDCA7 models 
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demonstrated sequential localisation of cysteines in two zinc fingers (Fig. 6.8) more similar 
to the arrangement of the classical C2H2 DNA-binding domain or protein-binding LIM domain 
(Cassandri et al., 2017). However, there is a sequence discrepancy between the classic C2H2 
domain and CDCA7 ZFD, since CDCA7 does not obey the rules for containing histidines in zinc-
coordinating positions. Histidine residues are located proximally to the cysteines, however, 
their role in the ZFD arrangement was not clear, as they did not obey previously described 
sequence patterns (Cassandri et al., 2017; Miyamoto et al., 2017). It is also possible that the 
cross-brace orientation of the zinc fingers exists in CDCA7 but was not captured in either 
model. The structures identified by the TM-align server (Zhang and Skolnick, 2005) to be the 
most similar to the CDCA7 model included the ZFDs of DNMT3A and DNMT3L proteins (Fig. 
6.9). Their ZFD are predicted to have a GATA-1-like and PHD domain, with the former 
following a continuous cysteine arrangement coordinating one Zn2+ and the latter having a 
cross-brace arrangement with two zinc atoms (Ooi et al., 2007; Otani et al., 2009). The GATA-
1 and PHD ZFDs comprise the ADD (ATRX, DNMT3A, DNMT3L) domain, which binds the 
histone H3 tail unmethylated at lysine 4 (Ooi et al., 2007; Otani et al., 2009). The DNA-binding 
domain of DNMT3A is located downstream of the ADD domain and binds DNA with assistance 
from the methyltransferase-like domain of DNMT3L (Ren et al., 2018; Zhang et al., 2018). 
Therefore, neither the ZFD of DNMT3A nor DNMT3L are expected to participate in interaction 
with DNA, which further strengthens the argument against CDCA7 ZFD binding to DNA.  
The location of CDCA7 ZFD (Fig. 6.4) corresponds to the location of the ICF mutations (see 
Section 1.4). When both arginines were converted to histidines or a cysteine (R285C/H, 
R315H), these CDCA7 mutants could still maintain interaction with LSH in reticulocyte lysates 
(Jenness et al., 2018). This indicates either that the ZFD does not participate in LSH interaction 
or the interaction with LSH can still be maintained by the CDCA7 mutant but it changes LSH 
conformation. Therefore, LSH can no longer remodel nucleosome. However, an additional 
argument for CDCA7 ZFD being crucial for DNA interaction comes from a pull-down 
experiment, where the R285C/H mutations decreased MBP-CDCA7 binding to DNA beads and 
LSH recruitment (Jenness et al., 2018), indicating that CDCA7 ZFD provides a platform for 
nucleosome binding. The third ZFD mutation, R315H, abolished DNA binding by CDCA7 in 
vitro but not in chromatin egg extracts (Jenness et al., 2018), which may point to additional 
binding factors participating in vivo.  
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Zinc finger domains rely on zinc ions coordinated by cysteines and/or histidines. The sulphur 
atom of cysteine residue or nitrogen on histidine imidazole ring chelate zinc atom providing 
structural stability (Pace and Weerapana, 2014), therefore, introduction of a neighbouring 
cysteine or histidine may introduce additional chelating point, thus disrupting the initial 
tetrahedral geometry of zinc coordination, shifting the domain conformation and impairing 
the protein function as a result. If introduction of histidines does not directly affect zinc 
coordination, it could also introduce additional electrostatic points of contact between 
histidines and nucleobases, making CDCA7-DNA interaction more rigid, however, this 
mechanism does not explain the experimentally-observed decrease of MPB-CDCA7 in DNA 
binding (Jenness et al., 2018). Therefore, mutagenesis and structural experiments would be 
required to dissect the mechanism of CDCA7-DNA binding and the molecular impact of the 
ICF mutations.  
Here, the recombinant murine CDCA7 with an N-terminal GST tag was purified from Sf9 insect 
cells, albeit with a range of caveats. First, a significant DNA contamination was observed after 
GSH resin and 3C cleavage step. This contamination was not affected by incubation with 
either benzonase or DNAseI. Therefore, it has a potential to complicate any downstream 
experiments involving DNA binding, since the binding sites on CDCA7 may be already 
occupied by insect DNA. Second, CDCA7 was always co-eluted with a pair of proteins, which 
was revealed to be 14-3-3-ε (epsilon) and 14-3-3-ζ (zeta) by MALDI-TOF mass spectrometry. 
Third, any residual contaminations could not be removed by gel filtration due to apparent 
interaction of CDCA7 with the column matrix.  
Therefore, an up-to-date standard protocol for murine CDCA7 purification includes standard 
pellet preparation with lysis in high NaCl (500 mM), followed by a 2-3 h incubation with GSH 
resin and an overnight incubation with 3C protease. This method allowed to obtain CDCA7 in 
complex with 14-3-3 proteins with an overall sample purity of around 90-95% (by visual 
estimation). This level of purity allows to perform biophysical assays to characterise the 
protein, however, they are complicated by the low protein yield. Biochemical assays aiming 
to reveal interaction patterns of CDCA7 would be complicated by the contaminating DNA.  
CDCA7 appears to be a strong DNA binder, as revealed by persistent DNA contamination. This 
interaction is most likely to be mediated through the zinc finger domain, however, that could 
only be confirmed by experimental work involving, for instance, C-terminal truncations of 
CDCA7. The present result indirectly supports the hypothesis that CDCA7 may allow LSH to 
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perform chromatin remodelling by acting as an additional point of contact with DNA, 
mimicking the function of DNA-binding domains of the other chromatin remodellers.   
As revealed previously, phosphorylated human CDCA7 was interacting with 14-3-3 protein, 
which resulted in the sequestration of the former into the cytoplasm. Here, a mass 
spectrometry analysis revealed that heterologous murine CDCA7 and endogenous 14-3-3-ε 
and – ζ were bound to CDCA7 with high affinity which was not disrupted by 500 mM NaCl. 
This indicates that CDCA7 is likely to be phosphorylated on serines 197 and 225 and 
threonines 170 and 203 as identified by similarity in the bioinformatics analysis (see Section 
1.4 of Introduction). The PTMs were not confirmed in the scope of the present study due to 
a low protein yield.  
Attempts to remove nucleic acid contamination from CDCA7 sample have not yet been 
successful. They included increasing salt concentration in lysis and wash buffers, varying 
nucleases treatment conditions and a chromatography run with heparin column. Additional 
methods could be tried. For example, polyethyleneimine (PEI) precipitation with subsequent 
ammonium sulfate precipitation. Even though a heparin column was not successful in 
removing nucleic acid, ion exchange may still be tried. An anion exchange column may be 
used. CDCA7 has an overall positive charge, however, when it is bound to DNA, the positively 
charged residues may be masked by DNA and negatively charged residues more exposed, 
allowing CDCA7 to bind the anion resin. Otherwise, cation exchange chromatography can be 
tried. Finally, addition of EDTA to the lysis buffer may release (completely or partially) Mg2+ 
bound to the protein, which may cause conformational change in the protein and release of 
DNA, however, that can also destabilise the protein.  
In the attempt to improve CDCA7 yields, I explored the option of expressing it in bacterial 
cells. I designed three constructs with various N-terminal truncations that could potentially 
stabilise the protein. Even though Western blot and mass spectrometry confirmed the 
presence of CDCA7, none of the expressed fragments had the correct molecular weight, 
indicating degradation. All three constructs retained the GST tag, as indicated by their ability 
to bind GSH resin. CDCA7 expressed in insect cells, presumably retained post-translational 
modifications (PTMs). These modifications may play a crucial role in stabilising the protein, 
therefore, the lack of PTMs in the bacterially expressed CDCA7 may explain the observed 
degradation. Further studies of CDCA7 PTMs are likely to shed more light on the CDCA7 
structure and its stability.  
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7. INVESTIGATION OF THE LSH-CDCA7 INTERACTION 
7.1 Introduction 
Jennes et al. (2018) showed that the LSH-CDCA7 interaction is required for nucleosome 
remodelling and their co-immunoprecipitation experiments demonstrated that LSH and 
CDCA7 directly interact (Jenness et al. 2018). However, it was not clear whether the proteins 
form a stable complex and whether the nucleosome core-particle was necessary to mediate 
their interaction. In their experiments with protein co-depletion from Xenopus eggs, LSH 
depletion did not cause depletion of CDCA7 and vice versa, indicating that only a fraction of 
the proteins may interact (Jenness et al. 2018). Nevertheless, it is feasible that the LSH-CDCA7 
complex still exists if only in association with nucleosome. Elucidating the mode of interaction 
of LSH and CDCA7 in vitro would require a stable complex, which would allow to study the 
structural and molecular aspects of the interaction and to obtain functional insights. If they 
do not form a stable complex, then additional techniques such as chemical crosslinking 
and/or gradient fixation could potentially be used. Therefore, I tested interaction using 
mouse homologues of LSH and CDCA7 in the absence of the nucleosome by a GST pull-down, 
as well as by co-infection or pellet co-lysis.   
 
7.2 LSH-CDCA7 interaction was detected by a GST pull-down 
A GST pull down was chosen over an Ni-NTA pull-down due to the higher specificity of the 
former and higher protein background of the latter. An Ni-NTA pull-down was only used to 
detect expression of LSH-6xHis. Lysates were used as a quick way to check if any interaction 
can be detected without going into a length protein purification process. Additional 
advantage of a pull-down from lysates is that the proteins of interest may already be bound 
to any necessary accessory proteins or nucleosome, which facilitate the interaction between 
LSH and CDCA7.  
Therefore, Sf9 lysates containing either LSH-6xHis or GST-CDCA7 were prepared and 
incubated with GST resin. The control samples included LSH and GST-CDCA7 (both from 
lysates), purified GST and these were compared with a mix of LSH-6xHis and GST-CDCA7 from 
Sf9 lysates. Both the input samples and the protein left on the beads after washes were 
resolved on 12% SDS-PAGE gel and blotted using antibodies against LSH, CDCA7 and GST. To 
avoid antibody background and any potential cross-reactivity, I cut the membrane at around 
35 kDa mark and blotted LSH and CDCA7 separately from GST. Strong LSH bands were present 
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on all input lanes (Fig. 7.1 lanes 1, 3, 4), compared with the GSH resin samples (Fig. 7.1 lanes 
5-8), indicating that LSH expression was more efficient than GST-CDCA7. A small amount of 
LSH was detected on the GSH resin (Fig. 7.1 lane 5), compared with input (Fig. 7.1 lane 1), 
indicating that there was some non-specific interaction, perhaps due to insufficiently 
stringent wash. A strong GST-CDCA7 band was present in the GSH resin lane (Fig. 7.1 lane 6), 
consistent with the affinity of the construct for the resin. The LSH+GST lane (Fig. 7.1 lane 3) 
did not show much GST in the input but it was enriched in the GST resin sample (Fig. 7.1 lane 
3). A strong LSH band present in the input was weak and similar to the LSH only sample (Fig. 
7.1 lane 3), indicating that LSH has some non-specific affinity for the resin, but not for the 
GST tag. The lane containing both LSH and GST-CDCA7 had a strong LSH band in the input 
(Fig. 7.1 lane 4), but barely visible GST-CDCA7 band (Fig. 7.1 lanes 4, 8). The respective GST 
lane had a stronger LSH signal compared to the LSH only and LSH+GST controls (Fig. 7.1 lane 
8), implicating that LSH was retained on the resin due to interactions other than non-specific 
interaction with GST resin or GST tag. Therefore, it is possible to hypothesise that LSH 
interacted with GST-CDCA7, enriched on the resin, in the present pull-down.  
 
 
Figure 7.1 GST pull-down of LSH and CDCA7 visualised by Western blot using α-LSH, α-CDCA7 and α-
GST antibodies. The blue boxes surrounding the membrane indicate the borders where the 
membrane was cut in two and probed separately. The top part was probed with primary antibodies 
α-LSH and α-CDCA7 and secondary IR800-fused α-mouse and α-rabbit, respectively. The bottom part 
was probed with primary antibody rabbit α-GST and secodary IR800-fused α-rabbit. Extra bands 





7.3 LSH and CDCA7 co-expression and co-purification  
Since both LSH and CDCA7 had low expression in Sf9 cells and a significant fraction of both 
proteins was present as insoluble, I attempted to co-express them to check if the 
simultaneous production improves their yields and solubility and if they form a nuclear 
complex that could be purified. The assumption here was that proteins that were shown to 
interact might form a complex if co-expressed and stabilise each other. I did not clone LSH 
and CDCA7 as a polycistronic assembly in a single plasmid, instead, I expressed them from 
individual plasmids, generated baculoviral V0 and V1 and used V1 viral generation for 
separate expressions of each protein as controls and for co-infection, adding equal volumes 
of a V1 sample of each to Sf9 cells (see Section 2.1.3.6).  
Separate expressions and co-infection were followed by pellet processing and analysis of the 
soluble fractions by Ni-NTA and GSH pull-downs (see Section 2.3.4). All samples were treated 
with 750 U of benzonase, which could potentially digest the hypothetical bridging 
nucleosome, however, eukaryotic sample contain large amounts of DNA and without proper 
nucleic acid digestion downstream purification steps can be problematic. The assumption 
was that if there was a bridging nucleosome between LSH and CDCA7, its phosphodiester 
bonds could be protected by the bound proteins from complete digestion. Pull-downs for 
separately expressed proteins demonstrated expression as indicated by the presence of the 
bands on the respective resin lanes: LSH-6xHis was present of Ni-NTA resin and GST-CDCA7 
was present on the GSH resin (Fig. 7.2 A, lanes Ni-NTA resin and GSH resin). When the 
proteins were GSH probed following co-infection, both proteins were observed in the pellet 
fraction (Fig. 7.2 lane P) indicating their insolubility, without giving any insight whether they 
formed a complex. No obvious protein bands were detected on the GSH resin lane (Fig. 7.2 
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B), indicating that the proteins were not present in the soluble fraction in sufficient levels to 
be visualised by Coomassie staining (Fig. 7.2 B).   
 
 
Figure 7.2 Coomassie stained 12% SDS-PAGE of separate expression (A) and co-infection (B) of LSH 
and GST-CDCA7 in Sf9 cells. L+benz – lysate incubated with 3 µl of 250 U/µl of benzonase;. SN – Sf9 
supernatant; P – pellet; FT – flow-through. Wash fractions were not run on these gels. Red arrows 
point to LSH-6xHis at ~100 kDa and GST-CDCA7 at around 70 kDa. 
Following co-infection, I attempted to improve the visibility of the bands by scaling up the 
cultures. I also tried mixing the pellets containing each protein instead of co-infecting. I used 
250 ml of Sf9 to co-infect it with V1 of both LSH and CDCA7 and 500 ml of Sf9 infected with 
each protein’s virus separately for a subsequent co-lysis.  
The pellets of individually expressed proteins that were then mixed together and processed 
following the standard protocol (see Section 2.1.3.10) and the proteins were isolated by a 
GST pull-down with the subsequent 3C protease cleavage overnight to remove the GST tag. 
Interestingly, a band corresponding in size to CDCA7 (at 70 kDa) was observed in the 3C flow-
through sample, however, the bands corresponding to uncleaved GST-CDCA7 and LSH 
persisted, indicating that the proteins may show some interaction, which prevented efficient 
3C cleavage (Fig. 7.3). This assumption was reinforced by the presence of a significant 
amount of both proteins on GSH resin (Fig. 7.3 lane 3C o/n GSH).  
When the proteins were expressed by co-infection, GST-CDCA7 was still present in its 
uncleaved form following incubation with 3C in the 3C flow-through, which should have 
contained cleaved CDCA7 and LSH. Even though CDCA7 has been efficiently cleaved by 3C 
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protease, when expressed on its own (see Section 6.2 and Fig. 7.3), it appeared to be less 
prone to cleavage in the presence of LSH (Fig. 7.3).  
 
Figure 7.3 Coomassie stained 12% SDS-PAGE of co-lysis and co-infection of LSH and GST-CDCA7 in 
Sf9 cells. Lanes on the gel are as follows: L+benz – lysate incubated with 3 µl of 250 U/µl of 
benzonase;. SN – supernatant; P – pellet; FT – flow-through; 3C o/n FT – flow-through following 
overnight incubation with 3C protease; 3C o/n – GSH resin following overnight incubation with 3C 
protease. 
 
Since co-infection following the GSH resin purification step did not result in a high yield of 
the proteins, I decided to try applying the 3C flow-through containing cleaved CDCA7 and 
potentially a CDCA7-LSH-6xHis complex on a Superdex200 24 ml column. The first labelled 
peak 1 on the chromatogram had a significant nucleic acid presence (Fig. 7.4 A, peak 1) as 
indicated by A260/280 of 1.9. When that peak fraction was run on a 12% SDS-PAGE, it revealed 
to contain predominantly LSH as indicated by the migration pattern being consistent with the 
expected mass of LSH (Fig. 7.4 B). The peak’s elution volume of 10 ml did not correspond to 
LSH molecular mass (expected elution volume should be around 14.2 ml), which may indicate 
that LSH was in a complex with a large nucleic acid fragment. A small amount of CDCA7 was 
detected in peak 2 (Fig. 7.4 lanes 3, 4, 5) elution volume of 17 ml), which corresponds to its 
molecular mass of 44 kDa, after the GST tag cleavage (Fig. 7.4 A, B). However, the A260/280 
corresponding the peak 2 was 1.9, indicating the presence of nucleic acid. If CDCA7 was in a 
complex with nucleic acid, it would elute earlier due to higher molecular mass of the CDCA7-
nucleic acid complex. A possible explanation to this discrepancy may be that there was a DNA 
fragment similar to CDCA7 in size and steric parameters that eluted together with CDCA7. 
Peak 3 represented a protein of around 30 kDa (Fig. 7.4 A, B), which could correspond to one 





Figure 7.4 Purification of co-lysed samples containing LSH-6xHis and CDCA7. A) Chromatogram of 
LSH+CDCA7 following gel filtration on a Superdex200 24 ml column; B) Coomassie stained 12% SDS-
PAGE of the fractions collected in gel filtration on a Superdex200 24 ml column. Co-lysis of pellets 
containing each protein expressed individually.   
 
In summary, the LSH-CDCA7 complex was not detected following either co-infection or pellet 
mixing and co-lysis. Even though LSH was present in the GST pull-down, it may be not due to 
its association with CDCA7 carrying the GST tag, but due to its non-specific interaction with 
the GSH resin. As was seen in the GST pull-down from Sf9 lysates, LSH has some affinity for 
GSH resin (Fig. 7.1). These results reinforce the notion that LSH and CDCA7 are likely to 
interact when a mononucleosome is present and which can bridge the two proteins. The 
presence of a mononucleosome may trigger conformational changes in either or in both 
proteins and cause them to form a transient complex, which readily dissociates once 
remodelling has taken place.  
 
7.4 Discussion 
In order to stabilise CDCA7 and/or increase its solubility, I tried co-expressing it or co-
purifying it together with LSH, since they were predicted to interact by mass spectrometry 
and biochemical experiments (Jenness et al, 2018). Neither approach improved CDCA7 
solubility or yield, however, 3C protease cleavage of GST tag from CDCA7 N-terminus 
appeared to be inhibited in the presence of LSH, indicating that LSH may bind CDCA7 either 
at the N-terminus or its middle part and to induce conformational changes resulting in 
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protection of the 3C cleavage site. It is unclear, however, whether these results only followed 
non-specific binding or were a genuine protein-protein interaction event.  
During CDCA7 expression, a large part of the expressed protein was pelleted in the insoluble 
fraction. GST pull-down of the two proteins resulted in larger amount of LSH being bound to 
GST resin in the presence of CDCA7 compared with LSH only control (Fig. 6.31), indicating 
that LSH is retained on the resin in the presence of CDCA7, therefore, complex formation 
might have been occurring.  
In order to stabilise CDCA7 and/or increase its solubility, I tried co-expressing it or co-
purifying it together with LSH, since they were predicted to interact by mass spectrometry 
and biochemical experiments (Jenness et al., 2018). Neither approach improved CDCA7 
solubility or yield, however, 3C protease cleavage of the N-terminal GST tag appeared to be 
inhibited in the presence of LSH (Fig. 6.33), indicating that LSH may bind CDCA7 either at the 
N-terminus or its middle part and to induce conformational changes resulting in protection 
of the 3C cleavage site. Since both proteins participate in the nucleosome binding, it is 
feasible to suggest that any potential complex is stabilised in the presence of the 
nucleosome, however, further work is required to test this assumption.  
In the present study, LSH has been successfully expressed and purified in insect cells, 
however, CDCA7 could not be completely cleared of contaminating nucleic acid, which 
complicated any possible downstream application. Therefore, a number of approaches can 
be utilised to further elucidate the modes of binding and catalysis involving LSH, CDCA7 and 
a mononucleosome.  
Since published results showing active LSH and CDCA7 in chromatin remodelling relied on 
both proteins from Xenopus, and robust expression systems have been established (Jenness 
et al. 2018), the next step would be to explore those expression systems for producing active 
proteins in sufficient (mg) amounts for structural and biochemical studies. Production of high 
yield contamination-free CDCA7 is cardinal for the crucial downstream experiments. 
Expression system optimisation is also crucial for producing various truncated versions of 
each protein, which would be indispensable for dissecting their functions.  
Dissecting the CDCA7 binding to the nucleosome is a crucial step in elucidation the 
mechanism of LSH mechanism of chromatin remodelling, therefore, pure CDCA7 free from 
nucleic acid contaminants should be produced, including the full-length protein and its 
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truncates, with domains gradually removed from the N-terminus. Such constructs should 
then be used for a binding shift assay, such as EMSA, as well as an ATP hydrolysis assay, in 
which LSH-nucleosome, CDCA7-nucleosome, LSH-CDCA7 and LSH-CDCA7-nucleosome 
complexes should be compared, and the rate of ATP hydrolysis measured. This can be done 
with a malachite green or thin layer chromatography (TLC) assays.  
Following that, protein truncations combination should be tested in a restriction enzyme 
remodelling assay, wherein a recombinant nucleosome with an engineered PstI restriction 
site is incubated with the proteins and PstI restriction enzyme. Confirmation of LSH 
























8. POSSIBLE MODELS FOR THE LSH-CDCA7 COMPLEX ROLE IN 
CHROMATIN REMODELLING 
CDCA7-facilitated nucleosome remodelling by LSH is a crucial mechanism in normal organism 
development. The main pathological phenotype associated with LSH and CDCA7 is the 
Immunodeficiency, Centromeric instability, Facial anomaly (ICF) syndrome characterised by 
congenital defects of DNA methylation (Vukic and Daxinger, 2019) with less than 100 cases 
described worldwide (van den Boogaard et al., 2017).  ICF syndrome manifests in reduction 
or absence of B cells and antibody titres, altered chromosomal configuration, the presence 
of characteristic facial features, intellectual disability and early mortality (van den Boogaard 
et al., 2017; Vukic and Daxinger, 2019; Weemaes et al., 2013). Whereas the most common 
mutations found in ICF are associated with DNMT3B catalytic activity, 12 cases each have 
been described for CDCA7 and LSH (Thijssen et al., 2015). LSH and CDCA7 mutations are also 
associated with a subset of ICF patients demonstrating α-satellite repeat hypomethylation 
but not subtelomeric repeats (Hu et al., 2019; Toubiana et al., 2018).  
Interestingly, other chromatin remodellers have also been linked to B cell and neuronal 
development. Chd4 of the Nucleosome Remodeling and Deacetylase (NuRD) complex was 
shown to be crucial for B cell progenitor maturation and is likely to direct their lineage 
transcription programme through chromatin accessibility, preventing spurious expression of 
other cell types (Arends et al., 2019). Chd4 was found to regulate B cell development at the 
gene expression level and Chd4 loss was abolished pre-B cell population but did not appear 
to affect survival of mature B cells (Yen et al., 2019).  
Mutations in the ATPase domain of Chd3 resulted in decreased chromatin remodelling 
activity in vitro and manifested in neurodevelopmental impairment and patients with 
intellectual disabilities and facial anomalies (Blok et al., 2018). An additional mutation 
manifesting in this phenotype, but not disrupting the ATPase domain of Chd3, was also 
present in yeast Snf2 (W1158 in both Chd1 and Snf2) (Liu et al., 2017a). In murine LSH this 
residue (W679) is also conserved and is located two residues away from Q682R implicated in 
ICF syndrome (Q682) (see Section 3.2) indicating a possible common mechanism in 
chromatin remodelling. Similarly, mutations across Chd1 protein (including its ATPase and 
DNA-binding domains) were found in a neurological syndrome with facial dysmorphic 
features (Pilarowski et al., 2018).  
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Additionally, Brahma SWI/SNF through its chromatin remodelling activity was shown to 
provide enhanced accessibility to CSL transcription factor (Pillidge and Bray, 2019), which is 
a part of the Notch signalling pathway implicated in a variety of developmental processes, 
including neuronal development (Gaiano and Fishell, 2002) and T cell lineage progression 
(Laky et al., 2015). Taken together these findings reinforce the role of LSH-mediated 
chromatin remodelling in immunological and neuronal syndromes and can potentially shed 
more light on the mechanism of LSH impairment.  
Dissection of the causes of ICF syndrome are complicated by the participation of each 
implicated protein in a range of processes not associated with de novo DNA methylation. For 
instance, LSH has also been found to interact with the maintenance DNA methyltransferase 
DNMT1 in vitro (Dunican et al., 2013). Another ICF implicated zinc finger protein ZBTB24 
(~30% of all cases) is a positive regulator of CDCA7 expression (Wu et al., 2016b) through it 
C2H2 zinc finger motifs (Aktar et al., 2019; Ren et al., 2019). ZBTB24-CDCA7 axis was found 
to be important for survival of T cells (Qin et al., 2019), providing another link between these 
proteins and immunodeficiency. 
Potentially, LSH may link the ICF phenotype not with DNA methylation but with its role in 
double-strand break (DSB) repair. LSH may be required for efficient DSB repair in the non-
homologues end joining (NHEJ) in class switch recombination mechanism for antibody 
generation in B cells. Inability of LSH to carry out its chromatin remodelling functions as well 
as impaired recruitment to chromatin by mutated CDCA7 can undermine remodelling or even 
remodelling-independent recruitment of NHEJ proteins Ku70 and Ku80 (Unoki et al., 2018).  
From the work performed previously and in the scope of this study, it appears that LSH binds 
the nucleosome, and the interaction is predominantly through binding to DNA rather than 
the histone octamer, as LSH demonstrated a similar binding pattern (as indicated by the 
EMSA experiments) between free DNA and a mononucleosome. LSH is likely to bind to the 
mononucleosome via its ATPase domain, and the exact role of its N- and C-termini have yet 
to be elucidated. It is known that LSH required CDCA7 for recruitment to chromatin (Jenness 
et al. 2018). From the EMSA experiments performed in this study, it appears that LSH can 
bind DNA on its own, however, in the nuclear context this binding and retention of LSH on 
chromatin is likely to require additional partners, such as CDCA7. It is feasible to suggest that 
LSH adopts the conformation poised for catalysis only in the presence of CDCA7.  
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Sequence examination and ab initio modelling of CDCA7 confirmed that is possesses a zinc 
finger domain likely of a non-classical type. Previous studies indicated that it is a RING zinc 
finger, however, even though a characteristic cross-brace conformation is not present in 
CDCA7 models according to the ab initio models, it is not clear whether CDCA7 indeed binds 
DNA or this interaction is artefactual, since RING zinc fingers predominantly interact with 
proteins not nucleic acids. Experiments with protein truncations would be required to 
elucidate that. For example, LSH with truncated N- and/or C-terminus should be expressed 
to elucidate the role in the ATPase core in the DNA-binding EMSA experiments. Similarly, 
CDCA7 should be expressed in truncated versions, where the N-terminal part prior to the first 
predicted coiled coil and then the second coiled coil should be removed, which would allow 
to start with the DNA and LSH interaction experiments.  
Taken together, the homology modelling and biochemical findings from the present study 
indicate that there are several options for LSH interaction with the nucleosome and its 
subsequent role in chromatin remodelling and ICF syndrome. There are two parts in LSH 
remodelling activity: first, 1) it binds the nucleosome, then 2) it performs chromatin 
remodelling and allow other proteins perform their roles in chromatin metabolism. In the 
first step, 1.A) CDCA7 bind dsDNA in core nucleosome or linker DNA through its RING zinc 
finger domain and then through its coiled coils recruits LSH (Jenness et al., 2018), which then 
binds the nucleosome at SHL2 through its ATPase domain. This is consistent with the 
homology modelling data for LSH, showing that LSH is likely to interact with the nucleosome 
on SHL2 site (Fig. 8.1 A). However, it contradicts the in vitro binding experiments that 
indicated that LSH can bind the nucleosome on its own. It is more likely that LSH has a more 
independent binding more with the nucleosome, however, CDCA7 may induce 
conformational changes in LSH, which facilitate its remodelling activity.  
Alternatively, 1.B) LSH is constitutively present on the chromatin without requiring additional 
factors for binding (as indicated by my EMSA experiments showing that LSH can 
independently bind nucleosomes in vitro (Fig. 5.6 and 5.8) and as indicated by experiments 
in vivo (Kollarovic et al., 2018), bound at SHL2 or linker DNA through its ATPase domain, 
existing in an equilibrium of nucleosome-bound and apo state. It then recruits CDCA7, which 
binds LSH via its RING zinc finger, induces conformational changes in LSH and acts as a 
stabilising and positioning factor (Fig. 8.1 B), however, that is inconsistent with the findings 
from Jenness et al., which demonstrated that CDCA7 recruits LSH to chromatin (Jenness et 
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al., 2018). CDCA7 may be required to relocate LSH from an indiscriminate position anywhere 
on dsDNA to SHL2 specifically, which would be consistent with initial indiscriminate binding 
of LSH and its subsequent “recruitment” on SHL2 by CDCA7. Homology modelling (see 
Section 3.2) demonstrates the most likely positioning of LSH to be SHL2, however, it is unclear 
whether is locates there itself or is aided by another protein.  
 
Figure 8.1 Schematic diagram showing possible ways of LSH interaction with the nucleosome and CDCA7. A) 
CDCA7 initially binds to the nucleosome and recruits LSH to SHL2 site; B) LSH binds the nucleosome 
independently of other proteins, and then recruits CDCA7, that stabilises LSH on the nucleosome.  
 
Once bound to the nucleosome and adopted the correct position and/or conformation for 
remodelling, 2.A) LSH performs chromatin remodelling and also acts as a platform for 
recruiting other proteins, such as Ku70 and Ku80 (Unoki et al., 2018), end-resection 
machinery (Kollarovic et al., 2018), cohesin-assembly associated protein Scc1 (Rad21 in 
humans) (Litwin et al., 2017) or transcription factor E2F3 (von Eyss et al., 2012) (Fig. 8.2 A). 
All these functions can still be related to the chromatin remodelling activity of LSH, and their 
binding may be dependent on nucleosome-free regions exposed by LSH remodelling of 
chromatin.  
Alternatively or complementary to its assistance to the proteins not directly involved with 
DNA-methylatinon, 2.B) LSH performs chromatin remodelling to provide binding space to 
DNMT3B for de novo DNA methylation (Myant and Stancheva, 2008; Zhu et al., 2006) or 
DNMT1 for constitutive DNA methylation (Dunican et al., 2013) (Fig. 8.2 B). LSH, however, is 
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likely to play a redundant role in maintenance methylation. There can be further, more 
intricate mechanism, wherein LSH is displaced from chromatin by DNMTs, which induce its 
conformational change, or an LSH-CDCA7 complex acts as a platform for DNMTs binding, 
however, the experimental evidence for that is insufficient. In vitro binding assays can be 
used to test LSH interaction with DNA repair proteins, however, this is a more speculative 




Figure 8.2 Role of the nucleosome-bound LSH in chromatin metabolism. A) Following chromatin remodelling 
accelerated by CDCA7, LSH acts as a binding platform for the proteins involved in various chromatin-related 
activities or provides nucleosome-free areas for them; B) Nucleosome-free areas provided by LSH are targeted 




If CDCA7 ZFD participates in enhancing LSH ATPase activity not through DNA binding, but 
through its interaction with LSH, it is still unclear whether LSH binds DNA linker through its 
N- and/or C-terminal regions or does not interact with the linker at all. Unlike the remodellers 
that form regularly spaced nucleosomes, LSH does not have a DNA-binding domain, which 
was reflected in its ability to follow centre-to-end direction, rather than end-to-centre 
(Jenness et al., 2018). Experiments from Jenness et al. indicate that CDCA7 is likely to bind 
DNA and this way insure LSH remodelling activity, however, the exact binding mode and 
conformational changes of both proteins should be elucidated in further experiments.  
Experiments with a histone deacetylase (HDAC) inhibitor trichostatin A showed that its 
application abolished LSH association with chromatin (Yan et al., 2003). This indicates that 
LSH recognises acetylated chromatin and requires it for binding. To dissect this possibility, 
octamers with chemically modified histone tails can be produced carrying acetylation marks 
on various residues. These may involve active (H3K27ac, H3K9ac and H3K14ac) marks 
(Karmodiya et al., 2012). In vitro binding experiments, such as EMSA or surface plasmon 
resonance (SPR), with modified histone tails could demonstrate difference in affinity for 
differentially modified nucleosomes. However, a potential caveat with this system may be 
that LSH could be sensitive to these modifications in the nuclear context but not in vitro. 
Moreover, it is still unclear whether LSH requires CDCA7 for proper positioning, therefore, 
the LSH-histones interaction may be artefactual.  
CDCA7 is a highly disordered (> 60%) protein that has predicted coiled coil regions and a C-
terminal zinc finger domain. A number of DNA-binding proteins undergo conformation 
changes upon binding their nucleotide substrates and protein binding partners (Poddar et 
al., 2018). CDCA7 has been shown to tightly bind DNA, however, it is not clear whether this 
binding is specific. Utilising chemical crosslinking to CDCA7 in different states (semi-pure with 
nucleic acid contamination, free from nucleic acid contamination, incubated with LSH and/or 
NCP) would allow to gain insights into the possible range of its conformations. The caveat in 
this approach will be the disordered nature of CDCA7, which can potentially result in various 
captured contacts reflecting dynamic conformation of the protein.  
In the present study, I attempted to chemically crosslink LSH to the mononucleosome using 
BS3 and EDC+sulfo-NHS crosslinkers. Neither chemical resulted in a shift different from the 
LSH only control. One option could be to optimise LSH and NCP concentrations to detect the 
optimal binding conditions, since some binding was detected by EMSA.   
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Another option could be to set up a DNA-to-protein UV crosslinking (Flett et al., 2018). In this 
system, specific sites on free or nucleosomal DNA would be labelled with the 
photoactivatable nucleotide 5-Iodouracil (5IdU) and a 3′ biotin-TEG tag. These nucleotides 
are then covalently cross-linked to proximal aromatic amino acids using UV irradiation at 
312 nm. This system would allow to detect the direct binding to DNA, which is the most likely 
site of LSH contact.  
Gradient fixation method (Kastner et al., 2008; Stark 2010) is a common approach for 
stabilising molecular complexes in preparation for cryo-EM. Previously, I tried to capture LSH-
NCP complex by GraFix, however, LSH appeared to aggregate during centrifugation and could 
not be resolved on the gel. Even though in the present study, LSH-CDCA7 complex was not 
observed, it is worth trying to capture the LSH-CDCA7-NCP complex as presumably more 
stable, being a trimolecular remodelling entity. This approach would require optimisation of 
the fixative and centrifugation time and speed. If GraFix could be carried out, it would 
produce a stable complex for structural studies, which would reveal the orientations of LSH 
and CDCA7 in the nucleosome binding.  
Taken together, this work provided further insights into LSH interaction with the nucleosome, 
analysis of its binding partner CDCA7 and the approaches to their purification for biochemical 
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